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Abstract 
Over the last decade new psychoactive substances (NPS) flooded Europe and the challenging 
task for drug law enforcement is how to effectively respond to the dynamically and constantly 
changing drug market. NPS are regarded as legal alternatives to internationally controlled 
drugs of abuse. NPS are sold via the internet as, inter alia, “designer drugs”, “legal highs”, or 
“bath salts” in colourful and professionally designed packages mixed with herbal products or 
as pure powder. There is a persisting race between the legal prosecution and the producers of 
designer drugs as those strive to be one step ahead by rapidly generating new NPS products in 
reaction to new legislative measures. The rapid emergence of novel products means that 
developing and maintaining selective analytical methods and reference standards is 
challenging. Beside laboratory methods, the demand for portable analytics is high given the 
versatile distribution channels and the related particular risk for public institutions handling 
these products including postal delivery facilities, custom controls and prisons. 
In this thesis, new analytical methods were developed for the detection of synthetic 
cannabinoids and synthetic cathinones, the most frequently seized NPS subgroups. An ion 
mobility spectrometry (IMS) method was developed as an in-field alternative presumptive test 
for the non-destructive and selective detection of NPS in different matrices by wiping the 
surface of a sample with a swab. The suitability of the method for on-site analysis was 
demonstrated in a prison in Rhineland-Palatinate. The contactless and non-destructive 
detection of NPS was investigated using THz radiation for the first time.  
Fast characterisation of newly emerged and unknown substances was examined using portable 
and laboratory-based Raman spectrometers. Data analysis used a combination of a newly 
developed principal component analysis model and frequency tables. In addition, it was 
shown, that the analysis of herbal mixtures was possible using a simple solid/liquid extraction 
followed by precipitation of the synthetic cannabinoid constituents. New laboratory methods 
were developed to complement the screening techniques. The possibility to quantify NPS via 
the calibration curves of a small set of NPS, for which reference material is commercially 
available was demonstrated and validated via the analysis of seizures using ultra-performance 
liquid chromatography-diode array detection. Finally, capillary electrophoresis-diode array 
detection with a chiral selector was used for the chiral discrimination of NPS in the form of a 
general unknown screening method for mixtures and bulking agents on the one hand and a 
high throughput method for the fast analysis of single substances on the other hand. With the 
methods developed here, the analytical portfolio of NPS drug analysis was greatly expanded 
to meet the challenges of the dynamically and constantly changing drug market. All methods 
were successfully applied to real samples and partly in routine analysis in different criminal 
investigations offices and in public institutions (Wittlich prison). 
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Zusammenfassung 
Seit Jahren halten neue psychoaktive Substanzen (NPS) Einzug in den europäischen 
Drogenmarkt und stellen die Drogenpolitik vor große Herausforderungen. NPS werden meist 
über das Internet als "Designerdrogen", "Legal Highs" oder "Badesalze" verkauft und gelten 
als legale Alternative zu international kontrollierten Drogen. Die Produkte werden meist in 
bunten und professionell gestalteten Verpackungen vermarktet, entweder als reines Pulver 
oder auf bestimmten Matrizes wie Kräutermischungen. Es existiert ein Wettlauf zwischen 
dem In-Verkehr-Bringen immer neuer chemischer Varianten bekannter Stoffe und den 
anzupassenden strafrechtlichen Verfolgungen und die dynamische Verbreitung neuer NPS-
Produkte fordert die Entwicklung selektiver Analysemethoden und Referenzstandards. Neben 
dem Einsatz von laborbasierten Methoden wächst die Nachfrage an portablen 
Analysentechniken in öffentlichen Einrichtungen wie z.B. Postverteilerzentren, 
Zollkontrollstellen und Gefängnissen, die meist unwissentlich mit diesen Produkten in 
Kontakt kommen. Die hier vorgestellte Arbeit beschreibt die Entwicklung neuer Methoden 
für die Analyse von synthetischen Cannabinoiden und synthetischen Cathinonen, der zwei am 
häufigsten sichergestellten NPS-Substanzklassen. Ein alternativer Schnelltest für den 
zerstörungsfreien und selektiven Nachweis von NPS in unterschiedlichen Matrizes wurde 
mittels portablen Ionenmobilitätsspektrometrie entwickelt. Die Anwendung des Verfahrens 
wurde in einer rheinland-pfälzischen Justizvollzugsanstalt nachgewiesen. Außerdem wurde 
erstmals die berührungslose und zerstörungsfreie Analyse von NPS mittels THz-Strahlung 
diskutiert. Für die Anwendung portabler und laborbasierter Raman-Spektrometer wurde eine 
Referenzdatenbank, ein chemometrisches Hauptkomponenten-Modell und spezifische Raman 
Frequenztabellen entwickelt, die in ihrer Kombination eine schnelle und effektive 
Charakterisierung von bekannten, aber auch unbekannten Substanzen ermöglichen. Es wurden 
laborbasierte Techniken zur Identifizierung und Quantifizierung von synthetischen 
Cannabinoiden und Cathinonen entwickelt. Eine effiziente Quantifizierung von synthetischen 
Cannabinoiden mittels Hochleistungsflüssigkeitschromatographie- Diodenarray Detektion 
wurde anhand sichergestellter Asservate demonstriert und validiert, indem Kalibrierkurven 
eines definierten Satzes ausgewählter und kommerziell verfügbaren Referenzsubstanzen 
verwendet wurden. Zum anderen wurden ein Screening Verfahren und eine High-throughput-
Methode für die chirale Diskriminierung von synthetischen Cathinonen mittels 
Kapillarelektrophorese-Diodenarray-Detektion entwickelt. Mithilfe dieser Arbeit wurde das 
analytische Portfolio von Analysenmethoden für die Charakterisierung von NPS stark 
erweitert, um somit den Herausforderungen des dynamischen Drogenmarkts gerecht zu 
werden. Alle Methoden wurden erfolgreich an Realproben getestet und werden teilweise in 
der Routineanalytik in verschiedenen Kriminalämtern und in öffentlichen Einrichtungen 
(Gefängnis Wittlich) eingesetzt. 
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1 Introduction 
1.1 New psychoactive substances - a never ending-story 
The continuous emergence of new psychoactive substances (NPS) on the recreational and 
illicit drug market has challenged law enforcement, executive apparatus, public health 
authorities and forensic and toxicological laboratories. The substances are marked as 
purportedly “legal” alternatives to internationally controlled drugs under various names such 
as “designer drugs”, “legal highs”, “herbal highs”, “bath salts”, “research chemicals” or 
“laboratory reagents”.1 NPS have initially been designed to mimic established illicit drugs, 
such as cannabis, cocaine, amphetamine and LSD.
2,3
 The United Nations Office on Drugs and 
Crime (UNODC) established a clear terminology: “New psychoactive substances are 
substances of abuse, either in a pure form or a preparation, that are not controlled by the 1961 
Single Convention on Narcotic Drugs
4
 or the 1971 Convention on Psychotropic Substances,
5
 
but which may pose a public health threat. In this context, the term ‘new’ does not necessarily 
refer to new inventions but to substances that have recently become available”.6  
 
Figure 1-1 NPS subclasses
7
 
The word NPS compromises several substance classes which are summarised in Figure 1-1. 
Synthetic cannabinoids and synthetic cathinones represented 51 % and 24 % of the most 
frequently seized new psychoactive substances in 2017, followed by benzodiazepines with 
5 % and opioids with 2 %.
8
 These percentages challenge the legislative drug control 
authorities. In some European countries, only specific substances are listed in the drug law 
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6 
and even small modifications in the chemical structure of such listed substances already allow 
circumventing existing law.
9
 Consequently there is a race between the legal prosecution and 
the producers as those strive to be one step ahead by generating new NPS-products. The 
physiological and psychological effects they have in NPS-consumers are unpredictable and 
sometimes fatal as there is no information about the active drug given on the product label.
10-
12
 National or international commissioning and support are required, hence, the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) implemented an early warning 
system
13
 in the European Union under the terms of a Council Decision 2005/387/JHA
14
 to 
guarantee a rapid exchange of information and provide a risk assessment for new 
psychoactive substances. By the end of December 2018, the EMCDDA described more than 
700 new substances that have appeared on Europe’s drug market over the past 20 years.  
1.1.1 Synthetic cannabinoids 
Synthetic cannabinoids are the largest group of new substances monitored by the EMCDDA 
and are becoming increasingly diverse with regard to their chemical structure. Synthetic 
cannabinoids were initially designed to mimic the effects of delta 9-tetrahydrocannabinol 
(THC) in cannabis products. Synthetic cannabinoids bind to the same cannabinoid receptors 
(CB1 and CB2) as THC which explains their psychotropic effects.
3
 The adverse events 
associated with synthetic cannabinoids include agitation and nausea and an abnormally fast, 
racing heartbeat. However, also serious adverse events were reported such as stroke, seizure, 
heart attack, breakdown of muscle tissue, kidney damage, psychosis and severe or prolonged 
vomiting and associated deaths.
15
 
 
Figure 1-2 Packaging materials of herbal mixtures 
The major manufacturers of the synthetic cannabinoids are chemical companies based in 
China.
16
 Substances are shipped as bulk powders to Europe using express mail and courier 
companies or air and sea cargo.
15
 Then, in Europe, synthetic cannabinoid powders are 
dissolved in a solvent such as acetone and sprayed onto the surface of dried plant material 
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7 
upon stirring. The solvent is evaporated while a thin coating of synthetic cannabinoid is 
deposited.
2
 Damiana (Turnera diffusa) and Lamiaceae herbs such as Melissa, Mentha and 
Thymus are commonly used as the plant base.
15,16
 Herbal mixtures are sold in colourful and 
professionally designed packages as substitutes for cannabis with misleading product 
descriptions such as “herbal incense” (see Figure 1-2).16,17 Due to the high potency of some 
synthetic cannabinoids, the amount of powder needed for each packet can be in the order of a 
few tens of milligrams. Synthetic cannabinoids have four major structural elements: tail, core, 
linker and linked group (see Figure 1-3). Common core groups are indole, indazole, 
carbazoles, azaindoles and gamma-carbolines. The structural variability leads to different 
synthesis routes of synthetic cannabinoids. For example, aminoalkylindoles are synthesised 
via Friedel-Crafts acylation at C3 followed by N-alkylation of a (substituted) indole 
represents and common precursors are 1-alkylindoles and 1-alkyl-2-methylindoles (alkyl: 
butyl, pentyl, hexyl or others, halogenated if applicable) or 1-naphthoyl chlorides (e.g. 
substituted at C4).
2
  
In most cases the nomenclature is related to the components of the chemical structure which 
allows to identify a synthetic cannabinoid without knowing the IUPAC name. The proposed 
naming syntax follows the rule: LinkedGroup-Tail-Core-Linker. In Figure 1-3, the name AB-
CHMINACA is an abbreviation from its chemical name: N-[(2S)-1-amino-3-methyl-1-
oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide.  
 
Figure 1-3 Structural elements of synthetic cannabinoids including the core, a linker, its linked group and the 
tail, exemplified for AB-CHMINACA 
Some synthetic cannabinoids were named according to their inventors, e.g. “JWH” after John 
W. Huffman or “AM” after Alexandros Makriyannis. Alternatively, the institution or 
company where they were first synthesised like ‘HU’ series of synthetic cannabinoids being 
from the Hebrew University in Jerusalem, or ‘CP’ from Carl Pfizer. Some names follow 
marketing strategies like AKB-48, which is the name of a popular Japanese girl band, or 
XLR-11, which was named after the first liquid fuel rocket developed in the USA.
15
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1.1.2 Synthetic cathinone derivatives 
Synthetic cathinone derivatives are chemically related to cathinone, the major active 
ingredient in the Khat plant.
18
 Synthetic cathinone derivatives are members of the 
phenethylamine family, which also includes amphetamine and methamphetamine. The 
essential distinctive characteristic for synthetic cathinone derivatives is the presence of a β-
keto group at the side chain of the phenethylamine (see Figure 1-4). Typically, synthetic 
cathinone derivatives are amphetamine type analogues, i.e. cathinone, ephedrone, and 
methylone are structurally related to amphetamine, methamphetamine and MDMA (3,4-
Methylenedioxymethamphetamine), respectively, and thus show similar stimulant effects to 
common illicit drugs.
19
  
a)     b)    c) 
   
Figure 1-4 General chemical structures of a) phenethylamines, b) general structure of cathinones, and c) the 
synthetic cathinone methylone 
Thus, stimulation of the central nervous system via effects on the levels and action of 
neurotransmitters such as serotonin, dopamine and noradrenaline was reported.
19-22
 Many 
synthetic cathinone derivatives have a single chiral centre and thus exist in two enantiomeric 
forms with differing potencies.
23
 Synthetic cathinone derivatives show a variety of 
behavioural effects including cardiac, psychiatric, and neurological signs,
20
 but also 
short-term adverse effects were reported including loss of appetite, blurred vision, anxiety, 
post-use depression, confusion, hallucinations, short-term psychosis and mania.
24,25
 
Intoxication by synthetic cathinones derivatives may also lead to severe adverse effects, 
including acute liver failure, acute kidney injury, high blood pressure and tremor.
26
 In contrast 
to synthetic cannabinoids, synthetic cathinones derivatives are usually marketed as powder, in 
pill or capsule form and sold as “research chemicals” or “bath salts”. Most synthetic 
cathinones derivatives appearing on the European market were synthesised outside Europe, 
with China and, to a lesser extent, India identified as the primary sources.
27
 
The synthesis of synthetic cathinone derivatives is analogous to the manufacture of 
amphetamine and MDMA-related substances including 1) reductive amination and 2) the 
Leuckart reaction, both with an aromatic ketone as precursor, 3) the use of aromatic aldehydes 
under Knoevenagel conditions
28
 and 4) the oxidation of the readily available pharmaceuticals 
pseudoephedrine and ephedrine.
27,29
 The routes 1) and 2) are the most common production 
processes found in clandestine laboratories. Here, the precursors like ketones contain a 
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stereogenic center at the ß-carbon of the ketone structure.
5,30
 In 1929, Saem de Burnaga 
Sanchez published a synthetic strategy for mephedrone as the first synthetic cathinone 
derivative starting with 1­tolylpropan­1­one as precursor, which was α­brominated and then 
reacted with methylamine to produce racemic 4-methylmethcathinone.
31
 Today, almost all 
synthetic cathinone derivatives exist as racemic mixtures.
26
 Synthetic cathinone derivatives 
are taken by insufflation, orally or, less common, via injection.  
1.2 NPS analytics - a challenging task in Forensic Science 
From an analytical point of view, the constantly changing availability of new substances 
poses the challenge to develop new methods and techniques for the identification and 
quantification of NPS, partly in mixtures and/or different matrices. Beside the characterisation 
of substances, quantification of samples is essential to determine the active ingredient content 
relevant for prosecution. The demand for both laboratory-based and portable analytical 
techniques is constantly increasing. The emergence of new drugs has created a need for 
reference material in order to verify their identification and especially to enable their 
quantification by routine laboratory methods such as HPLC. The in-house production of 
reference material entails capital investment, running costs, as well as operation of advanced 
analytical instruments and data interpretation.
32
 Therefore, analytical data for various recently 
launched NPS are lacking which impedes the analysis of casework samples. Reference 
spectral libraries should constantly be updated to keep up with the vast variety of substances 
available. Only a few techniques are able to identify a substance without a reference standard 
e.g. nuclear magnetic resonance (NMR) and mass spectrometry (MS). In addition, NMR is an 
absolute method and therefore suitable for the quantification of substances. 
A special problem, when no reference material is available, is the correct identification of 
positional isomers or enantiomers, which has been recognized to be of increasing relevance. 
This is due to the fact that their effects on humans are different and the level of legal penalties 
conforms to a specific isomer which is listed in drug laws. This also holds true for e.g. mass 
spectrometric analysis.
33
 A particular challenge lies in the analysis of synthetic cannabinoids, 
as they are often added to herbal mixtures. Here, the strategy for analysis is different to 
classical herbal drugs such as cannabis or drugs in other processed forms such as heroin, 
cocaine and amphetamine-type-stimulants: special sample preparation techniques or analytic 
techniques without any further extraction process have to be designed to guarantee a simple 
and fast analysis of seized samples. Sufficiently sensitive methods are necessary due to the 
low concentrations (typically 5-30 mg/g) in the herbal matrix with possible interferences from 
matrix constituents.
2
 In case of synthetic cathinone derivatives, the presence of bulking agents 
and extenders has to be taken into account already during method development. The 
following chapters provide insight into the current state of technology of NPS analytics.  
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1.2.1 Presumptive tests 
The demand for rapid drug detection by police, customs, federal armed forces, prisons and 
other public institutions is growing.
34
 However, the applicability of rapid drug testing for NPS 
is limited. In general, to uncover drug trafficking the police uses relatively simple 
presumptive tests with colour coding for specific drugs. 
 
Figure 1-5 Typical police roadside presumptive tests used in Rhineland- Palatinate 
Usually the Duquenois–Levine colour test is used for classical cannabinoids such as THC and 
the van Urk colour test is used for indole-containing drugs of abuse. However, both colour 
tests show negative results in the identification of synthetic cannabinoids. Isaac et al. tested an 
alternative colour test reagent, 2,4-dinitrophenylhydrazine, which reacts with a keto moiety. 
Therefore, it is capable of reacting with synthetic cannabinoids, such as the naphthoylindole, 
phenylacetylindole, benzoylindole, and cyclopropylindole classes. The analysis was carried 
out with substances either in powders or adsorbed onto plant material. No limits of detection 
(LOD) was given in the article, the solution tested contained at least 10 mg of synthetic 
cannabinoid powder suspended in 1 mL methanol.
35
 Moreover, synthetic cannabinoids which 
do not contain a ketone did not react. Two further colour tests commonly applied are the 
Marquis test, which reacts with all nitrogen-containing drugs, and the Dragendorff test, which 
is positive for the JWH series. In addition, fast blue BB (4-benzamido-2,5-diethoxybenzene 
diazonium chloride hemi zinc salt) reacts with cyclohexylphenols.
36
 
The colour coding detection of synthetic cathinone derivatives differs from that of synthetic 
cannabinoids. The Marquis reagent, which reacts with all nitrogen-containing drugs, is 
negative for cathinones without substituents or having only a methyl-substitution at the 
benzene ring like in cathinone itself and in mephedrone. For synthetic cathinone derivatives 
with a methylenedioxy moiety, the test also gives positive results. LODs are not reported. 
Thus, generally the combination of more than one reagent is required including Marquis, 
Ehrlich, Simon, Lieberman-Burehand, and Mandelin reagents to detect synthetic cathinone 
derivatives in samples.
37-39
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In addition to colour coding tests, immunoassays based on an antibody-antigen interaction are 
applied. Some commercially available immunoassay kits have been developed for the 
detection of specific synthetic cannabinoids like the JWH-type substances in urine, available 
on the drug market for a rather long time now.
40
 Every emerging synthetic cannabinoid would 
require a new and rather time-consuming development of a specified immunoassay.  
No commercial immunoassay is available for synthetic cathinone derivatives. Some 
researchers studied the detection of synthetic cathinones in urine using immunoassay 
technology,
41,42
 but some of them obtained false-positive results. For example, MDPV 
(methylenedioxypyrovalerone) showed cross reactivity with phencyclidine.
43
  
Thin layer chromatography (TLC) is a technique commonly used for the separation and 
identification of illicit drugs in the laboratory and is not part of the portable analytical 
techniques portfolio. The identification is possible via the retention factor in comparison to 
reference standards, which have to be available. 
Commonly, dissolved powders or extracts of herbal mixtures are prepared at a concentration 
of approximately 1 mg/mL in methanol. Afterwards 1 µL spots, 2 µL of the standard solutions 
and 2 µL of solvent (as a negative control) are applied on the TLC plate.
2,27
 In some 
publications, retention factors for NPS were determined.
2,27,36,44
 Logan et al. described the 
limitations of this technique due to the fact that many of the standards give the same 
responses (Rf and colour) with multiple visualisation techniques, differentiation based on 
TLC was not always possible and complementary analytical techniques were necessary for 
identification.
44
  
In conclusion, it is possible to detect synthetic cannabinoids and synthetic cathinone 
derivatives with portable techniques including different reagents or immunoassays but these 
test show significant limitations: They are unspecific. Possible cross reactivities with other 
substances including plant materials, flavours or bulking agents were not discussed in detail. 
The strongest limitation, however, stems from the great variety in the chemical structure 
within the substance class of the synthetic cannabinoids caused by the increasing NPS-
market. This would require the constant production of new rapid drug tests. To conclude, 
most presumptive tests are unspecific and not suitable for the high number of emerging NPS. 
In Chapter 2, ion mobility spectrometry will be introduced as an alternative presumptive test 
with substance specific parameters including drift time and reduced ion mobility. The good 
resolution and separation efficiency give rise to selectivity high enough to identify most NPS 
commonly on the market despite the presence of complex matrices. 
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1.2.2 Optical spectroscopy 
According to the recommendations of the scientific working group for the analysis of seized 
drugs (SWGDRUG), spectroscopic methods like NMR, Raman and Infrared (IR) 
spectroscopy as well as mass spectrometry are category A analytical techniques with 
maximum discriminating power.
45
 In recent years, NMR spectroscopy has also been used for 
the characterisation of NPS in herbal mixtures or powders to achieve unambiguous structural 
elucidation and determine the purity of unknown compounds in seizures.
46-58
 Thus, NMR is a 
powerful method to provide structural information necessary for the large number of 
emerging and structurally related NPS. The complete functional group assignment of a 
molecule can be achieved using NMR experiments involving 1-dimensional proton (
1
H) and 
carbon (
13
C) spectra and a combination of 2-dimensional correlation experiments including 
NOESY (Nuclear Overhauser Effect Spectroscopy), and HMQC (Heteronuclear 
Multiple-Quantum Correlation).
27
 
1
H-NMR is also very useful for the discrimination of 
regioisomers: Para-substituted aromatic molecules show different splitting patterns than ortho 
or meta substituted aromatic ring systems. In contrast, it is difficult to discriminate between 
ortho and meta substituted aromatic substance without further complementary experiments.
27
  
The analysis of challenging matrices was described in several publications including the use 
of preparative LC or preparative TLC to purify the target, which is then analysed by NMR 
spectroscopy.
54-58
 Major disadvantages of this technique are its costs and the required 
technical expertise, which lead to a limited applicability in routine analysis.
2
 
In the field of portable analytics, spectroscopic methods like IR- and Raman spectroscopy are 
the techniques of choice for rapid analysis of NPS as several manufacturers produce handheld 
or portable IR and Raman devices for the direct on-site analysis of substances.
59-61
  
In contrast to presumptive tests, these techniques allow compound identification via spectral 
fingerprinting. For structure elucidation of unknown compounds, Raman and IR spectroscopy 
would be very useful to differentiate isomers when it is not possible using ion trap techniques 
(MS
n
). One disadvantage is the difficulty in analysing synthetic cannabinoids in different 
interfering matrices like herbal mixtures, papers or tobaccos. IR-spectroscopy is more 
sensitive than Raman spectroscopy and with a further extraction step with methanol or 
acetone, it is possible to obtain a good IR spectrum after evaporating the extract directly on 
the ATR (attenuated total reflection) diamond cell.
2,62,63
 Pure powders or liquids can be 
analysed directly provided that there is a relative high concentration of the active ingredient in 
the sample. In recent years, Raman spectroscopy has been increasingly applied for the 
analysis of different illicit drugs including barbiturates,
64-66
 benzodiazepines,
66,67
 cocaine,
66,68-
75
 amphetamine,
71,72,74,76,77
 MDMA,
66,71,72,75,78,79
 methamphetamine,
66,77,80,81
 2,5-dimethoxy-4-
bromoamphetamine,
82
 ketamine,
72
 morphine,
83
 codeine,
83
 hydrocodone,
83
 heroin,
66,74,75
 and 
THC.
75
 In case of NPS analytics, publications are limited to specific focal points.
59,75,77,84-96
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One focus is the characterisation of NPS using different portable or benchtop Raman 
spectrometer at different wavelengths (785 and 1064 nm).
59,84,86,90,93,96
 Comparison of the 
Raman spectra generated by different Raman spectrometers or different operating conditions 
were evaluated using instruments` in-built algorithms to determine the Hit quality index 
(HQI)
86
 or dissimilarity calculations.
85
 These studies aimed at constructing and validating 
spectral libraries to guarantee a possible transfer of those databases to other (portable) Raman 
spectrometers, sometimes using chemometric models, especially principal component 
analysis (PCA).
84,85,88,91
 Another focal point represents the method development and 
application of surface enhanced Raman spectroscopy (SERS) for the trace analysis of NPS 
taking advantage of the reduced fluorescence in bulk samples.
92-94
 
The identification power of spectroscopic methods depends on the actuality and quality of the 
reference libraries. The analysis of unknown substances that are not (yet) present in the 
reference library is challenging. Until now, only two publications concentrate on the structural 
characterisation and interpretation of specific Raman bands in spectra of NPS.
89,95
 Christie et 
al. described the differences of specific vibrations for regioisomers of synthetic cathinone 
derivatives
89
 and Lobo et al. described Raman bands of 5F-AMB (methyl (2S)-2-[(1-(5-
fluoropentyl)-1H-indazol-3-yl)formamido]-3-methylbutanoate) with a detailed table for all 
possible vibrational modes.
95
 In addition, PCA models focused on the discrimination of 
substance classes but not on the distinction of substances within one substance class. The 
combination of frequency tables with PCA models can provide a lot of information to 
characterise even unknown samples. 
In Chapter 3, the analysis of NPS using different Raman spectrometers with different 
operating conditions was evaluated. The focus is on the question if it is possible to use only 
one reference library which is then transferred to different portable Raman spectrometers? To 
answer this question, instrument in-built correlation algorithms and different pre-processing 
methods were tested. A PCA model together with new vibration frequency tables allows 
characterising unknown substances within different substance classes. 
The demand for contactless analysis through packaging material or containers is rising. 
Therefore, another spectroscopic technique is discussed in Chapter 4: THz spectroscopy. For 
drug analysis, the use of the THz technology is not widespread and is currently limited to the 
detection of classical drugs. For NPS analytics, there are no publications and experimental 
data about the application of THz radiation. In this work a novel approach in case of 
uncovering drug trafficking was discussed: the detection of synthetic cannabinoids in postal 
packages using THz spectroscopy.  
In contrast to the spectroscopic techniques presented above, UV/VIS spectroscopy is 
classified as category B analytical technique by SWGDRUG. Here the identification strength 
is lower in comparison to NMR, IR, Raman or Mass spectroscopy due to the fact that only the 
UV or VIS absorbance of a substance is measured which results in a broad band. Therefore 
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UV/VIS spectroscopy is used in combination with other chromatographic techniques. In 
Chapter 5, the quantification of synthetic cannabinoids is presented and in this context, the 
UV-spectra of several synthetic cannabinoids are discussed.  
1.2.3 Separation Techniques 
For the qualitative and quantitative analysis of NPS in laboratories, chromatographic 
techniques coupled to mass spectrometry are the most common methods used in routine 
forensic laboratories.
97
 Gas chromatography-mass spectrometry is the most widely applied 
method for a general unknown screening or systematic toxicological analyses either in clinical 
or forensic toxicology.
98
 Substances that are appropriate for GC with interfaces for electron or 
chemical ionisation were analysed either per se or after derivatisation. GC-MS analysis 
affords sample clean-up and purification of the analytes due to the fact that only organic 
extracts can be injected. Sample preparation is simple and more or less identical in nearly all 
publications: Powdered samples and samples in herbal mixtures are dissolved/suspended in an 
organic solvent e.g. methanol or ethanol (approximately 1 mg/mL analyte concentration) 
under ultrasonication for 10 min. After centrifugation, the solution is filtered and directly 
measured using GC-MS.
99,100
 Many studies deal with the identification of both synthetic 
cannabinoids
36,44,54-58,62,100-107
 and synthetic cathinone derivatives 
47,108-114
 as pure substances 
or in different matrices by GC-MS. One major limitation is that some analytes are heat-
unstable and may thus be degraded already in the injection port of the GC-instrument. This is 
the case especially for cyclopropyl or ester analoga like UR-144 or QUPIC. The reported 
LODs for GC-MS analysis of NPS range from 0.5–1.0 mg/L.100  
Synthetic cannabinoids
101,115-132
 and synthetic cathinone derivatives
111,114,133-136
 have also been 
analysed by LC-MS with the advantage of a higher matrix tolerance. The ability to inject 
aqueous samples makes the method suitable for a rapid, high throughput screening application 
(dilute and shoot). In most cases, the publications concentrate on the analysis of synthetic 
cannabinoids and synthetic cathinone derivatives in biological materials including oral fluid, 
urine, blood, serum and hair as, summarised by Namera et al.
137
 Only a few publications deal 
with the analysis of powders or herbal mixtures using LC.
47,114,133,138-141
 Sample preparation 
steps for powders and herbal mixtures are similar to those for GC-MS analysis. The LODs 
obtained by LC-MS ranged from 2 ng/mL to 10 µg/mL with analysis times between 8 and 15 
min.  
In the field of NPS analytics, well-studied MS fragmentation pathways of synthetic cathinone 
derivatives
36,101,111-114,133,142
 and synthetic cannabinoids 
36,44,54-58,100-102,143
 were studied and 
together with retention times allow identification of the analyte, especially when reference 
standards are available. 
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For unambiguous identification, GC-MS and LC-MS analysis depend on the availability of 
reference standards and the establishment of a reference library. In general, quantification of 
substances efforts time consuming calibration or a validation performances and the presence 
of reference standards independent of the applied analytical technique. At present, there are 
no alternatives published for fast and effective quantification of NPS independent of the 
availability of reference standard (except NMR analysis). 
In Chapter 5, a quantitative screening method of synthetic cannabinoids is presented using 
UPLC-DAD with maximal retention times of 10 min. Here, the need for reference standards 
is lowered by evaluating cross calibration possibilities between different structurally related 
synthetic cannabinoids. 
1.2.4 Chiral analysis  
The chiral discrimination and the availability of stereoselective analytical methods gain in 
importance in medicinal chemistry, and forensic toxicology. In some cases, the level of 
penalties conforms to a specific enantiomer which is listed in drug laws. Synthetic cathinone 
derivatives have chiral centres; and the R and S enantiomers show significant differences in 
their pharmacodynamic activity and their pharmacokinetic properties due to differences in 
their affinity or intrinsic activity at receptor sites.
144,145
 Thus, the need for screening methods 
to investigate the chirality of unknown samples as well as the fast analysis of a large number 
of NPS samples is increasing.  
The most common technique for chiral investigation is HPLC-UV with chiral stationary 
phases
146-152
 or an achiral stationary phase with cyclodextrins (CDs) added to the mobile 
phase.
153
 The use of GC-MS for chiral analysis of synthetic cathinone derivatives separating 
diastereomers after derivatisation with chiral trifluoroacetyl-L-prolyl chloride
154-156
 or α-
methoxy-α-trifluoromethylphenylacetic acid150 is rather time-consuming.  
An alternative are capillary electrophoresis (CE-DAD or CE-MS) methods. The most 
common chiral selectors employed for the CE enantiomeric separations of low-molecular 
weight organic compounds are cyclodextrins. Especially the enantioselective separation of 
synthetic cathinone derivatives using capillary electrophoresis (CE-DAD or CE-MS) in 
combination with different CDs as chiral selector were published including ß-CD,
157,158
 highly 
sulphated-ß-CD (HS-ß-CD),
154,159
 highly sulphated-y-CD (HS-y-CD).
160
 In general, several 
alternative chiral selectors have been employed in chiral CE like crown ethers
161,162
, 
proteins
163
, or polysachcharides
164
. In literature, the application of those chiral selectors for 
the analysis of cathinone derivatives is only described in connection with capillary 
electrochromatography with chiral stationary phases. Each of these non-CD selectors has 
decisive limitations compared to CDs: Crown ethers demand a separation electrolyte free of 
potassium or ammonium ions because they compete with the enantiomers for the cavity. This 
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increases requirements on the purity and composition of electrolyte systems and limits some 
applications. Low separation efficiency, adsorption to the capillary wall and high UV 
absorption were observed for the use of proteins as chiral selector.
165,166
 Linear and positively 
charged polysaccharides show low solubility and adsorption to the inner surface of the 
capillary.
167
 
The simultaneous analysis of a large number (< 12) of newly emerged NPS with and without 
bulking agents has not been discussed in literature. In Chapter 6, an effective and fast chiral 
screening method and a high-throughput method for the large number of 36 newly emerged 
synthetic cathinone derivatives is presented. The utility of this approach is demonstrated by 
the successful analysis of seized samples containing bulking agents.  
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2 Ion mobility spectrometry as a fast screening tool 
for synthetic cannabinoids to uncover drug 
trafficking in jail via herbal mixtures, paper, food, 
and cosmetics 
2.1 Abstract 
The greatest challenge for European drug policies is how to effectively respond to the 
dynamic and constantly changing market for new psychoactive substances (NPS). Even small 
modifications in the chemical structure of substances often allow circumventing existing laws. 
Also in prison, the consumption of NPS is rising and there is growing evidence that NPS are 
responsible for a large share of drug-related problems. Ion mobility spectrometry (IMS) is the 
technique of choice for trace analysis of illicit drugs or explosives at security points e.g. 
airports. Currently, databases of the reduced mobility (K0) values are limited to classical 
drugs and should be completed with data of emerging NPS. In this paper, K0-values, LODs 
(0.7-3.6 ng) and drift times of 25 synthetic cannabinoids were evaluated. The data were added 
to existing databases of IMS which were then applied for fast screening in prison. The 
detection capability of the portable IMS technique was evaluated by the determination of 
intraday (0.089 %) and interday precision (0.004 to 0.14 %), systematic error (0.19 %) and 
separation capability for structurally related NPS. The applicability of the methodology was 
demonstrated by the successful analysis of 12 different pieces of paper impregnated with 
synthetic cannabinoids, 7 different cosmetics and 5 food samples (liquids), spiked with a 
mixture of narcotic drugs and a synthetic cannabinoid. In addition, 14 herbal mixtures and 36 
different casework samples from prisons were analyzed provided by the State Office of 
Criminal Investigation Rhineland-Palatinate (Germany).  
2.2 Introduction  
Over the last decade a new generation of drugs flooded Europe and the challenging task for 
drug policies is how to effectively respond to the dynamic and constantly changing drug 
market.
168
 The substances are known as “designer drugs”, “legal highs”, “herbal highs”, “bath 
salts”, “research chemicals” or “laboratory reagents”.1 They are sold via internet in 
specialized shops in colorful and professionally designed packages of herbal products or of 
pure powder.
16,17
 The United Nations Office on Drugs and Crime (UNODC) established a 
clear terminology: “New psychoactive substances are substances of abuse, either in a pure 
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form or a preparation, that are not controlled by the 1961 Single Convention on Narcotic 
Drugs 
4
 or the 1971 Convention on Psychotropic Substances,
5
 but which may pose a public 
health threat. In this context, the term ‘new’ does not necessarily refer to new inventions but 
to substances that have recently become available”.6 
These NPS have initially been designed to mimic established illicit drugs, such as cannabis, 
cocaine, amphetamine and LSD.
2,3
 In reality, the effects for NPS-consumers are unpredictable 
and sometimes fatal
10-12
 as there is no information about the active drug given on the product 
label. In some European countries, only specific substances are listed in the drug law and 
even small modifications in the chemical structure of such listed substances already allow 
circumventing existing law.
9
 There is a race between the legal prosecution and the producers 
as those strive to be one step ahead by generating new NPS-products. The rapid emergence of 
novel products means that developing supportive health intervention responses is 
challenging.
7
 The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
implemented an early warning system
13
 in the European Union under the terms of a Council 
Decision 2005/387/JHA
14
 to guarantee a rapid exchange of information and provide a risk 
assessment on new psychoactive substances. By the end of December 2017, the EMCDDA 
described more than 670 new substances that have appeared on Europe’s drug market over the 
past 20 years. In 2015 alone, there was an increase of NPS types by 25 % in comparison to 
2014.
169
 
The use of NPS in prison settings is developing rapidly. There is growing evidence that NPS 
are responsible for a large share of drug-related problems in some European prisons and 
appropriate responses are mostly lacking.
7,170
 In 2017, the EMCDDA carried out a target 
rapid information assessment between August and December 2017 for 22 European countries 
to understand the prevalence and patterns of NPS use and to analyze NPS-related problems in 
prison settings.
170
 The study discovered that synthetic cannabinoids are the most common 
NPS followed by synthetic cathinone derivatives. In the study presented here, the focus is on 
the analysis of synthetic cannabinoids. The supply routes range from the “throw-over“-
method
170
 of drugs over the prison wall to the manipulation of common foods with drugs. 
Another method for bringing NPS into prison was identified: the abuse of mail service. For 
this, the NPS are dissolved in a solvent such as acetone and sprayed onto a piece of paper, 
tobacco or textiles and sent as a postal package or letter to the prison. In most cases, the 
potential carrier substances are reduced to small pieces and then smoked or swallowed. The 
wide range of physical and mental health harms caused by the consumption of NPS
10
 also 
provides a challenge to prison officers.
171
 For an early and easy detection of NPS, there is a 
great demand for mobile techniques. They are inevitable to detect potential NPS in order to 
avoid their penetration into the prison.  
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From an analytical point of view the choice of rapid drug tests for NPS is limited, especially 
for synthetic cannabinoids.
172,173
 However, the demand for rapid drug detection for Police, 
customs, Federal armed forces and prisons is growing.
34
 
In general, to uncover drug trafficking the police uses relatively simple presumptive tests with 
color coding for specific drugs. In addition, immunoassays based on an antibody-antigen 
(drug) interaction are applied. These tests are commercially available for classical drugs like 
tetrahydrocannabinol, cocaine, amphetamine, lysergic acid diethylamide, heroin, 
buprenorphine, ephedrine, γ-hydroxybutyric acid, methamphetamine, MDMA, methadone, 
and ketamine. In most cases, test kits are used for the analysis of oral fluid
174
 and urine
40,175
 
samples. However, they are not suitable for the detection of synthetic cannabinoids
176
 due to 
the normally low concentration of the analytes in herbal mixtures and possible interferences 
by the sample matrix.
2
 Moreover, the differences in the chemical structure within the 
substance class of the synthetic cannabinoids caused by increasing NPS-market would require 
the constant production of new rapid drug tests.  
Currently, mobile spectroscopic techniques like Infrared- and Raman spectroscopy are the 
techniques of choice for rapid characterization of synthetic cannabinoids.
59-61
 In contrast to 
preliminary tests, these techniques allow compound identification. One disadvantage of these 
spectroscopic techniques is the difficulty in analysing synthetic cannbinoids in different 
interfering matrices like herbal mixtures, papers or tobaccos. A sample preparation step is 
required. In most cases the different matrices were dissolved in alcohols like methanol or 
acetone.
2,62,63
 Pure powders or liquids can be analyzed directly provided that there is a relative 
high concentration of the active ingredient in the sample matrix.  
For the qualitative and quantitative analysis of NPS in laboratories, chromatographic 
techniques coupled to mass spectrometry are the most common methods used in routine 
forensic laboratories. There are many studies dealing with the identification of NPS in 
different matrices with the help of gas chromatography-mass spectrometry
47,108-110
 and liquid 
chromatography-mass spectrometry.
123,134-136
 The sample preparation has to be adapted to the 
specific matrices but for herbal mixtures or powders, the samples are mostly suspended in 
alcohol.
2
 In the last few years, nuclear magnetic resonance spectroscopy (NMR) has also been 
used for the characterization of NPS in herbal mixtures or powders.
46-53
 It is a fast technique 
which allows unambiguous structural elucidation of unknown compounds. Disadvantages of 
this technique are the cost of NMR spectroscopy and the technical expertise required which 
leads to a limited applicability in routine analysis.
2
 
Ion mobility spectrometry (IMS) is a powerful analytical method that is used for trace 
analysis of organics. Due to its high sensitivity (ng-range), analytes can be detected in 
different matrices with hardly any sample preparation. The analytes are collected by wiping 
the surface of the sample with a teflon membrane (swab). The fast analysis times of less than 
10 s and the ease of sampling and handling allow applying mobile IMS at security points like 
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airports.
177,178
 The most common application of IMS is the detection of explosives and 
chemical warfare agents.
179-184
 In addition, there is a wide variety of analytical purposes 
including pharmaceutical applications (quality control,
185
 cleaning verification,
179,182,183
 
resolution of isomers
186-188
), environmental applications (air quality,
189,190
 water and liquid 
samples,
191-201
 solids and aerosols
202,203
), applications in the food and feed sector,
204-215
 
biomedical and clinical analyses (biomarkers in breath,
216-221
 urine,
222
 blood and serum,
223,224
 
lymph extracts
225
). Since 1990 IMS is frequently applied in forensic analysis. Especially for 
drug analysis, IMS proved to be very versatile and was applied for the analysis of classical 
drugs both in forensic science and forensic toxicology,
226-232
 the analysis of psilocin and 
psilocybin in mushrooms,
233
 the analysis of MDMA, MDEA, methamphetamine, cocaine and 
clenbuterol in hair samples,
234-236
 analysis of volatile drug markers of cocaine, MDMA and 
THC in air samples
237
 and the analysis of benzodiazepines.
238
 In the last few years, a number 
of NPS have been successfully analyzed using IMS such as synthetic cathinone 
derivatives,
239-242
 tryptamines,
239,240,242
 synthetic cannabinoids,
2,241,242
 and 
phenethylamines
241,242
. The selectivity of the mobile IMS is limited and some publications 
reported that analytes with nearly identical chemical structure like the synthetic cannabinoids 
cannot be distinguished.
2,181
 With the high sensitivity of IMS, it is possible that disturbing 
matrix components are detected and generate an alarm due to a false positive result. Some 
publications are concerned with the reduction of false positive responses commonly 
encountered in the field when drugs and explosives are detected.
243,244
 
The topic of this paper is the fast and effective detection of synthetic cannabinoids in various 
samples such as herbal mixtures, papers (postal packages), cosmetics and foods using mobile 
IMS. IMS serves as a preliminary test for the detection of NPS in suspicious objects found in 
or around the prison. Current databases of reduced mobility values (K0) are limited to 
classical drugs like amphetamine, methamphetamine, THC, heroine. In this study, the K0-
values of 25 synthetic cannabinoids were determined. The selection of substances complies 
with the current state of synthetic cannabinoid distribution in Rhineland-Palatinate (Germany) 
and refers to the number of appearance of each synthetic cannabinoid in the State Office of 
Criminal Investigation Rhineland-Palatinate. In conjunction with criminal cases referring to 
prisons, only the 25 synthetic cannabinoids listed here were seized during the last years. The 
data are added to existing databases for other drugs of abuse and drug testing in prison. The 
utility and applicability of the IMS method is demonstrated by the analysis of seized samples 
like herbal mixtures, papers, foods products and cosmetics from real criminal cases. 
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2.3 Materials and Methods 
2.3.1 Chemicals 
The reference standards of 25 synthetic cannabinoids (powders) employed in this study were 
taken from criminal cases provided by the State Office of Criminal Investigation Rhineland-
Palatinate (Germany) and listed in Table 2-1. These include 5F-ADB (N-[[1-(5-fluoropentyl)-
1H-indazol-3-yl]carbonyl]-3-methyl-D-valine, methyl ester), 5F-AMB (N-[[1-(5-
fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine, methyl ester), 5F-PB-22 (1-(5-
fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), 5F-SDB-005 (naphthalene-1-yl 
1-(5-fluoropentyl)-1H-indazole-3-carboxylate), AB-CHMINACA (N-[(1S)-1-
(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide), AB-
FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-
indazole-3-carboxamide), AB-PINACA ((S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide), AM-2201 ([1-(5-fluoropentyl)-1H-indol-3-yl]-1-
naphthalenyl-methanone), APICA (N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide), 
BB-22 (1-(cyclohexylmethyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), Cumyl-
PeGaClone (2,5-dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one), 
EAM-2201 ((4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone), EG-018 
(naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone), EMB-FUBINACA (ethyl (1-(4-
fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate), FDU-PB-22 (1-[(4-fluorophenyl)methyl]-
1H-indole-3-carboxylic acid, 1-naphthalenyl ester), FUB-AMB (N-[[1-[(4-
fluorophenyl)methyl]-1H-indazol-3-yl]carbonyl]-L-valine, methyl ester), JWH-018 (1-pentyl-
1H-indol-3-yl)-1-naphthalenyl-methanone), JWH-122 ((4-methyl-1-naphthalenyl)(1-pentyl-
1H-indol-3-yl)-methanone), MAB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-
1-(cyclohexylmethyl)-1H-indazole-3-carboxamide), MDMB-CHMICA (N-[[1-
(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester), MDMB-
CHMCZCA (methyl N –[[9-(cyclohexylmethyl)-9 H -carbazol-3-yl]carbonyl]-3-methyl-L-
valinate), MMB-2201 (N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-L-valine, methyl 
ester), PB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid), THJ-2201 ([1-(5-
fluoropentyl)-1H-indazol-3-yl]-1-naphthalenyl-methanone), UR-144 ((1-pentyl-1H-indol-3-
yl)(2,2,3,3-tetramethylcyclopropyl)-methanone). Each drug standard was dissolved in 
methanol p.A. (Geyer, Renningen, Germany) to prepare stock solutions of 0.05 mg/mL. For 
UPLC-DAD and GC-MS measurements, methanol (LC-MS-grade, Geyer, Rennigen, 
Germany) was used. 
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Table 2-1 Chemical structures of the synthetic cannabinoids evaluated in this study  
Indazole 
 
Indole 
 
Carbazole 
 
Substance R1 R2 Substance R1 R2 Substance R1 R2 
5F-ADB A A APICA B F EG-018 B G 
5F-AMB A B MDMB-CHMICA C A MDMB-CHMCZCA E H 
AB-CHMINACA C D MMB-2201 A B    
AB-FUBINACA D D Naphtyl-Indole 
 
Naphtyl-
Indole- 
carboxylate 
AB-PINACA B D 
EMB-FUBINACA D C 
FUB-AMB D B 
MAB-
CHMINACA 
C E 
Naphtyl-Indazole-carboxylate Substance R1 R2 Substance R1  
AM-2201 A - BB-22 C 
EAM-2201 A I 5F-PB-22 A 
JWH-018 B - FDU-PB-22 D 
JWH-122 B J PB-22 B 
THJ-2201 A -  
Substance R1  
 
R1A:  
R2A:  R2F:  
R1B:  
R2B:  R2G:  
R1C:  R2C:  R2H:  
R1D:  R2D:  
R2I: CH3 
R1E:  R2E:  
R2J: C2H5 
5F-SDB-005 A 
Cumyl-PeGaClone 
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The following solvents were used for solid phase extraction (SPE): acetone p.A., acetic acid 
100 %, sodium dihydrogen phosphate-1-hydrate, dichloromethane (Merck, Darmstadt, 
Germany), acetonitrile Rotisolv UV/IR grade≥ 99,9 %, ammonia solution Rotipuran 30-33 % 
(Carl Roth. KG, Karlsruhe, Germany), albumin from bovine serum (BSA) Cohn V fraction ≥ 
96 % (Sigma Aldrich, Germany), 2-propanol p.a. 99,7 % (Th. Geyer, Germany). 
For the NMR analysis, acetone-d6 (purchased from Deutero, Kastellaun, Gemany) and 
internal calibrant 3,5-dinitrobenzoic acid (Fluka, TraceCERT, 99.66 %) were used. The teflon 
membranes (swabs) for IMS measurements were provided by Smith Detection (Edgewood, 
USA). The drug mixture consisted of methadone hydrochloride ((RS)-6-(dimethylamino)-4,4-
diphenylheptan-3-on), DL-amphetamine sulphate ((±)-1-phenylpropane-2-amine), 
buprenorphine hydrochloride ((αS,5α,7α)-17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-
epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol), 
fentanyl hydrochloride (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide) which 
were purchased from LGC-Standards (Wesel, Germany) exept amphetamine sulphate which 
was purchased from Sigma Aldrich (St.Lous, MO, USA). 
2.3.2 Methodology: Characterization of NPS powders from seizures 
2.3.2.1 Gas chromatography-mass spectrometry 
As not all NPS were commercially available during experimental work of this study, material 
from seizures was used as standards. Identity and purity of each seized drug powder were 
determined using a gas-chromatograph with mass spectrometric detection (GC-MS). GC was 
performed on an Agilent 7890B equipped with a 5977A MS (Agilent, Waldbronn, Germany). 
The separation column was a 19091S-433 HP-1MS from Agilent with a length of 30 m, an 
inner diameter of 250 µm and a coating thickness of 0.25 µm. The MS detector was operated 
with electron ionization (EI) with an ionization potential of 70 eV, a scan range of 50-
550 amu and a data rate of 50 scans/s. The inlet heater temperature was 250 °C, the transfer 
line temperature was 270 °C, the ion source temperature was 230 °C and the quadrupole 
temperature was 150 °C. Helium served as the carrier gas at a flow rate of 0.8 mL/min. A split 
injection volume of 1 µL was used at a split ratio of 50:1. The temperature program of the 
oven started at 100 °C (hold time 0 min), and increased at a rate of 20 °C/min to 300 °C (hold 
time 25 min). The mass spectrum derived for each compound was compared to libraries. 
Standards containing other substances than the drug of interest (e.g. cutting agents) were 
excluded from method optimization and database setup. 
Five mg of powdered samples were dissolved in 1 mL methanol. For herbal mixtures or 
tobacco mixtures 200 mg of herbal mixture was suspended in 3 mL methanol. In cases, where 
less material was available, the amount of methanol was reduced until the whole material was 
covered with organic solvent. The solutions were filtered with syringe filters from Macherey-
Nagel (Düren, Germany) with a pore size of 0.20 µm and a diameter of 25 mm directly into 
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GC-MS vials for injection. Papers spiked with NPS were covered with methanol for 
extraction (10 min) in a glass vial. Afterwards, the solution was transferred into a second 
glass vial and evaporated to dryness. Then 100 µL methanol were added to the glass vial and 
the solution was transferred to a GC-MS vial with a cone-shaped insert (Wicom, 
Heppenheim, Germany). 
For the analysis of cosmetic products or foods, a solid-phase extraction (SPE) was done using 
octadecyl (C18) disposable extraction 3 mL SPE columns (Fisher Scientific, Schwerte, 
Germany). All extractions were performed using a vacuum manifold system (Carl Roth, 
Karlsruhe, Germany). For this, 0.5 g of the sample was suspended in 3 mL 0.1 M NaH2PO4-
buffer with 3 % BSA.  
The SPE procedure was: (i) conditioning of the cartridge with 3 mL methanol; (ii) 
conditioning of cartridge with 3 mL 0.1 M phosphate buffer (pH = 6) (iii) loading 3 mL of the 
sample dissolved in BSA-phosphate buffer; (iv) washing with 3 mL bidest. water; (v) washing 
with 3 mL of a water:methanol mixture (80:20), (vi) washing with 1 mL 0.1 M aqueous acetic 
acid, (vii) evaporating to dryness under vacuum (-10 mm kPa) for 10 min; (viii) eluting the 
acidic target analytes with 3 mL of dichloromethane and acetone (1:1); (ix) eluting the basic 
target analytes with 3 mL of a mixture of dichloromethane:isopropanol:ammonia solution 
(33 %) (40:10:1); (x) evaporating the eluted extracts to dryness under a gentle stream of 
nitrogen at 50 °C; (xi) reconstituting the extract in 100 µL of methanol. The reconstituted 
extracts were transferred into a GC-MS vial with an inlet conus. 
2.3.2.2 NMR 
The purity determination of NPS samples from seizures was conducted by quantitative NMR 
(qNMR) analysis. It is considered as a primary method being traceable to the SI unit mol. The 
number of nuclei is directly proportional to the signal intensity.
49
 The measurements were 
carried out with the NMR spectrometer AVANCE III HD 500 (Bruker, Rheinstetten, 
Germany) equipped with a Bruker 5 mm broad band inverse probe with z-gradient. 
Approximately 10 mg of the seizures were weighed directly in an NMR tube on an analytical 
balance together with the internal calibrant and 0.5 mL acetone-d6 were added as solvent. The 
measurements were performed without sample spinning. All quantifications were performed 
on the basis of a single pulse 
1
H-NMR experiment. The observing frequency for 
1
H was 
500.13 MHz. The number of scans was 4 and a 90° pulse was used for four accumulated 
scans. The transmitter offset was 5.5 ppm and the spectral width 17 ppm. An exponential 
multiplication was applied with a line broadening of 0.2 Hz. The time domain was set to 
128 k as well as the spectrum size. The purity of the analyte PX (expressed in % g/g) was 
calculated from the NMR signal intensity via an internal calibrant (IC) with known purity 
PStd: 
𝑃𝑥 =
𝐼𝑋
𝐼𝐼𝐶
×
𝑁𝐼𝐶
𝑁𝑋
×
𝑀𝑋
𝑀𝐼𝐶
×
𝑚𝐼𝐶
𝑚𝑠𝑎𝑚𝑝𝑙𝑒
× 𝑃𝐼𝐶  
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where I is the integral value, N the number of spins belonging to the respective molecular 
unit, M the molar mass and m the weighed-in mass.
49
 
2.3.2.3 UPLC-DAD 
For quantitative analysis of samples an ultra-performance liquid chromatography (UPLC) 
Aquity-System (Waters, Milford, MA, USA) equipped with a diode array detection (DAD) 
was utilized. The synthetic cannabinoids were separated on a Raptor Biphenyl column 
(2.7 µm, 150 x 2.1 mm) from Restek (Bad Homburg, Germany) using a gradient with 
methanol (A)/ammonium formate buffer (B) at a flow rate of 0.5 mL/min. The gradient was 
constructed as follow: (A) 70 %/(B) 30 % for 4 min, (A) 75 %/(B) 25 % for 2 min, (A) 
80 %/(B) 20 % for 4 min, (A) 90 %/B 10 % for 3 min and return to the start conditions within 
2 min. The scan range of DAD was set to 210-400 nm and the detection wavelength for all 
synthetic cannabinoids was set to 301 nm. The sampling rate was 20 points/s with a resolution 
of 1.2 nm. Powdered material (1 mg) and herbal mixtures (100 mg) were suspended in 10 mL 
methanol. The solutions were filtered with syringe filters from Macherey-Nagel (Düren, 
Germany) with a pore size of 0.20 µm diameter of 25 mm. Then, 100 µL of the filtered 
sample solution was mixed with 900 µL methanol directly into UPLC-vials for injection 
(injection volume 5 µL). 
2.3.2.4 IMS procedure 
For IMS analysis, the IONSCAN600 (Smith Detection, Hemel Hempstead, United Kingdom) 
was utilized for the qualitative analysis of 25 synthetic cannabinoids. The factory operating 
method “narcotics” was used as measuring mode (Table 2-2). The mean value of all 43 
segments was calculated for determination of K0- and drift time values for one substance. A 
teflon membrane substrate (called swab) was used for sampling and sample application. For 
the analysis of reference standards, 50 ng (1 µL of 0.05 mg/mL solution of standard in 
methanol) was pipetted onto the swab. Before each measurement, the empty swab was 
conditioned in the thermal desorption chamber and a plasmagram was recorded to assure that 
no carry over effects from analytes or matrix components were present. Reduced mobility 
(K0) and its tolerance window, drift time, threshold and full width at half maximum (FWHM) 
were considered during automatic data evaluation using a software detector controller (Smith 
Detection). A positive detection alarm was programmed. The limits of detection (LODs) were 
estimated using the function LOD = yblank+ 3x SDblank where yblank represents the mean 
amplitude of the background (n = 5) and SDblank the standard deviation of the amplitude of the 
background.
245
 These calculated LODs were 100 du on average and this value was set as the 
threshold for the alarm to avoid false positive alarms. 
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Table 2-2 IMS operating conditions (positive ionization mode) 
Measuring mode “Narcotics”, positive mode 
ionization source APCI, corona discharge 
Sampling method teflon membrane substrate (swab) 
Drift tube length 8 cm 
Positive calibrant Nicotinamide 
Electric field strength +240 Vcm
-1
 
Inlet temperature 180 °C 
Drift tube temperature 170 °C 
Flash Heater temperature 240 °C 
Drift gas /carrier gas Dried purified air 
Drift flow 206 cc/min 
Absolut pressure 102 kPa 
Number of scans 43 
Scan time 19 ms 
 
Based on these values, the concentration range of a 5-point-calibration curve was set (1.0-
8.0 μg/mL) using standards in methanol (n = 3). LODs were then calculated from slope and 
intercept.
246
 For analysis, 1 μL of each concentration level was spiked onto the swab. This 
equals 1-8 ng standard per analysis. For the analysis of herbal mixtures the surface of the 
plant material was touched with a wooden rod (n = 3) and the adherent particles were 
transferred to the swab. To simulate drug transport via paper, pieces of paper were 
impregnated with synthetic cannabinoids at concentrations correlating to current dosages as 
described on internet platforms (see Table 2-3).
247
 For each synthetic cannabinoid, 2 different 
working solutions differing in concentration were prepared in methanol (see Table 2-3) and 
spiked to papers, which were allowed to dry at room temperature. For sample preparation, the 
papers were directly stroked by the swab (n = 3). The cosmetics and food samples were 
prepared by mixing a standard of 6 different compounds in methanol: 5F-ADB, fentanyl 
hydrochloride, methadone, amphetamine, tetrazepam, buprenorphine (1 mg/mL each). 
Afterwards, 100 µL of the mixture were added to 1000 µL of the different liquid cosmetics 
and food samples homogenized via vortexing for 30 s. Then, 1 µL of the spiked sample was 
then applied to the swab for analysis (effective amount of 100 ng for each compound).
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Table 2-3 Concentration levels based on different internet platforms published in 
247
 for the preparation of 
impregnated papers with synthetic cannabinoids 
Substance 
Dosage 
low concentration in mg 
Dosage 
high concentration in mg 
5F-ADB 0.02 0.2 
5F-AMB 0.1 2 
5F-PB-22 1 2 
AB-CHMINACA 1 2 
AB-FUBINACA 0.5 4 
AB-PINACA 0.5 4 
MAB-CHMINACA 0.25 0.5 
AM-2201 0.5 3 
APICA 2 5 
BB-22 0.5 - 
JWH-018 2 5 
MDMB-CHMICA 0.1 0.3 
 
2.4 Results 
2.4.1 Characterization of NPS with UPLC, GC-MS and NMR 
For standards, samples from seizures were used. The powders were characterized by UPLC-
DAD, GC-MS and NMR to determine their purity and to exclude the presence of impurities. 
These substances served as reference material in this study. Initially, the powder material was 
analyzed via GC-MS and the retention times and the characteristic m/z values of each 
substance are reported in Table 2-4 (arranged according to their importance). For 
identification of the synthetic cannabinoids, the MS-spectra of the different samples were 
compared to MS libraries. In addition, each sample was characterized with UPLC-DAD. 
Measuring conditions are given in Section 2.3.2.3 and the on-column UV-spectra are shown 
in the publication of Metternich et al. (Figure S1).
248
 The retention times and the λmax are 
presented in Table 2-4 for each standard. The purity was determined using 
1
H-NMR to be 
> 94.6 %, except FDU-PB-22 with only 76.4 %. This sample also contained diethylamine and 
ethanol, which did not impair IMS measurements. Other samples with impurities were not 
taken into consideration including cutting agents that could also be present as an active 
ingredient in seized samples like paracetamol, caffeine, sugars or other drugs like e.g. 
amphetamine, cocaine and THC. 
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Table 2-4 List of 25 synthetic cannabinoids with the data from GC-MS with fragment masses (m/z-values) and 
retention times (Rt), absorption maximum (λmax) of the UPLC-DAD measurements, sample purity as determined 
by NMR, drift times and reduced mobility K0 of IMS analysis with reference, where available  
Substance 
MW 
in 
g/mol 
GC-MS 
UPLC-
DAD 
NMR IMS 
m/z 
Rt 
in 
min 
λmax  
in 
nm 
Purity 
in  
% 
Drift 
time 
in ms 
K0  
in 
cm2V-1s-1 
Ref. K0 
in cm2V-1s-1 
5F-ADB 377.46 
233, 145, 
130, 289, 321 
10.9 301 98.7 10.564 0.9917 0.984
249
 
5F-AMB 363.44 
233, 145, 
304, 249, 131 
10.9 301 98.5 10.288 1.0123  
5F-PB-22 376.43 
232, 144, 
116, 89, 376 
18.2 
215, 
294 
99.6 10.48 0.9995  
5F-SDB-005 376.4 
233, 145, 
115, 213, 115 
15.2 301 97.3 10.696 0.9827  
AB-
CHMINACA 
356.47 
241, 312, 
145, 55, 131 
13.5 300 95.2 10.528 0.9975  
AB-
FUBINACA 
368.41 
109, 252, 
324, 145, 83 
13.4 301 94.9 10.396 1.0128  
AB-PINACA 330.41 
215, 286, 
145, 216, 131 
11.8 302 96.3 10.064 1.0463  
AM-2201 359.45 
359, 127, 
284, 232, 144 
15.2 
217, 
247, 
315 
99.8 10.288 1.0127 1.0163
2
 
APICA 364.54 
214, 144, 
307, 364, 347 
16.9 302 98.5 11.044 0.9508 0.9466
241
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Substance 
MW 
in 
g/mol 
GC-MS 
UPLC-
DAD 
NMR IMS 
m/z 
Rt 
in 
min 
λmax  
in 
nm 
Purity 
in  
% 
Drift 
time 
in ms 
K0  
in 
cm2V-1s-1 
Ref. K0 
in cm2V-1s-1 
BB-22 384.48 
240, 144, 
116, 241, 55 
24.8 
215, 
294 
97.2 11.116 0.9456  
Cumyl-
PeGaClone 
372.50 
254, 197, 
118, 91, 372 
13.9 
250, 
324 
98.6 10.822 0.9741  
EAM-2201 387.50 
232, 287, 
312, 144, 370 
19.9 
221, 
315 
98.5 10.924 0.9592  
EG-018 391.50 
334, 391, 
335, 127, 179 
23.8 
216, 
276, 
298, 
340 
94.6 11.284 0.9328  
EMB-
FUBINACA 
377.5 
109, 253, 
324, 269, 254 
12.31 301 98.8 10.948 0.9571  
FDU-PB-22 395.44 
109, 252, 
253, 143, 83 
22.8 
218, 
293 
76.5 13.024 0.8069  
FUB-AMB 383.40 
109, 253, 
324, 254, 383 
10.9 300 99.9 10.624 0.9884  
JWH-018 343.47 
127, 341, 
214, 284, 144 
13.7 
217, 
247, 
315 
98.6 10.204 1.0301 1.0288 
2
 
JWH-122 355.48 
355, 298, 
215, 115, 338 
15.0 
221, 
315 
99.9 10.528 0.9970 0.9950 
2
 
MAB-
CHMINACA 
370.50 
241, 326, 
145, 131, 55 
13.4 302 91.6 10.768 0.9724  
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Substance 
MW 
in 
g/mol 
GC-MS 
UPLC-
DAD 
NMR IMS 
m/z 
Rt 
in 
min 
λmax  
in 
nm 
Purity 
in  
% 
Drift 
time 
in ms 
K0  
in 
cm2V-1s-1 
Ref. K0 
in cm2V-1s-1 
MDMB-
CHMICA 
384.51 
240, 144, 
296, 328, 268 
12.6 
290, 
216 
97.0 11.128 0.9415 0.968
249
 
MDMB-
CHMCZCA 
434.5 
290, 434, 
179, 346, 378 
23.1 
235, 
277 
98.3 12.256 0.8576  
MMB-2201 362.50 
232, 248, 
144, 362, 233 
11.7 
216, 
289 
96.6 10.432 1.0065  
PB-22 358.44 
214, 144, 
116, 89, 358 
17.7 
216, 
294 
98.2 10.564 0.9917  
THJ-2201 360.44 
127, 271, 
360, 259, 155 
14.1 
218, 
320 
97.2 10.156 1.0341 1.031
249
 
UR-144 311.46 
214, 144, 
296, 311, 252 
10.3 
215, 
245, 
305 
98.8 9.995 1.0511 
1.042
242
 
1.0484
241
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2.4.2 IMS measurements 
2.4.2.1 Determination of drift times and K0-values  
A standard method preprogrammed for the IMS was used. All 25 synthetic cannabinoids were 
analyzed by IMS and the K0-values were calculated from drift times of analytes (td analyte) and 
of nicotinamide (td cal) as internal standard to correct for pressure and temperature changes 
using the following equation
181
: 
𝐾0 𝑎𝑛𝑎𝑙𝑦𝑡𝑒 =
𝐾0 𝑐𝑎𝑙  ×  𝑡𝑑 𝑐𝑎𝑙
𝑡𝑑 𝑎𝑛𝑎𝑙𝑦𝑡𝑒
  
 
The drift times for synthetic cannabinoids were in the range of 9.995-13.024 ms 
corresponding to K0-values of 1.0511-0.8069 cm
2
V
-1
s
-1
 as summarized in Table 2-4. The 
plasmagrams for each synthetic cannabinoid are shown in Figure 2-1. K0-values were 
reported for 8 synthetic cannabinoids in previously published studies corroborating the results 
in this study.
2,241,242,249
 To the best of our knowledge, for the other substances no reference 
values have been published. For alarm generation for the synthetic cannabinoids, a library 
with K0-values was built.  
A positive result (an alert) was assumed with a specific tolerance range. This range was set in 
the following way: Drift times were determined at the peak`s left and right inflection points of 
the smallest and the largest peak within the 43 segments during one analysis and K0-values 
were calculated for both points. These inflection points are based on the baseline intercepts of 
tangent lines to a Gaussian peak and are equivalent to the peak width at 13.4 % of the height. 
The tolerance range of K0 is expressed as: 
 
𝑡𝑜𝑙𝑒𝑟𝑎𝑛𝑐𝑒 𝑟𝑎𝑛𝑔𝑒 = 𝐾0 ±
𝐾0 𝐿𝑠 + 𝐾0 𝐿𝑙 
2
 −  
𝐾0 𝑅𝑠 + 𝐾0 𝑅𝑙
2
 
 
where L means the position on the left flank and R the position of the right flank and s means 
the smallest and l the largest peak at W0,1 (peak width at 13.4 % of peak height) within the 
43 scans. The additional detection alarm parameters were defined as follows: full width at 
half maximum (FWHM) of 200-250 µs and threshold of 100 du in order to avoid false 
positive alarms.  
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Figure 2-1 Plasmagrams of the 25 synthetic cannabinoids evaluated in this study applying 50 ng each on the 
swab (standard concentration of 0.05 mg/mL each), the signal at 5.959 ms stems from the internal calibrant 
nicotinamide 
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2.4.2.2 Figures of merit of the IMS method 
In order to fully demonstrate the applicability of the IMS method, the precision, the separation 
capability and limits of detection were determined. The detection capability of the portable 
IMS technique was evaluated and the intra-day and inter-day precision of the K0-values are 
shown in Table 2-5. For intraday precision (n = 5) the RSD values were below 0.089 % and 
for interday precision (n = 3 on two different days at one week interval) the RSD values 
ranged from 0.004 to 0.14 %. The precision of the method and instrumentation presented here 
was similar to other studies.  
Table 2-5 Precision, linearity and LOD values of the IMS analysis for the 25 synthetic cannabinoids injected 
separately  
Substance 
Intraday 
RSD in % 
Interday 
RSD in % 
Linearity 
R² 
LOD in ng 
Reference 
LOD in ng 
5F-ADB 0.0084 0.0121 0.9946 2.0  
5F-AMB 0.0044 0.1425 0.9937 1.5  
5F-PB-22 0.0071 0.0997 0.9778 1.6  
5F-SDB-005 0.0170 0.0170 0.9988 2.7  
AB-CHMINACA 0.0110 0.0385 0.9756 1.3  
AB-FUBINACA 0.0070 0.0450 0.9783 2.5  
AB-PINACA 0.0321 0.0321 0.9955 0.7  
AM-2201 0.0107 0.0760 0.976 3.6  
APICA 0.0120 0.0142 0.981 1.5 0.04-0.08 
241
 
BB-22 0.0088 0.0088 0.9924 1.1  
Cumyl-PeGaClone 0.0245 0.0245 0.9945 2.0  
EAM-2201 0.0074 0.0483 0.9929 1.0  
EG-018 0.0117 0.0117 0.9939 2.0  
EMB-FUBINACA 0.0087 0.0087 0.9899 1.1  
FDU-PB-22 0.0055 0.0055 0.9893 3.0  
FUB-AMB 0.0000 0.0195 0.9923 2.4  
JWH-018 0.0053 0.0312 0.9928 2.7  
JWH-122 0.0090 0.0090 0.9894 1.5  
MAB-CHMINACA 0.0046 0.0287 0.995 0.7  
MDMB-CHMICA 0.0095 0.0170 0.9892 1.0  
MDMB-CHMCZCA 0.0082 0.0082 0.9891 2.0  
MMB-2201 0.0191 0.0529 0.9855 1.6  
PB-22 0.0115 0.0115 0.9629 2.6  
THJ-2201 0.0043 0.0043 0.9812 2.8  
UR-144 0.0707 0.0707 0.9967 0.7 0.02-0.08 
241,242
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The systematic error of the mobile IMS was also evaluated using the formula  
𝐷𝑡 =
𝑙𝑑
𝑡𝑑
= 𝐾 ×  𝐸 
where the ion mobility K represents the proportional constant between the set value of the 
electric field strength E and the drift velocity Dt which is defined as the length of the drift 
distance ld divided by the time td, which the ions need to reach the detector plate. Assuming 
that the electric field strength and the drift distance for the measuring system are nearly 
constant, the uncertainty of IMS measurements can be expressed by the following equation: 
𝐾 × 𝑡𝑑  =  
𝑙𝑑
𝐸
 =  𝑐𝑜𝑛𝑠𝑡. 
The uncertainty of the measurements was 0.19 % which corresponds to an absolute drift time 
deviation of ±0.024 ms and an absolute deviation of the K0 values of ±0.0019 cm²V
-1
s
-1
. The 
LODs of the 25 compounds are listed in Table 2-5 and range from 0.7-3.6 ng with an 
acceptable linearity of 0.9988 > R² > 0.9756 (description of the determination of LODs in 
section “IMS Procedure”). Compared to literature (see Table 2-5) the evaluated LOD in this 
study were larger by a factor of 10-100. The dynamic range is limited by the ionization 
efficiency and thus by the consumption of reactant ions during the ionization process of 
analyte molecules. The range was in the ng to µg range for qualitative analysis of substances. 
Resolution was determined using the definition from chromatography. The drift time (and K0) 
differences necessary to discriminate two analytes was > 0.15 ms (> 0.013 cm²V
-1
s
-1
) at a 
resolution of R = 0.75, and was > 0.35 ms (> 0.024 cm²V
-1
s
-1
) for baseline separation of two 
analytes (R > 1.5). Figure 2-2 demonstrates a mixture of 5 different synthetic cannabinoids 
analyzed via IMS with drift time differences > 0.15 ms. For samples with two or more 
synthetic cannabinoids the differences in drift times and reduced mobility values of < 0.15 ms 
(0.013 cm²V
-1
s
-1
) led to an alarm for only the substance present at higher concentration in the 
sample. 
 
Figure 2-2 IMS plasmagram of a mixture of 5 different synthetic cannabinoids THJ-2201, FUB-AMB, MDMB-
CHMICA, MDMB-CHMZCZA, FDU-PB-22 applying 50 ng each on the swab (standard concentration of 
0.05 mg/ml each) and nicotinamide as internal calibrant 
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2.4.2.3 Model applications and matrix tolerance 
The applicability of the method developed in this study was demonstrated by analyzing 
synthetic cannabinoids spiked to different matrices like herbal mixtures, impregnated papers, 
cosmetic products and liquid food samples. 14 herbal mixtures containing different synthetic 
cannabinoids (5F-ADB, 5F-AMB, 5F-PB-22, AB-CHMINACA, AB-FUBINACA, AM-2201, 
APICA, BB-22, EAM-2201, FUB-AMB, JWH-018, MAB-CHMINACA, MDMB-CHMICA, 
MMB-2201) were casework samples provided by State Office of Criminal Investigation 
Rhineland-Palatinate (Germany). The papers (standard copy papers 80 g/m²) were 
impregnated with different synthetic cannabinoids dissolved in methanol at the two 
concentration levels given in Table 2-3 referring to common dosages.
247
 For sample 
preparation of herbal mixtures and papers the swab was directly wiped over the sample 
surface. All synthetic cannabinoids could be detected by IMS without false alarms in these 
samples. Figure 2-3 shows the analyte 5F-ADB spiked into different matrices like papers, 
herbal mixtures and an herbal mixture with tobacco remains.  
 
Figure 2-3 IMS-plasmagrams of 50 ng 5F-ADB a) spiked onto a paper, b) in a herbal mixture and c) in a herbal 
mixture with tobacco remains (casework Sample 5) and nicotinamide as internal calibrant 
For the selection of cosmetic products and food samples, the product list of kiosk 
confectionery of a prison in Rhineland-Palatinate was used to choose potential matrices for 
drug trafficking. A mixture of 6 different compounds (5F-ADB, fentanyl hydrochloride, 
methadone, amphetamine, tetrazepam, buprenorphine) as representatives for different 
substance classes were spiked to several cosmetic products and food samples. These 6 
compounds represent typical substances found in prison
170
 and were included for the detection 
alarm system of the IMS. The following cosmetic products were analyzed: alcohol free mouth 
rinse, face cleansing lotion, face cleansing milk, contact lens solution, nasal spray, liquid soap 
and toothpaste. The analysis of food samples was limited to liquids including cola, orangeade, 
milk, coffee and peppermint tea. The analysis revealed positive alarms for 6 compounds in all 
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matrices except in liquid soap and toothpaste (false negative). For those two matrices only 
methadone, amphetamine and tetrazepam were detected with IMS (Figure 2-4).  
 
Figure 2-4 Plasmagrams of 1) the toothpaste (blank) with * signals deriving from the toothpaste matrix and a) 
internal calibrant nicotinamide and 2) the toothpaste spiked a mixture of 6 different compounds (5F-ADB, 
fentanyl hydrochloride, methadone, amphetamine, tetrazepam, buprenorphine), only b) amphetamine, c) 
tetrazepam and d) methadone were detected with IMS 
Overall, IMS measurements provided a selectivity which was high enough to discriminate all 
25 different synthetic cannabinoids taken up in the database. 
2.4.2.4 Application to casework samples 
The developed IMS method with automated detection alarm system was applied to prison 
settings in order to uncover drug trafficking. In total, 36 suspicious samples were analyzed via 
IMS. Results were verified by GC-MS analysis. The results are summarized in Table 2-6. In 
35 out of 36 cases the IMS alarm generation reached a hit quality of > 89 %. The hit quality is 
calculated by the mean value of all K0-values of the analyte within the 43 segments per scan 
subtracted from the K0- value entered into the database.  
The identification corresponded well to the GC-MS results. The major limitation of the 
method is the inability to detect more than one analyte in a sample which is shown in Case 6 
and Cases 28-30 (Table 2-6). Only the active ingredient of higher peak intensity was 
identified. However, for the application in prison settings, the detection of only one analyte is 
sufficient to start hazard prevention. Nicotine is an analyte often detected in casework sample. 
To characterize nicotine with IMS, a nicotine standard was dissolved in methanol 
(0.5 mg/mL) and 1 µL (effective amount 50 ng) was pipetted onto the swab (n = 5). The K0-
value of nicotine was 1.5632 cm²V
-1
s
-1
 and the drift time was 6.565 ms. Thus, there are no 
interferences with any analyte. Moreover, 11 commercially available tobacco brands were 
tested by striking the swab over the tobacco. Each tobacco sample revealed a nicotine signal 
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at 6.565 ± 0.0042 ms and 1.5632 ± 0.0007 cm²V
-1
s
-1
. Since nicotine is not relevant under 
criminal law, it was not included in the IMS database to avoid alarm generation.  
Table 2-6 IMS and GC-MS results of the measurement of casework samples from prisons 
Case Description IMS 
Hit 
in % 
GC-MS 
1 plastic foil with herbal mixture 
Cumyl 
PeGaClone 
97 Cumyl-PeGaClone 
2 Finely grounded tobacco remains FUB-AMB 95 FUB-AMB, nicotine 
3 Piece of paper No alarm - Nicotine 
4 4 self-made cigarettes, tobacco remains No alarm - Nicotine 
5 Remains of 2 self-made cigarettes 5F-ADB 96 5F-ADB, nicotine 
6 Yellow pieces of paper 5F-ADB 94 
AB-CHMINACA, 
APINAC, 5F-ADB 
MMB(N)-2201, 
caffeine 
7 tobacco No alarm - Nicotine 
8 Piece of paper No alarm - Nicotine 
9 Remains of 1 self-made cigarette No alarm - Nicotine 
10 Tobacco in plastic foil No Alarm - Nicotine 
11 Tobacco in plastic foil No Alarm - Nicotine 
12 4 Self-made cigarettes 5F-ADB - 5F-ADB, nicotine 
13 2 Self-made cigarette No Alarm - Nicotine 
14 Piece of paper No Alarm - No signals 
15 Yellow piece of paper No Alarm - Nicotine 
16 Yellow piece of paper No Alarm - Nicotine 
17 Yellow piece of Paper No Alarm - 
Palmitic acid, 
Leucocrystal violet 
18 Remains of herbal mixture in plastic foil 
Cumyl-
PeGaClone 
97 Cumyl-PeGaClone 
19 Herbal mixture and tobacco 
Cumyl-
PeGaClone 
93 
Cumyl-PeGaClone, 
nicotine 
20 Fine tobacco FUB-AMB 95 FUB-AMB, nicotine 
21 Piece of paper No Alarm - Nicotine 
22 4 Self-made cigarettes FUB-AMB - FUB-AMB, nicotine 
23 
Envelope with two dark spots (from a 
liquid) 
No Alarm - Glycerol 
24 10 Pieces of paper No Alarm - Leucocrystal violet 
25 Photo No Alarm - No signals 
26 Envelope of greeting card No Alarm - Palmitic acid 
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Case Description IMS 
Hit 
in % 
GC-MS 
27 Greeting card No Alarm - No signals 
28 Brown herbal mixture 5F-ADB - 
5F-ADB, FUB-AMB, 
nicotine 
29 Brown herbal mixture 5F-ADB - 
5F-ADB, FUB-AMB, 
nicotine 
30 Brown herbal mixture 5F-ADB 94 
5F-ADB, PB-22, 
nicotine 
31 Envelope No Alarm - Palmitic acid 
32 Handwritten letter Cocaine* 89 
Cocaine, caffeine 
paracetamol 
33 Vial with transparent colorless liquid Methadone 99 Methadone 
34 Eye drops No Alarm - No signals 
35 Eye and nasal ointment Methadone 95 Dexpanthenol 
36 Eye and nasal ointment No Alarm - Cholesterol 
*substances from the general database from Smith Detection, they are no part of the database 
for synthetic cannabinoids which was developed during the study 
2.5 Discussion 
The portable IMS is a powerful analytical method for the application in prisons to uncover 
NPS drug trafficking. This thesis is supported by the key figures shown in this study. Due to 
the rapid emergence of novel NPS products the demand for rapid and simple drug detection is 
growing.
34
 In prisons, the wide range of physical and mental health harms caused by the 
consumption of NPS
10
 is also challenging for prison officers.
171
 IMS offers the decisive 
advantage over other mobile analysis techniques, that the analysis of synthetic cannabinoids 
in different matrices is possible with high sensitivity. In this study no false negative alarms 
were generated when analyzing synthetic cannabinoids in different matrices. Each synthetic 
cannabinoid was successfully detected. In addition, the analysis is fast (less than 10 s), easy to 
use and non-destructive, which is important for daily work for prison officers especially also 
for paper samples. Color coding tests or immunoassays are rapid, sensitive, inexpensive and 
easy but they lack specificity. There is a risk of false positive results due to cross-reactivity 
with other non-targeted drugs of similar chemical structure. In case of more than one 
cannabinoid with close drift times in a sample the selectivity is limited to the detection of only 
one substance. Due to the fast changing drug market of NPS, the development of new test kits 
is constantly required. Other portable techniques like IR- or Raman spectroscopy are not able 
to examine synthetic cannabinoids in different matrices like herbal mixtures, papers, 
cosmetics or food samples.
59-61
 In seizures, the concentration of an active ingredient is too low 
and the matrix impairs the spectral quality.
59
 A further sample preparation step is thus 
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necessary.
62,63
 In the case of pure powders, the unique identification of an active compound is 
given by its spectral fingerprint. An unambiguous assignment is not possible with IMS, 
because it is a preliminary test which gives a hint to a possible active ingredient based on the 
size and shape of the ion with the reduced mobility as the only parameter available for 
preliminary identification. In order to fully demonstrate the applicability of the IMS method 
in prison, the precision, the separation capability and limits of detection were determined. The 
estimated LODs for the synthetic cannabinoids are in the range of 0.7-3.6 ng. The evaluated 
LOD in previously published studies were 10-100 times lower than the LOD determined in 
this study [55]. This could be attributed to the fact, that the threshold was set to 100 du in this 
study to avoid false positive alarms. In contrast, Gwak et al.
241
 set a threshold of 2.5 du and 
demonstrated lower LOD. Higher LODs are also due to different ionization techniques. Gwak 
et al.
241
 and Armenta et al.
242
 used a 
63
Ni ionization source whereas in this study, a corona 
discharge ionization source based on APCI was used. However, for criminal investigations or 
to uncover drug trafficking in prisons, the LOD in the ng-range is sufficient. From common 
dosages described in different platforms we know, that there is a realistic value for the 
detection of consumable amounts of synthetic cannabinoids especially in herbal mixtures or 
on impregnated papers.
247
 A higher threshold and thus a lower sensitivity were accepted to 
avoid generation of false positive results in prison.  
Some publications reported that analytes with nearly the same chemical structure like the 
synthetic cannabinoids cannot be distinguished.
2,181
 In this study, all synthetic cannabinoids in 
demand were successfully detected by IMS when present as single substances independent of 
the matrix. The selectivity of the IMS was not always sufficient as shown for cases with two 
or more active ingredients with close K0 values. The necessary resolution R > 0.75 of mobile 
IMS for identification was estimated to require differences in drift times and reduced mobility 
values of > 0.15 ms ( > 0.013 cm²V
-1
s
-1
). Smaller differences led to an alarm only for the 
substance present at higher concentration. The active ingredients 5-F-ADB, AB-
CHMINACA, FUB-AMB and PB-22 from casework Samples 6, 28-30 show smaller 
differences in drift time and reduced mobility values. The limitation of portable IMS was the 
analysis of active ingredients in highly viscous matrices (toothpaste or liquid soap) and 
medicinal products (casework Sample 35). This was caused by the poor solubility and 
inhomogeneous distribution of the analytes in the cosmetic products. The latter was due to the 
high viscosity of the matrices. Methadone, amphetamine and tetrazepam could be detected but 
not 5F-ADB, buprenorphine and fentanyl HCI. In general, it seems that only liquids with a 
low viscosity are amenable for the detection of synthetic cannabinoids. Medicinal products 
contain an active ingredient. The selectivity of the mobile IMS is limited and may lead to 
false positive alarms. In these cases, chromatographic techniques coupled to mass 
spectrometry represent the analytical techniques of choice due to their high separation 
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capability and identification power, however, at the cost of speed, simplicity costs and 
especially the necessity of a laboratory environment and personnel.
47,108-110,123,134-136
 
2.6 Conclusion 
In this study, 25 different synthetic cannabinoids were successfully characterized by IMS in a 
rapid screening. For most of them, K0-values (1.0511-0.8069 cm
2
V
-1
s
-1
) and drift times 
(9.995-13.024 ms) were reported for the first time. LODs were sufficient to detect these 
analytes with regard to common dosages. The IMS software was programmed to generate 
alarms to allow prison staff to quickly test suspicious samples for illicit drugs. The 
applicability of this study is demonstrated by the analysis of several seized drug samples 
including 14 different herbal mixtures (from real cases of the Detection Centre of Rhineland 
Palatinate), 12 papers and 36 cases from prisons from Rhineland Palatinate. Of all sample 
types testes, on highly viscous matrices and medicinal products could not be analyzed 
successfully. This new IMS approach is an effective and non-destructive presumptive test 
with a direct indication of the presence of synthetic cannabinoid. The IMS guarantees a fast 
operation with a simple sample application by wiping the surface of a sample with a swab. It 
can easily be used by prison officers without requirement of special skills. Therefore, IMS is 
suitable for mobile usage in prisons. 
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3 Discrimination of synthetic cannabinoids in herbal 
matrices and of synthetic cathinone derivatives by 
portable and laboratory-based Raman 
spectroscopy 
3.1 Abstract 
One of the greatest challenges for European drug police and customs forces is how to 
effectively respond to the dynamically changing market for new psychoactive substances 
(NPS). Due to the NPS phenomenon, there is an increasing demand by customs or drug 
enforcement organisations for rapid and portable analytical techniques to characterise 
unknown samples, such as Raman spectroscopy, which are frequently used as first indicative 
techniques to detect controlled substances like illicit drugs. In this study, the effective 
discrimination of 28 synthetic cannabinoids and 15 synthetic cathinone derivatives using three 
different Raman spectrometers with different excitation wavelengths (532, 785 and 1064 nm) 
was investigated. The results show a high comparability of the Raman spectra from different 
spectrometers using spectral pre-processing methods. A PCA model allows assigning a 
substance to a specific substance class and additionally provides information on the nature of 
structural building blocks of the synthetic cathinone derivatives or synthetic cannabinoids 
being in the focus of this study. Characteristic group frequencies for synthetic cannabinoids 
and cathinone derivatives are summarised in tables to support future identification in other 
studies and in police and customs forensic case work. Combining both the use of 
chemometrics and Raman frequency tables has been shown as a successful tool to improve 
the characterisation of 60 seized herbal mixtures containing synthetic cannabinoids as active 
ingredients. 
3.2 Introduction  
The appearance of new psychoactive substances (NPS) on the European drug market is not a 
new phenomenon, but they still cause serious harm to consumers and represent a persisting 
challenge to drug enforcement organisations. 
6,250
 The distribution channels for NPS partly 
differ from those of classical drugs and the ordinary mail service is frequently used for the 
transport of hazardous NPS. The online market differentiates between three different selling 
strategies: shops offering NPS in the surface web 1) under their actual chemical names as 
“research chemicals”, 2) as blended and branded products in categories like “designer drugs,” 
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“legal highs,” “herbal highs,” “bath salts, ”Spice”1 or 3) shops offering NPS in the dark 
web.
251
 NPS have initially been designed to mimic established illicit drugs, such as cannabis, 
cocaine, amphetamine and lysergic acid diethylamide (LSD).
2,3
 In most cases no specific 
information on the active substance is given on the product label, thus the effects for NPS 
consumers are unpredictable and sometimes fatal.
10-12
 According to the versatile distribution 
channels, there is also a particular risk for public institutions handling these products 
including postal delivery facilities, custom controls and prisons.
252
 The term NPS comprises a 
wide variety of several types of psychotropic compounds with different effects including 
predominantly synthetic cannabinoids, synthetic cathinone derivatives, new synthetic opioids 
(e. g. fentanyl derivatives) and designer benzodiazepines.
170
 
The focus of this study is on the most common NPS in the European Union, that are 
represented by synthetic cannabinoids with 45 % of all seizures followed by synthetic 
cathinone derivatives with 33 %.
250
 Synthetic cannabinoids were initially designed to mimic 
the effects of delta 9-tetrahydrocannabinol (THC) in cannabis products. Therefore, pure 
synthetic cannabinoids are dissolved in a solvent such as acetone and sprayed onto the surface 
of dried plant material while stirring and sold in colourful and professionally designed 
packages as “herbal incense”.16,17 In contrast, synthetic cathinone derivatives are generally 
sold in powder form, they are chemically related to cathinone, the major active ingredient in 
the Khat plant
18
 and have similar effects to amphetamine and other stimulant drugs.
19
 Only 
few European countries list specific synthetic cathinone derivatives and cannabinoids in their 
drug law
9
, but the discrimination of new substances with often only small modifications in the 
chemical structure require selective analytical methods, which can easily comprise further 
compounds.
7
 
Currently, inherently portable spectroscopic methods like Infrared- and Raman spectroscopy 
are the techniques of choice for rapid and mobile on-site analysis of NPS due to their high 
identification potential via spectral fingerprinting.
59-61,253
 According to the recommendations 
of the scientific working group for the analysis of seized drugs (SWGDRUG), Raman and IR 
spectroscopy are category A analytical techniques with maximum discriminating power along 
with other typically laboratory-based techniques (such as NMR- and mass spectrometry).
45
 
An important feature of portable Raman instruments compared to IR spectrometers is the 
possibility of direct analysis of packaged substances. Plastic bags and glass bottles are often 
transparent to the laser radiation of Raman spectrometers and a direct contact of the operator 
with hazardous and highly potent materials such as fentanyl derivatives is avoided.
74
 
Several publications evaluated the use of Raman for NPS products with different focal 
points.
59,75,77,84-95
 In some publications, the effect on Raman spectra generated using different 
excitation wavelengths including 785 nm and 1064 nm were discussed.
86,90,96
 Major 
limitations in NPS analysis with these techniques, however, may arise from matrix 
components, especially herbal mixtures in case of synthetic cannabinoids due to low active 
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ingredient contents. Comparison of the Raman spectra generated by different Raman 
spectrometers or different operating conditions were evaluated using instruments` in-built 
algorithms to determine the Hit quality index (HQI) 
86
 or dissimilarity calculations.
85
 These 
studies aimed at constructing and validating spectral libraries to guarantee a possible transfer 
of those databases to other (portable) Raman spectrometers, sometimes using chemometric 
models, especially principal component analysis (PCA). Hargreaves et al. described the 
identification of classical drugs including cannabis, cocaine, amphetamine, MDMA and 
heroine using PCA.
71
 Regarding NPS, Omar et al. described the prediction potential when 
assigning an unknown substance to a substance class, whose spectrum is not present in a 
reference library, originally recorded for fentanyl derivatives, synthetic cathinone derivatives 
and synthetic cannabinoids.
84
 Mohammadi et al. expanded the investigated substances classes 
with aminoindanes and diphenidines using surface enhanced Raman scattering.
91
 The 
potential of dual laser excitation wavelengths (785 and 1064 nm) was discussed in the work 
of Assi et al., where aminoindanes, benzodiazepines, synthetic cathinone derivatives, 
phenmetrazine derivatives, phenidate derivatives and methamphetamine derivatives.
88
 Calvo-
Castro et al. demonstrated the predictive potential of representative libraries and their PCA 
models for structurally related NPS subgroups.
85
 Mostly, PCA models focus on substance 
classes but not on the distinction of substances within one substance class. 
For further characterisation within the class of cathinone derivatives and synthetic 
cannabinoids, a detailed interpretation of Raman spectra is necessary with a clear assignment 
of specific bands to a group frequency for NPS, especially for synthetic cannabinoids. Lobo et 
al. described Raman bands of 5F-AMB with a detailed table for all possible vibrational 
modes.
95
 For criminal investigations, it would be of interest to be able to identify the different 
core structures, linkers and linked group by Raman spectroscopy. This aspect is envisaged in 
the study presented here. Furthermore, we show for the first time that a straightforward 
sample preparation procedure using solid/liquid extraction followed by precipitation of the 
contained synthetic cannabinoids allows their identification in herbal products. We here 
combine PCA models with frequency tables from the reference library to more deeply 
characterise synthetic cannabinoids and cathinone derivatives using both benchtop and 
portable Raman spectrometers. The applicability of this approach was proven by the 
successful analysis of 60 herbal mixtures from police seizures. 
3.3 Materials and Methods 
3.3.1 Chemicals 
The reference material of 43 NPS (powders) employed in this study was provided by the EU-
project “ADEBAR”, which was co-funded by the Internal Security Fund of the European 
Union (IZ25-5793-2016-27). It is a cooperation project of the Federal Criminal Police Office, 
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seven State Bureaus of Criminal Investigation and German Customs. Seized samples are used 
to generate analytical standards not commercially available otherwise. Thus, new drugs 
appearing on the illicit drug market in Germany from 07/2017 to 07/2019 from various 
sources were identified by different analytical techniques (e.g. 
1
H-NMR). Technical 
information, the sample preparation steps and method parameters of the purity determination 
of NPS samples from seizures which was conducted by quantitative NMR (qNMR) are 
described by Schoenberger.
49
 In Chapter 2 and in the publication of Metternich et al., the 
details of NMR analysis are summarised.
248
  
Table 3-1 shows all 43 reference standards of this study, 28 synthetic cannabinoids and 15 
synthetic cathinone derivatives. Exemplarily, Figure 1-3 shows the structure of the synthetic 
cannabinoid AB-CHMINACA with specific components core, linker and linked group.
15
 
60 herbal mixtures from police seizures with 10 different synthetic cannabinoids as active 
ingredients were provided by the State Office of Criminal Investigation Rhineland-Palatinate.  
Table 3-1 Chemical structures of the reference standards (powders) including a) synthetic cannabinoids and b) 
synthetic cathinone derivatives evaluated in this study with information of the corresponding source ADB (EU-
project ADEBAR) or RLP (seized samples provided by State Office of Criminal Investigation Rhineland-
Palatinate) 
substances 
Chemical 
structure 
MW 
in 
g/mol 
substances 
Chemical 
structure 
MW 
in 
g/mol 
Synthetic cannabinoids 
Indazole-cores Indole and azaindole-cores 
5-Cl-AKB-48 
 
399.21 5F-PB-22 
 
376.43 
5F-ADB 
 
377.21 APICA 
 
364.53 
AB-CHMINACA 
 
356.47 
 
JWH-200 
 
384.48 
A-CHMINACA 
 
391.56 
MDMB-
FUBICA 
 
396.46 
Raman spectroscopy 
 
 
45 
 
substances 
Chemical 
structure 
MW 
in 
g/mol 
substances 
Chemical 
structure 
MW 
in 
g/mol 
ADB-
CHMINACA 
 
370.50 
MMB-
CHMICA 
 
379.49 
ADB-
FUBINACA 
 
382.44 SDB-006 
 
306.41 
AKB-48  
 
362.52 UR-144 
 
325.50 
AMB-
FUBINACA 
 
383.42 XLR-11 
 
329.46 
THJ-2201 
 
360.43 
AB-5F-
P7AICA 
 
348.42 
THJ-018 
 
342.44 
MDMB-5F-
P7AICA 
 
377.46 
Carbazole and gamma-carboline-cores 
AB-FUBINACA 
 
368.41 
Cumyl-5F-
P7AICA 
 
367.47 
5F-AMB 
 
363.43 EG-018 
 
391.51 
5F-AKB-48 
 
383.51 
MDMB-
CHMCZCA 
 
448.61 
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substances 
Chemical 
structure 
MW 
in 
g/mol 
substances 
Chemical 
structure 
MW 
in 
g/mol 
Cumyl-4-CN-
BINACA 
 
360.46 
Cumyl-
PeGaClone 
 
372.51 
Synthetic cathinone derivatives 
Benzyl-cathinones 3,4-methylenedioxybenzene-cathinones 
alpha-PiHP 
 
245.37 dibutylone 
 
235.28 
alpha-PPP 
 
203.29 ephylone 
 
249.31 
buphedrone 
 
177.25 MDPHP 
 
289.38 
1-(4-methylphenyl)-cathinones 1-(4-chlorophenyl)-cathinones 
4-methylpentedrone 
 
205.30 
4-Cl-
butylcathinone 
 
239.74 
N-ethyl-4-
methylnorpentedrone 
 
219.33 
4-Cl-
ethcathinone-
HCl  
211.69 
N-ethylnorhexedrone 
 
233.36 
4-Cl-N,N-
dimethylcathino
ne  
211.69 
N-methylbenzedrone 
 
267.37 
4-Cl-
pentedrone-HCl 
 
225.72 
 
4Cl-PVP-
HCl 
 
265.78 
3.3.2 Methodology 
3.3.2.1 Raman spectroscopy 
The analysis of the reference standards was carried out with three different Raman 
spectrometers including one benchtop and two portable devices. Seized herbal mixtures were 
analysed using only the benchtop spectrometer with microscope. Identical operating 
conditions were used for powders and extracts from herbal mixtures. 
Spectrometer 1: A benchtop Bruker (Ettlingen, Germany) Senterra Infinity 1 Raman 
spectrometer with a laser wavelength of 532 nm and a laser power of 10 mW was used. The 
operating software was OPUS 7.0. The reference standards were prepared by placing 1-5 mg 
onto a glass slide. Solid/liquid extraction of 100 mg herbal mixture with 1 mL 
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dichloromethane (Merck, Darmstadt, Germany) was accomplished, followed by filtration with 
syringe filters from Macherey-Nagel (Düren, Germany) with a pore size of 0.20 µm and a 
diameter of 25 mm and precipitating the synthetic cannabinoids by adding 2 mL ice cold 
water to the organic extract while keeping plant constituents in the organic phase. The 
precipitate was collected by decantation and dried directly on a glass slide under a flow of 
nitrogen at 45 °C and then placed under the microscope of the Raman spectrometer. The 
sample spectra were acquired with a runtime of 30 s with 10 scans/spectrum and stored in a 
database (OPUS 7.0). The wavelength resolution was set to 3-5 cm
-1
 with a scan range of 150-
3400 cm
-1
. All microscope data were collected using a 20x objective with a pinhole-type 
aperture of 50 µm. For each sample, 3 measuring points were sampled to check the spatial 
consistency of the spectral profiles. Homogeneity of the samples was verified by overlaying 
the 3 generated Raman spectra and a visual comparison of the spectral quality. Thus, for 
further analysis, averaged spectra were used. 
Spectrometer 2: The first portable Raman spectrometer, a Progeny ResQ from RIGAKU 
(Neu-Isenburg, Germany) was equipped with a 1064 nm Nd:YAG laser. The Raman spectra 
were recorded at the maximum laser power of 490 mW with a wavelength resolution of 8-
11 cm
-1
 and a scan range of 200-2 500 cm
-1. Each Raman spectrum was collected in the “auto 
mode”, which means that the scans/spectrum (1-3) and the duration of a scan (1 000-
3 000 ms) were set automatically by the system.  
Spectrometer 3: The second portable Raman spectrometer from BWTek LLC (Newark, USA) 
was an i-Raman Plus system with a BWS465-785S spectrometer, which was equipped with a 
laser emitting at a wavelength of 785 nm. The scan range was 174-3200 cm
-1
 and the 
wavelength resolution was set to 4.5 cm
-1
. All microscope data were recorded using a 20x 
objective with BAC151B Raman Video Microsampling System (camera: active pixels: 1 280 
x 1 024) using: BWSpec 4.03_23_C software. The integration time (in ms) was chosen and 
adjusted in a way that a relative intensity preferably above 45 000 for the most intensive peak 
was reached. The laser power was set to 207 mW, the integration time ranged from 5 000-
250 000 ms. 10 scans/spectra were recorded. The powdered material was measured directly 
through a grip-bag or on a cap with the Video Microsampling System.  
3.3.2.2 UPLC-DAD 
The quantitative analysis of synthetic cannabinoids in 60 herbal mixtures from seizures were 
carried out using an UPLC Aquity-System (Waters, Milford, MA, USA) equipped with diode 
array detection (DAD). Further technical information, method parameters are given in 
Chapter 2.3.2.3 and in the publication of Metternich et. al.
248
 
The quantification of herbal mixtures was carried out using a 7-point-calibration (n = 3) in the 
range of 0.25-0.005 mg/mL (in methanol) with the appropriate reference standard. 100 mg of 
the herbal mixture were suspended in 10 mL methanol for 20 min. The solutions were filtered 
with syringe filters from Macherey-Nagel (Düren, Germany) with a pore size of 0.20 µm and 
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a diameter of 25 mm. Subsequently, 100 µL of the filtered sample solution were transferred 
into UPLC vials and diluted with 900 µL methanol for injection (injection volume 5 µL). For 
recovery calculations of the solid/liquid-extraction (described in Section 2.2.1.1), the 
precipitate was dissolved in methanol (Merck, Darmstadt, Germany) to achieve a 
concentration of 1 mg/mL. Subsequently, 100 µL of the filtered sample solution were 
transferred into UPLC vials and diluted with 900 µL for injection (injection volume 5 µL). 
3.3.3 Data treatment and chemometrics  
Raman spectra of Spectrometer 1 were recorded directly with OPUS 7.0 software and saved 
in spc-format. Data from the portable Spectrometers 2 and 3 were exported as spc-files and 
imported into OPUS 7.0 software. Data pre-treatment was independent of the instrument. 
3.3.3.1 Baseline correction 
All spectra were baseline corrected using the “concave rubberband correction” algorithm 
(patented method by Bruker (Ettlingen, Germany)) with 10 iterations and 60 baseline points. 
This method divided the spectra into 60 wavenumber ranges ( = baseline points) of equal size 
and the intensity minima of each range are determined. These minimal baseline points were 
connected by straight lines. 
3.3.3.2 Algorithm for spectral comparison  
The comparison of the Raman spectra recorded by spectrometers against the reference library 
(recorded by Spectrometer 1) is achieved by a Min-Max normalisation. This normalisation 
method performs a linear transformation on the data by transferring the minimum value of a 
band to 0 and the maximum value to 1. All other values were transformed to a decimal 
between 0 and 1. The maximum and minimum of a value x (minx and maxx) for each band are 
calculated to get normalised data point x´: 
 
𝑥` = [
(𝑥 − 𝑚𝑖𝑛𝑥)
(𝑚𝑎𝑥𝑥 − 𝑚𝑖𝑛𝑥)
] 
 
Afterwards, the algorithm “spectra correlation” (OPUS 7.0) was applied to show the 
comparability of Raman spectra recorded by different instruments. Here, the sum of the 
squared deviations between the library spectrum (Libm) (from Spectrometer 1) and the 
spectrum (Unknm) from Spectrometer 2 or 3 for each data points is calculated. The Hit quality 
(HQ) is calculated as follows: 
 
𝐻𝑄 = [1 −
(𝐿𝑖𝑏𝑚 ∗ 𝑈𝑛𝑘𝑛𝑚)
2
(𝐿𝑖𝑏𝑚 ∗ 𝑈𝑛𝑘𝑛𝑚)(𝑈𝑛𝑘𝑛𝑚 ∗ 𝑈𝑛𝑘𝑛𝑚)
] ∗ 100 
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𝐿𝑖𝑏𝑚 = 𝐿𝑖𝑏 − [
∑ 𝐿𝑖𝑏𝑖
𝑛
𝑖=1
𝑛
] 
 
𝑈𝑛𝑘𝑛𝑚 = 𝑈𝑛𝑘𝑛 − [
∑ 𝑈𝑛𝑘𝑛𝑖
𝑛
𝑖=1
𝑛
] 
 
A HQ of 100 % indicates identity to the library spectrum. In this study, the threshold for a 
positive hit was set to 85 % for all spectrometers. 
3.3.3.3 PCA 
Principal component analysis (PCA) was conducted using the software “Unscrambler X” by 
CAMO Analytics (Trondheim, Norway) after import of baseline corrected Raman spectra 
(concave rubber band method) in the spc-file format. 
PCA requires a prior normalisation step of all spectra, which was performed by a standard 
normal variate (SNV).
254
 This algorithm centre and scale individual spectra to removes scatter 
effects from spectral data without smoothing the spectra information.  
3.4 Results and discussion 
3.4.1 Comparison of different Raman spectrometers  
All Raman spectra generated by Spectrometers 2 and 3 were matched against the reference 
library (recorded by Spectrometer 1) to determine the Hit qualities. The Raman spectra (pre-
processed) of all reference sample recorded by Spectrometer 1 are shown in the publication of 
Metternich et al. (Figure S1).
255
 Both, non-processed (without any chemometric data 
treatment) and pre-processed (for details see Section 2.3 Data treatment and chemometrics) 
Raman spectra were investigated. Figure 3-1 a, b and c show the effects of the pre-processing 
steps for the Raman spectra of a representative cathinone (4-chlorobutylcathinone). 
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Figure 3-1 Comparison of Raman spectra (Trace 1 recorded with Spectrometer 1, Trace 2 recorded with 
Spectrometer 2 and Trace 3 recorded with Spectrometer 3) of a)-c) 4-chlorobutylcathinone and d) AMB-
FUBINACA including Raman spectra a) without any chemometric pre-treatment, b) after baseline correction 
and c) after baseline correction and normalisation d) normalised and baseline-corrected with T, C, L and LG 
which indicate characteristic bands for tail, core, linker and linked group 
Both, non-processed (without any chemometric data treatment) and pre-processed (for details 
see Section 2.3 Data treatment and chemometrics) Raman spectra were investigated. Figure 
3-1 a), b) and c) show the effects of the pre-processing steps for the Raman spectra of a 
representative cathinone (4-chlorobutylcathinone). Despite differences in exposure time, laser 
power, resolution and laser wavelength, the frequencies and the relative intensities of specific 
Raman bands were similar for the three Raman spectrometers. Clearly, resolution decreases 
for Spectrometer 1 to 3. In addition, signal-to-noise (S/N-) ratios differ with Spectrometer 1 
showing an S/N of 101-592, Spectrometer 2 of S/N = 30-107, and Spectrometer 3 of 
S/N = 18-48. A similar result is obtained for synthetic cannabinoids as shown in Figure 3-1d 
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for AMB-FUBINACA, demonstrating also that the chosen spectral pre-processing with 
baseline correction and normalisation is suitable. Especially, the concave rubberband baseline 
correction was advantageous for spectra recorded with Spectrometer 3 in particular, where 
fluorescence was observed. To guarantee that no information is lost upon pre-processing, 
processed Raman spectra were matched against non-processed spectra recorded with 
Spectrometer 1. Hit qualities above 98 % were obtained. Further normalisation tools were 
tested, which were offered by OPUS 7.0. Among then, Min-Max normalisation revealed 
better Hit qualities than vector normalisation. Regarding correlation of spectra, we observed 
that the correlation algorithm was better suited for the comparison of the Raman spectra than 
the “Euclidean distance algorithm” (OPUS 7.0 software). However, we experienced it to be 
less tolerant to slight peak shifts ( > 2 cm
-1
), differences in the peak width at half height as 
well as relative intensities which could be present due to the use of different spectrometers. 
Thus, for further analysis, the correlation algorithm was preferred. Table 3-2 summarises the 
Hit qualities between the reference spectra (Spectrometer 1) and spectra from the two portable 
Raman devices of non-processed and pre-processed spectra for the 43 reference standards. 
The Hit quality ranged between 87-96 % with a threshold set to 85 %. This threshold value is 
recommended by the manufacturer of the applied portable Raman spectrometers and is also 
preferred in forensic institutions in Germany, which is further justified with regard to the 
different operating parameters of the instruments. Guirguis et al. 
86
 described correlations 
between internet products with NPS signature with Hit qualities that ranged from 57.0 to 
84.1 % using an excitation wavelength of 785 nm and from 60.0 to 91.3 % using a laser 
excitation wavelength of 1064 nm. The authors showed that every tested standard was 
correctly identified with the help of the reference library, also with Hit qualities < 90 %. 
Overall, “Spectrometer 3” showed better Hit qualities (by 2 % on average) for non-processed 
Raman spectra. This is due to the facts that the S/N ratio was a factor of 10 smaller than for 
Spectrometer 1. Other baseline correction methods provided by OPUS 7.0 like scattering 
correction and normal rubber band correction revealed the same Hit qualities. In contrast, the 
Hit quality obtained in the comparison with spectra from “Spectrometer 2” was largely 
independent of the data pre-treatment: non-processed spectra showed similar results. It can be 
concluded that the determination of Hit qualities of Raman spectra between different 
spectrometers requires test measurements and the evaluation of different chemometric models 
to enhance comparability. 
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Table 3-2List of 28 synthetic cannabinoids and 15 synthetic cathinone derivatives with the data from UPLC-
DAD measurements with the absorption maximum (λmax), sample purity as determined by NMR, Hit quality 
values of the portable Raman spectrometers (Spectrometers 2 and 3) against the reference database generated 
with Spectrometer 1 for both pre-processed and non-processed spectra 
Substance 
Hit quality (Portable Spectrometers against reference library) 
“Spectrometer 2” “Spectrometer 3” 
Pre-processed 
spectra in % 
Non-processed 
spectra in % 
Pre-processed 
spectra in % 
Non-processed 
spectra in % 
5-Cl-AKB-48 93 93 91 91 
5F-ADB 94 92 86 92 
5F-PB-22 87 87 88 92 
5F-AMB 91 90 90 91 
5F-AKB-48 91 90 89 90 
AB-5F-P7AICA 93 92 87 89 
AB-CHMINACA 92 92 87 88 
A-CHMINACA 93 93 90 89 
ADB-CHMINACA 91 90 87 87 
AB-FUBINACA 90 89 89 90 
ADB-FUBINACA 88 87 87 90 
AKB-48 (APINACA) 94 94 88 92 
AMB-FUBINACA 96 92 87 93 
APICA 89 88 90 93 
Cumyl-4-CN-BINACA 95 94 87 91 
Cumyl-5F-P7AICA 93 90 89 90 
Cumyl-PeGaClone 92 92 90 91 
EG-018 97 97 90 93 
JWH-200 87 87 87 90 
MDMB-5F-P7AICA 96 87 90 94 
MDMB-CHMCZCA 86 88 90 91 
MDMB-FUBICA 94 93 87 88 
MMB-CHMICA 90 90 88 89 
SDB-006 90 90 88 89 
THJ-018 93 92 89 92 
THJ-2201 93 93 87 90 
UR-144 91 91 88 91 
XLR-11 92 93 87 91 
4-chlorobutylcathinone 93 92 89 90 
4-chloroethcathinone-HCl 95 95 91 91 
4-chloro-N,N-dimethylcathinone 91 92 90 88 
4-chloropentedrone-HCl 92 91 90 89 
4Cl-PVP-HCl 92 93 88 87 
4-methylpentedrone 90 91 86 86 
alpha-PiHP 91 90 87 89 
alpha-PPP 93 94 88 86 
buphedrone 92 91 87 95 
dibutylone 90 94 90 94 
ephylone 93 92 93 96 
MDPHP 90 90 86 88 
N-ethyl-4-methylnorpentedrone 92 91 87 88 
N-ethylnorhexedrone 92 92 88 92 
N-methylbenzedrone 94 94 84 91 
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3.4.2 Principal Component Analysis 
PCA was carried out with all spectroscopic data of the 43 reference standards recorded by the 
three Raman spectrometers. A common region of interest (ROI) of 550-1750 cm
-1
 of the 
Raman spectra was selected. This ROI provided the most reliable information in the 
fingerprint region with a large number of bands being significant for discrimination (see 
discussion below). In addition, especially Spectrometer 3 showed noisy baselines in the 
spectral region of 200-550 cm
-1
 as visible in Figure 3-1. Figure 3-2 and Figure 3-3 show the 
score and loadings plots for synthetic cathinone derivatives (Figure 3-2a and b) and synthetic 
cannabinoids (Figure 3-3a-f). The variances covered by the first two principal components 
(PCs) are relatively low (49 % for synthetic cathinone derivatives and 37 % for synthetic 
cannabinoids) because all data points of the Raman spectra in the range of 550-1750 cm
-1
 
were considered for PCA. Differences in signal intensities, resolution, noise and S/N-ratios of 
the three Raman spectrometers further induce variances. Nevertheless, the first two PCs 
provided sufficient information for the discrimination of structural features for both substance 
classes as visible from Figure 3-2 and Figure 3-3 (see discussion below). Similarly, Omar et 
al. grouped fentanyls, synthetic cannabinoids and synthetic cathinone derivatives using PCA 
with PC-1 and PC-2 contributing only to 37 % among the data. They also successfully used 
the whole Raman spectra for comparison in the range of 680–1725 cm-1.84 The use of the 
whole Raman spectrum is advantageous with regard to the ease of application in fast 
screening scenarios. The Raman spectra generated by different Raman spectrometers (and 
thus different operation conditions) showed a high degree of similarity which is corroborated 
by PCA. Synthetic cathinone derivatives with a 3,4-methylenedioxybenzene group and 
indazole-type synthetic cannabinoids form clusters plotting PC-1 vs. PC-2 (see Figure 3-2a 
and Figure 3-3a). 
In Figure 3-2a, the score plot of PC-2 versus PC-1 for synthetic cathinone derivatives is 
shown. Four clusters are visible without overlap, which can mainly be assigned to the 
different substituents on the benzene ring. The 3,4-methylenedioxybenzene (MDB) cathinone 
derivatives are described by negative scores on PC-1 and positive scores on PC-2 with 
characteristic loadings at ~1354 cm
-1
, ~1600 cm
-1 
(PC-1) and 1680 cm
-1
 (PC-1 and PC-2) 
marked with MDB in Figure 3-2b. The 1-(4-chlorophenyl)-cathinones show positive scores 
on PC-1 and PC-2 with a large impact by bands of ~1088 cm
-1
 (PC-2), ~1690 cm
-1
 and 
~1588 cm
-1
 (PC-1 and PC-2) according to the loadings plot in Figure 3-2b, labelled with Cl. 
The substitution on the benzene ring influences the frequency of molecular vibration. 
Whereas the 1-(4-methylphenyl)-cathinones have scores on PC-1 and PC-2 close to zero (not 
explicitly shown in Figure 3-2b), the benzyl group itself leads to negative scores on PC-2 
(marked with Benz in Figure 3-2b). Responsible for this shift is the band near 1000 cm
-1
, 
representing a band with the highest loadings for PC-2. Only negligible differences are 
induced by methyl substituents.  
Raman spectroscopy 
 
 
54 
 
 
Figure 3-2 PCA score plots and loading plots computed for the Raman spectra of all reference samples 
measured with three different Raman spectrometers (including one benchtop-spectrometer (“Spectrometer 1”) 
and two portable devices (“Spectrometer 2 and 3”), with a) all synthetic cathinone derivatives with the degree of 
similarity between pre-processing Raman spectra recorded on different Raman spectrometers (1-3) for selected 
substances with b) loadings plot of PC1,2 with characteristic loadings for MDB = 3,4-methylenedioxybenzene 
cathinones, Cl = 1-(4-chlorophenyl)-cathinones and Benz = benzyl-cathinones 
In Figure 3-3a, the scores plot of PC-1 versus PC-2 for synthetic cannabinoids, labelled 
according to their core structure, is shown. The aromatic system is well described by the first 
five PCs (63 % of the variance explained on total). Two clusters of synthetic cannabinoids 
with an indazole core structure can be observed. The larger cluster consisting of nine different 
cannabinoids (overall 27 data points for the three different Raman spectrometers) shows 
negative scores on PC-1 and positive scores on PC-2 with characteristic loadings 
for  1405 cm
-1
, 1350 cm
-1
, 1470 cm
-1 
(PC-1) and 775 cm
-1 
(PC-2), marked with Iz in Figure 
3-3b. The second smaller cluster consists of two indazole-based synthetic cannabinoids, THJ-
2201 and THJ-018, with overall 6 data points for the three different Raman spectrometers. 
These substances show negative scores for PC-2 similar to synthetic cannabinoids with 
carbazole core structure. These two substances have a keto group as a linker connected to a 
naphthyl-moiety as a linked group as in EG-018 (see Table 3-1), producing relatively similar 
Raman spectra. In Figure 3-3c, a graph of PC-4 versus PC-3 is shown, which provides 
information to distinguish between these substances. Specific wavelengths of carbazole core 
structures can be identified by negative scores on PC-2 at 1570 cm
-1
 (Figure 3-3b) and PC-3 
at 1220 cm
-1
 (Figure 3-3d).  
Overall, indazoles can well be discriminated from indoles and azaindoles due to the N-N 
stretching vibration in the region of 1405 cm
-1
 (see loadings plot for PC-1 in Figure 3-3b) in 
the indazole ring system). The indoles and azaindoles are primarily described by positive 
scores on PC-1 and PC-2 with loadings at 1620 cm
-1
 (PC-1 and PC-2), 1520 cm
-1
, 1340 cm
-1
 
and 1010 cm
-1
 (PC-1), labelled with I in Figure 3-3b. The classes of azaindoles and indoles 
have overlapping clusters when plotting PC-2 vs. PC-1. However, comparing PC-5 versus 
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PC-2 (20 % variance explained) allows further distinguishing between these classes due to 
large positive scores on PC-5 (see Figure 3-3e and f) for azaindoles evoked by the band at 775 
cm
-1
 marked with Az in the corresponding loadings plot. A relatively wide cluster of indole 
compounds can be observed due to the high variety in the linker group including amide, keto 
and ester-linkages. The amide linkage shows positive scores only for PC-1 whereas keto-
linkage shows positive scores for both PC-1 and PC-2. In addition, the indole compound 5F-
PB-22 is the only substance that carries an ester-group as a linker. This substance has both 
PC-1 and PC-2 values close to zero. No influence by the tail group was observed on cluster 
formation (data not shown explicitly). It was illustrated that for synthetic cannabinoids and 
synthetic cathinones derivatives, the assignment to a specific group according to their cores 
was very efficient using PCA. However, the application is limited in case of structurally 
closely related substances. The close-ups in Figure 3-2a and Figure 3-3a demonstrate that for 
MDPHP (Figure 3-2a) and AMB-FUBINACA (Figure 3-3a) the differences in PC-1 and PC-2 
are too small to be discriminated when different spectrometers are used. This shows that PCA 
alone is not capable to identify unknown substances when using different spectrometers, but 
has to be supported by a reference library. 
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Figure 3-3 PCA score plots and loading plots computed for the pre-processes Raman spectra of all reference 
samples measured with three different Raman spectrometers (including one benchtop-spectrometer 
(“Spectrometer 1”) and two portable devices (“Spectrometer 2 and 3”), with a-f) synthetic cannabinoids with 
the degree of similarity between Raman spectra recorded on different Raman spectrometers (1-3) for selected 
substances with a) PC-2 vs. PC-1 and c) PC-5 vs.PC-2 and e) PC-4 vs. PC-3 with characteristic loadings (b), d), 
f)) for I = indoles and azaindoles, Iz = indazoles, Ca = carbazoles and Az = azaindoles (to distinguish between 
indoles) 
 
3.4.3 Characteristic Raman bands for both, synthetic cathinone derivatives 
and synthetic cannabinoids 
Only a few publications have interpreted Raman spectra of synthetic cathinone derivatives 
and synthetic cannabinoids with regard to group frequencies.
77,89,95
 In our study, we identified 
discriminating and characteristic structural vibrations of NPS based on the PCA results, 
especially the loadings plots (see Tables 3-7). Raman spectra for representative substances are 
presented in Figure 3-4, where the main vibrational frequencies are marked. The Raman 
spectra of all reference sample (pre-processed as described in Section 2.3 Data treatment and 
chemometrics) recorded by Spectrometer 1 are shown in the publication of Metternich et al. 
(Figure S1).
255
 The Tables include the observed wavenumbers of the vibration, the intensity 
(recorded with Spectrometer 1) and a tentative assignment to the associated functional group 
and the characteristic values derived from the loadings plot for all NPS analysed. These 
Tables served as a powerful tool for substance identification in seized samples as 
demonstrated in section 3.4.4.  
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Figure 3-4Raman spectra (baseline corrected and normalised) recorded with Spectrometer 1 with specific 
vibrational frequencies of a) four representative synthetic cathinone derivatives, each with different substituents 
on the benzyl-group, with 1 = 4-methylpentedrone, 2 = ephylone, 3 = buphedrone, 4 = 4-Cl-PVP (with arrows 
labelled bands are discussed in the text) and b) four representative synthetic cannabinoids, each with different 
core-groups including 1 = 5F-ADB, 2 = MDMB-5F-P7AICA, 3 = XLR-11 and 4 = MDMB-CHMCZCA 
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3.4.3.1 Raman bands specific for synthetic cathinone derivatives 
In Table 3-3, the Raman bands of four classes of synthetic cathinone derivatives are described 
differing in the substitution at the aromatic ring: benzyl-cathinones without an additional 
functional group, 3,4-methylenedioxybenzene-cathinones and 1,4-disubstituted-cathinones 
possessing either a methyl group (1-(4-methylphenyl)-cathinones) or a chloro-atom (1-(4-
chlorophenyl)-cathinones). The spectrum of one representative of each class is given in 
Figure 3-4a. Benzyl-cathinones experience a strong in-plane ring deformation at 1010 
±10 cm
-1
 assigned as Wilson mode ν12, which involves displacing alternating carbon atoms 
around the ring. The modes give rise to the most intense bands in the Raman spectra of N-
ethylnorhexedrone, alpha-PiHP, alpha-PPP and buphedrone (all benzyl-cathinones) as also 
visible in the loadings plot of PC-2. This band is specific for benzyl-cathinones (see Figure 
3-2a and b) as this breathing motion is independent of the substituent as long as the 
substituents are located at the 1-, 1,3-, or 1,3,5-position. When the benzene is 3,4- or 1,4-
disubstituted both groups of alternating carbon atoms in the aromatic ring are substituted and 
the band corresponding to Wilson mode ν12 is shifted from 1010 cm
-1
 to 1056-1101 cm
-1
. The 
following trend was observed: benzyl-cathinones (998-1000 cm
-1
) < 1-(4-methylphenyl)-
cathinones (1056-1073 cm
-1
) < 1-(4-chlorophenyl)-cathinones (1087-1091 cm
-1
) < 3,4-
methylenedioxybenzene-cathinones (1095-1101 cm
-1
), see also Table 3-3. Obviously, beside 
steric effects and mass differences, electron-accepting moieties (Cl, methylenedioxy) increase 
the double-bond character of the aromatic ring system and thus increase the frequency of the 
bond-vibration. Two further strong bands for synthetic cathinone derivatives were identified 
from their high loadings on PC-1 at 1596 ±11 cm
-1
 and 1684 ±14 cm
-1
 (see Figure 3-2b) in the 
spectra of all synthetic cathinone derivatives being strongest for 3,4- and 1,4-disubstituted 
benzenes. The first band at ca. 1596 cm
-1
 is distinct and assigned to the ν8β mode. The 
intensity of second band around 1684 cm
-1
 from aromatic C=C stretching is enhanced 
compared to benzyl cathinones due to the conjugated carbonyl stretching vibration. MDPHP, 
ephylone and dibutylone show an additional band at 1610-1623 cm
-1
, representing a useful 
marker for the 3,4-methylenedioxy substituted-cathinone derivatives not present for any other 
NPS (marked MDB in PC-2 in Figure 3-2b). This distinguishing feature has also been 
reported to be present in the Raman spectrum of MDMA 
77
. Another region of interest is 
1206-1257 cm
-1
 where bands are observed from aromatic C-H in-plane deformation 
vibrations. There is a clear shift in wavenumbers according to the substitution on the benzene 
ring: 1-(4-methylphenyl)-cathinones (1205-1212 cm
-1
) < benzyl-cathinones (1208-1238 cm
-
1
) < 1-(4-chlorophenyl)-cathinones (1230-1241 cm
-1
) < 3,4-methylenedioxybenzene-
cathinones (1252-1257 cm
-1
). The C-H out-of-plane deformation vibrations in the region of 
580.2-811.3 cm
-1
 show an opposite trend in the shift in wavenumbers: 1-(4-methylphenyl)-
cathinones (801-811 cm
-1
) > benzyl-cathinones (752-772 cm
-1
) > 1-(4-chlorophenyl)-
cathinones (744-754 cm
-1
) > 3,4-methylenedioxybenzene-cathinones (580-584 cm
-1
).  
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Bands at 614-638 cm
-1
 arise from aromatic C-C in-plane deformation vibration. Typically, 
this vibration is assigned to benzene as a medium strong band near 606 cm
-1
 (benzyl 
cathinones at 615 cm
-1
), which becomes shifted to higher wavenumbers upon substitution 
(vibration called ν6b mode). Strong shifts to 626-638 cm
-
1 are observed for para-substituted 
benzenes and even further to 713 cm
-1
 in case of 3,4-methylenedioxy-cathinones (see Figure 
3-2b).Para-substituted cathinone derivatives, including 1-(4-methylphenyl)-cathinones and 1-
(4-chlorophenyl)-cathinones, can be distinguished due to ring breathing coupled with C-Cl 
stretching vibrations with a typical band of strong-to-medium intensity in the region 265-
385 cm
-1
 due to C-Cl in-plane deformation vibration. The substances 4-chloro-N,N-
dimethylcathinone, 4Cl-PVP, 4-chloroethcathinone, 4-chloropentedrone and 4-
chlorobutylcathinone show weak bands at 289-300 cm
-1
 with overtone bands of medium 
intensity at 1510-1450 cm-
1
. The 1-(4-chlorophenyl)-cathinones have a weak band between 
1453-1468 cm
-1
, described to be characteristic for these compounds by Christie et al.
103
 and 
Stewart et al. 
77,89
 and also visible in Table 3-3 (specific for benzyl-cathinones, 3,4-
methylenedioxybenzene-cathinones and those with a methyl or fluoro-moiety on the benzene 
ring).  
3.4.3.2 Raman bands specific for synthetic cannabinoids 
In Tables 4-7, the group frequencies of specific structural elements with the highest intensity 
in the spectra of synthetic cannabinoids (shown in bold) are summarised with the core (Table 
3-4), the linker (Table 3-5), the linked group (Table 3-6) and the tail (Table 3-7). These 
structural elements are depicted in Figure 1-3. One spectrum for a representative synthetic 
cathinone derivative of each class of ring substitution is given in Figure 3-4b. 
a) Core group 
The identification of synthetic cannabinoids via characteristic Raman bands of the indole-core 
is supported by studies on indole and tryptophan by Miura et al. and Takeuchi et al. and 
summarised from this study in Table 3-4. In total, eighteen fundamental vibrations due to the 
plane vibrations (W1-W18) of the indole ring were visible in our spectra 
256,257
. The bands 
W1-W6 appear in the region of 1624-1379 cm
-1
. Indole-rings show C-H stretching vibrations 
in the wavenumber region 1463-1471 cm
-1
 (W5) and C-H out-of-plane deformation vibrations 
at 763-774 cm
-1 
(W18). The strongest bands in the Raman spectrum are observed at 1612-
1627 cm
-1
 and 1572-1574 cm
-1
, both caused by aromatic C-C stretching vibrations of the 
indole ring with the highest potential energy for C7-C8 (W1). These bands also have a strong 
impact on the PCA causing high values for PC-1. Other ring stretching vibrations were 
observed at 1480-1497 cm
-1
 (C8-C9), 1338-1342 cm
-1
 (C2-C3) and 1012-1020 cm
-1 
(C5-C6). 
Two bands were observed from vibrations involving the nitrogen-atom of the indole ring, 
identified from a N1-C stretching vibration at 1515-1528 cm
-1
 and from N-H in-plane 
deformation vibration at 1379-1403 cm
-1
.
256
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Several vibrations in indazole-cores were similar to indole-core vibrations. Indazole ring C-H 
stretching vibrations appeared in the region of 3052-3074 cm
-1
 and 1447-1471 cm
-1
, C-H in-
plane deformation vibration at 1483-1494 cm
-1 
and 1413-1398 cm
-1
 and C-H out-of-plane 
deformation vibrations at 764-779 cm
-1
. Ring (C-C) stretching vibrations were visible at 
1616-1622 cm
-1
, 1569-1578 cm
-1
, 1345-1359 cm
-1
 and 1002-1009 cm
-1
.
258
 Two bands were 
observed which stem from vibrations including the nitrogen-atom of the indole ring at 1522-
1538 cm
-1
 (an N1-C2 stretching) and at 1369-1379 cm
-1
 (N-H in-plane deformation 
vibration). In the region of 1494-1398 cm
-1
 there are several perceptible vibrations are 
observed involving nitrogen atoms including N2-C3, N1-C5 and N1-N2 stretching vibrations 
and N1-H10 in-plane deformation vibrations. 
A discrimination between indole- and indazole-based synthetic cannabinoids is possible via 
the strongest bands in the spectra (see also Table 3-4): (1) bands specific for indazoles were 
observed at 1413-1398 cm
-1
 from stretching vibrations of N2-C3, N1-N2 and C-C of the 
phenyl ring, in-plane deformation vibrations of N1-H10, C7-H13 and C6-H12 and 764-
779 cm
-1
 which arise from C-H out-of-plane deformation vibration, and (2) bands specific for 
indoles at 1612-1627 cm
-1
 and 1572-1574 cm
-1
, both caused by aromatic C-C stretching 
vibrations of the indole ring with the highest potential energy for C7-C8 (W1). Both findings 
are supported by the PCA and the loadings plots of PC-1 and PC-2. 
The synthetic cannabinoids MDMB-5F-P7AICA, AB-5F-P7AICA and Cumyl-5F-P7AICA 
contain azaindole (a pyrrolo[2,3-b]pyridine) as a core, but the vibrations are closely related to 
those of indoles, so that PC-1 and PC-2 do not allow discriminating between them (see Figure 
3-3a). Here, plotting PC-5 versus PC-2 provides additional discrimination power, so that the 
band around 775 cm
-1
 can be used for distinction with azaindoles having the strongest band at 
775 cm
-1
 whereas the strongest band for indoles is located around 1622 cm
-1
.  
The third core-group of synthetic cannabinoids are carbazoles and their specific vibrations 
were characterised by Anandhi et al. 
259
 Carbazoles show C-C stretching vibrations at 1628-
1623 cm
-1
, 1572-1584 cm
-1
, 1456-1465 cm
-1
, 1334-1340 cm
-1
, 1288-1228 cm
-1
, 1291-
12272 cm
-1
 and 1011-1014 cm
-1
. There are also C-H deformation vibrations at 1477-1481 cm
-
1
, 1320-1325 cm
-1
 and 1149-1146 cm
-1
. The band at 1288-1291 cm
-1
 stems from C-N 
stretching vibrations which have a lower potential energy. With these bands, a discrimination 
form other core groups is possible. 
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Table 3-3Main vibrational bands and their intensities (vs (very strong = 90-100 %), s (strong = 90-70 %), m 
(medium = 70-30 %) and w (weak = 30-10 %) in the spectra of different synthetic cathinone derivatives and 
their assignments (ν = stretching vibration, δ = in-plane deformation vibration, γ = out-of-plane deformation 
vibration measured with Spectrometer 1, compared to literature values, characteristic vibrational frequencies 
with dominant contribution to the components in loadings plots of PCA analysis 
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Table 3-4Main vibrational bands and their intensities (vs (very strong = 90-100 %), s (strong = 90-70 %), m 
(medium = 70-30 %) and w (weak = 30-10 %) of different cores in the spectra of synthetic cannabinoids and 
their assignments (ν = stretching vibration, δ = in-plane deformation vibration, γ = out-of-plane deformation 
vibration measured with Spectrometer 1, compared to literature values of related structures,* characteristic 
vibrational frequencies with dominant contribution to the components in loadings plots of PCA analysis 
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b) Linker 
Table 3-5 summarises the characteristic vibrations of the different linkers found in synthetic 
cannabinoids. C-O-C asymmetric stretching vibrations at 1249 and 1222 cm
-1
 are due to ester-
linkages.
260
 Ketones show an asymmetric C-CO-C stretching vibration at 1152-1164 cm
-1
. 
Aliphatic ketones have a strong in-plane deformation of the C-CO-C group at 630-620 cm
-1
. 
The band is shifted to lower frequencies of 580-565 cm
-1
, if alpha-branching occurs,
260
 visible 
in the Raman spectra of cannabinoids with a band at 593-601 cm
-1
 (e.g. JWH-200, XLR-11, 
UR-144, THJ-2201, THJ-018). However, most of the synthetic cannabinoids have an amide-
linkage. A strong band at 1569-1577 cm
-1
 is due to aromatic C-C stretching vibrations of the 
indole or indazole-core but also due to N-H deformation vibration of secondary amide linker.  
Table 3-5 Main vibrational bands of different linker in the spectra of synthetic cannabinoids and their 
assignments (ν = stretching vibration, δ = in-plane deformation vibration, as = asymmetric) measured with 
Spectrometer 1 
Amide Ester 
Substance 
δ N-H 
in cm
-1
 
Substance (as) ν C-O-C in cm-1 (as) ν C-O-C in cm-1 
SDB-006 1573 5F-PB-22 1249 1222 
APICA 1573 Ketone 
MMB-CHMICA 1574 Substance (as) ν C-CO-C in cm-1 (as) δ C-CO-C in cm-1 
MDMB-FUBICA 1572 JWH-200 1164 593 
5F-ADB 1574 XLR-11 1157 581 
5F-AMB 1576 UR-144 1152 595 
AMB-FUBINACA 1576 THJ-2201 1152 598 
MDMB-5F-P7AICA 1573 THJ-018 1164 601 
AB-CHMINACA 1575 
  
AB-FUBINACA 1572 
ADB-FUBINACA 1577 
ADB-CHMINACA 1575 
AKB-48 1576 
5F-AKB-48 1572 
5Cl-AKB-48 1573 
A-CHMINACA 1571 
4-CN-BINACA 1572 
MDMB-CHMCZCA 1572 
AB-5F-P7AICA 1569 
Cumyl-5F-P7AICA 1569 
 
c) Linked group and tail 
The substances evaluated in this study show different linked groups including ester (ν C=O 
and ν C-O-C 1800-1700 cm-1 and 1300-1000 cm-1), amides (ν C=O ~1650 cm-1, δ N-H 
~1570 cm
-1 
and ~620 cm
-1), naphthalenes (ν C=C ~1510 cm-1, γ C-H ~796 cm-1), quinolines 
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(ν C=C ~1470 cm-1), cyclopropyl-groups (γ C-H ~1400 cm-1) or adamantyl-group (with many 
characteristic bands 
261
) (see Table 3-6). 
Table 3-6 Main vibrational bands of different linked group in the spectra of synthetic cannabinoids and their 
assignments (ν = stretching vibration, δ = in-plane deformation vibration, as = asymmetric) measured with 
Spectrometer 1 
Ester Vibrational band in cm-1 
 
Substance ν C=O (as) ν C-O-C (s) ν C-O-C 
MMB-CHMICA 1734 1258 1199 
MDMB-FUBICA 1725 1254 1199 
5F-ADB 1727 1244 1214 
5F-AMB 1740 1240 1216 
AMB-FUBINACA 1733 1257 1222 
MDMB-5F-P7AICA 1736 1256 1199 
MDMB-CHMCZCA 1737 1258 1228 
Amido Vibrational band in cm-1 
Substance ν C=O δ N-H γ C=O 
AB-CHMINACA 1652 1575 617 
AB-FUBINACA 1636 1572 620 
ADB-FUBINACA 1655 1577 616 
ADB-CHMINACA 1651 1575 628 
AB-5F-P7AICA 1650 1569 623 
Naphthyl Vibrational band in cm-1 
Substance ν C=C γ C-H δ Ring 
JWH-200 1517 798 645 
THJ-2201 1507 795 643 
THJ-018 1510 795 644 
EG-018 1506 795 646 
Cyclopropyl Vibrational band in cm-1 
 
Substance γ C-H2 γ C-H 
XLR-11 1415 1369 
UR-144 1411 1369 
Quinolinyl Vibrational band in cm-1 
Substance ν C=C γ C-H ν C-C δ C-H 
5F-PB-22 1510 787 1486 1465 
Adamantyl Vibrational band in cm-1 
 
δ H-C-H δ H-C-C  ν C-C  δ C-C-C  
APICA 2922 2851.9 1438 1311 123 1103 977 942 644 450 
AKB-48 2922 2852 1438 1315 1247 1101 979 944 644 453 
5F-AKB-48 2922 2850 1436 1315 1244 1104 980 944 644 460 
5Cl-AKB-48 2939 2847 1437 1310 1250 1102 980 943 644 460 
A-CHMINACA 2923 2849 1436 1313 1248 1102 979 943 644 450 
 
Also the tail, attached to the core of the synthetic cannabinoid (see Figure 1-3) shows 
characteristic vibrations as summarised in Table 3-7. Tails are similar in structure to the 
linked group, but further moieties including fluorobenzenes and fluoropentanes, (ν C-H 
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~3000 cm
-1, γ C-H ~635 cm-1, ~750 cm-1, ~330 cm-1), chloropentanes (ν C-Cl ~790 cm-1, 
~365 cm
-1
)
 and cyclohexanes (ν C-C ~1055 cm-1) can be present. Exemplarily, the Raman 
spectrum of AMB-FUBINACA is presented in Figure 3-1b. This synthetic cannabinoid 
contains an ester group as a linked group and a fluorobenzene as a tail. Characteristic 
vibrations for the ester group include 1733 cm
-1
, 1257 cm
-1
and 1222 cm
-1 
and for the amide 
linker 1576 cm
-1
.
261
 
Table 3-7 Main vibrational bands of different tails in the spectra of synthetic cannabinoids and their 
assignments (ν = stretching vibration, δ = in-plane deformation vibration, as = asymmetric) measured with 
Spectrometer 1 
Fluorobenzene Vibrational band in cm-1 
Substance ν C-H δ C-F  δ C-H  Aromatic δ C-F 
MDMB-FUBICA 2996 754 635 332 
AMB-FUBINACA 3008 748 635 329 
ADB-FUBINACA 3008 749 636 331 
AB-FUBINACA 3007 764 620 332 
Fluoropentane Vibrational band in cm-1 
 
Substance ν C-H δ C-F  δ C-H  
XLR-11 1028 743 644 
5F-ADB 1036 745 639 
5F-AMB 1020 748 620 
5F-AKB-48 1044 748 633 
MDMB-5F-P7AICA 1039 744 638 
5F-PB-22 1027 749 631 
THJ-2201 1024 735 643 
AB-5F-P7AICA 1034 750 623 
Cumyl-5F-P7AICA 1037 763 621 
Chloropentane Vibrational band in cm-1 
 
Substance ν C-Cl  δ C-Cl  
5Cl-AKB-48 791 365 
Cyclohexane Vibrational band in cm-1 
Substance ν C-C  
 
MMB-CHMICA 1053 
AB-CHMINACA 1053 
ADB-CHMINACA 1053 
A-CHMINACA 1060 
MDMB-
CHMCZCA 
1051 
 
Due to the structural similarity to other structural elements of synthetic cannabinoids, the 
identification of the tail and the linked group proved to be challenging. For example, the 
linker may possess an amide-group which is also present in some linked groups, e.g. in AB-
CHMINACA. MMB-CHMICA has an ester group in the linked group, but an amide-linker 
giving rise to four specific Raman bands (1734 cm
-1
, 1258 cm
-1
, and 1199 cm
-1
) for the ester 
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as a linked groups and one (1574 cm
-1
) for the amide linker so that further bands have to be 
considered for a full discrimination or reference spectra must be available. In contrast, the 
absence of certain Raman bands from a spectrum assures the absence of a functional group 
with high certainty.
262
 
3.4.4 Identification of synthetic cannabinoids in 60 herbal mixtures from 
casework samples 
Synthetic cathinone derivatives normally seized in pure form without any bulking agents 
(according to statistical data from State Office of Criminal Investigation Rhineland-Palatinate, 
Germany) can well be identified by Raman spectroscopy.
59,77,89,93
 In contrast, synthetic 
cannabinoids are present in herbal mixtures making their identification by Raman 
spectroscopy challenging or even impossible as discussed by several authors, due to the low 
concentration of the active ingredient 
59
 and problems with fluorescence generation from 
herbal matrix components after laser excitation.
59,94,95
 In our study, we developed a simple 
sample preparation step to successfully remove (fluorescent) matrix components (see 2.2.2 
UPLC-DAD). This included solid/liquid extraction with dichloromethane followed by 
precipitation of the cannabinoid upon addition of water. Results are given in Table 3-8 
showing that ten different synthetic cannabinoids could be identified as active ingredients in 
the herbal mixtures. Identification was verified by UPLC-DAD (see Section 2.2.2 UPLC-
DAD). A preliminary assignment to a specific substance class of the casework samples was 
possible using the PCA model including 10 spectra, which were averaged (for better 
visualisation on scores plot) and pre-processed (baseline subtraction and SNV-normalisation). 
In Figure 3-3a, all 10 synthetic cannabinoids in the 60 casework samples were correctly 
assigned to the cluster of synthetic cannabinoids with an indazole core (labelled as 
unknowns). As already observed for the reference substance, Cumyl-PeGaClone, the only 
substance with a gamma-carboline-core, had PC-1 and PC-2 values close to zero, so PCA did 
not support identification.  
In a second step, the spectra of the ten different active agents (shown in Figure 3-5) were 
more closely investigated using Hit qualities and the reference library (see Table 3-8). It was 
demonstrated, that the band position and intensity were consistent but spectra of the herbal 
mixtures showed S/N ratios of 110-244 being lower by a factor 2-3 compared to the library 
spectra (385-309). 
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Figure 3-5 Raman spectra of six synthetic cannabinoids (exemplary) purified from herbal mixtures according to 
the protocol described in Section 2.2.1.1 Benchtop Raman spectrometer with microscope. Each plot shows the 
library spectrum (black) and the spectrum of the herbal mixture (grey) of a specific substance, generated both 
with Spectrometer 1 (spectra are normalised and baseline corrected according to Section 2.3 Data treatment 
and chemometrics) 
Hit qualities ranged from 87.6 to 92.6 % (see Table 3-8) demonstrating that the combination 
of sample preparation and Raman spectroscopy can well be used for the characterisation of 
seizures. The observed bands were consistent with the characteristic group frequencies in 
Tables 4-7.  
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Table 3-8 Results of 60 casework samples (herbal mixtures) with UPLC-DAD data including λmax, R² deriving 
from the calibration lines, content of the active ingredient in the herbal mixture determined and the recovery 
data with the absolute extracted amount and corresponding active ingredient content in the methanolic extract 
(see Section 2.2.2 UPLC-DAD) and Hit qualities of the Raman spectra against the reference library measured 
with Spectrometer 1 
Casework 
sample 
UPLC-DAD Raman 
λmax in nm R² 
Active 
ingredient 
content 
herbal 
mixture in %  
Recovery 
Hit Quality 
in % 
Extracted 
amount in 
mg 
Active 
ingredient 
content in 
extract in % 
Cumyl-PeGaClone 
1 
221, 315 0.9998 
1.0 1.35 26.2 90.7 
2 1.5 1.69 32.1 92.7 
3 3.8 1.05 54.2 92.2 
4 3.8 1.18 50.9 92.0 
5 0.5 0.93 23.0 87.8 
6 3.4 1.72 45.6 87.7 
7 3.3 5.22 45.5 93.8 
8 0.9 1.70 28.2 80.3 
9 3.3 1.48 50.8 92.2 
10 2.9 1.82 41.8 92.7 
AMB-FUBINACA 
11 
301 0.9996 
9.3 5.60 77.1 87.2 
12 16.3 9.42 76.8 87.4 
13 18.3 9.61 70.2 87.4 
14 15.0 9.90 75.6 88.5 
15 15.5 6.30 79.9 92.6 
16 20.1 6.89 77.3 89.0 
17 11.3 4.15 70.5 87.2 
18 12.1 7.75 77.9 87.3 
19 10.7 4.87 69.8 87.7 
20 8.3 2.63 63.1 92.7 
5F-ADB 
21 
301 0.9999 
2.10 0.554 73,6 87.4 
22 3.61 2.081 24,7 87.7 
23 1.81 1.896 26,2 87.1 
24 3.82 3.078 23,8 87.9 
25 3.63 2.746 44,9 86.5 
26 2.24 1.451 25,6 85.9 
27 5.02 2.758 30,8 88.5 
28 1.50 1.409 21,8 87.3 
29 4.11 2.245 33,8 88.3 
30 3.30 2.389 36,4 90.6 
AB-CHMINACA 
31 
302 0.9997 
1.91 1.43 24.3 87.9 
32 1.72 1.59 29.9 87.5 
33 24.0 9.40 61.6 92.9 
34 4.22 2.06 29.8 90.4 
35 6.57 - - - 
36 3.12 1.48 31.2 88.0 
37 1.87 1.57 24.3 88.9 
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Casework 
sample 
UPLC-DAD Raman 
λmax in nm R² 
Active 
ingredient 
content 
herbal 
mixture in %  
Recovery 
Hit Quality 
in % 
Extracted 
amount in 
mg 
Active 
ingredient 
content in 
extract in % 
38 24.0 9.26 62.1 93.8 
39 2.13 1.64 17.2 88.1 
40 2.93 2.56 31.8 87.2 
ADB-CHMINACA 
41 
301 0.9998 
3.82 2.23 42.9 87.6 
42 2.12 1.23 39.3 90.1 
43 1.91 1.75 20.9 87.4 
44 1.02 1.64 12.2 87.1 
45 0.55 1.21 7.1 87.3 
46 1.68 1.99 18.7 87.0 
47 1.28 1.42 13.0 90.0 
48 1.34 1.30 19.2 87.8 
49 0.93 0.95 18.7 87.0 
50 5.58 1.31 53.9 89.7 
AB-FUBINACA 
51 
301 0.9999 
11.41 3.52 75.5 88.0 
52 9.11 4.22 63.1 87.2 
THJ-018 
53 
218, 320 0.9997 
6.92 3.83 49.9 88.9 
54 6.22 2.33 38.1 89.9 
5F-AMB 
55 
301 0.9998 
12.5 3.91 53.1 91.3 
56 12.3 5.01 62.3 92.7 
AKB-48 
57 
301 0.9995 
1.61 1.71 22.0 91.2 
58 2.62 1.82 28.1 91.7 
5F-AKB-48 
59 
301 0.9995 
9.11 2.13 52.8 92.5 
60 8.92 1.82 53.7 92.6 
 
However, some limitations of the approach are still present: When the concentration of the 
active ingredient was below 0.5 % (due to low concentration in sample or insufficient 
extraction), no Raman spectra could be recorded. This concentration may be found for highly 
potent synthetic cannabinoids (dose of 5 mg/g).
247
 However, when screening the literature on 
quantitative results for synthetic cannabinoids in herbal mixtures 
44,63,263,264
 concentrations 
ranged from 5 to 446 mg/g in 765 samples investigated on total. Angerer et al. described the 
analysis of 342 herbal mixtures covering different brands, where 14 products showed active 
ingredients of one synthetic cannabinoid < 4 mg/g, sometimes with two or more additional 
active ingredients present in one sample (total content then > 5 mg/g).
265
 Together with the 60 
herbal mixtures investigated during this study, the total content of active ingredient of 
synthetic cannabinoids < 4 mg/g is particular rare according to the statistics. Thus, the 
Raman spectroscopy 
 
 
73 
 
estimated limit of detection of about 5 mg/g is suitable for most seizures. Otherwise, further 
preconcentration or more sensitive surface enhanced Raman spectroscopy or portable ion 
mobility spectrometry
248
 would be an alternative. 
Besides the analysis with Raman spectroscopy, the dried precipitate also quantified via 
UPLC-DAD to determine the recovery of the sample preparation (see Table 3-8). The 
concentration range in the 60 herbal mixtures was very broad with 0.5-24 % active ingredient 
present. 0.5-9.9 mg active agent was recovered on the glass slide after sample preparation 
from 100 mg sample giving rise to recoveries between 7.1 and 79.9 %. In general, that low 
initial active ingredient contents were linked to low recoveries.  
3.5 Conclusion 
We here show that Raman spectroscopy is well suited to characterise seizures of synthetic 
cannabinoids and synthetic cathinone derivatives. Problems with regard to excitation of 
fluorescence with synthetic cannabinoids in plant matrix were solved using a simple 
solid/liquid extraction of only 100 mg herbal material in dichloromethane followed by 
precipitation of the active agent in water with recoveries high enough for subsequent Raman 
analysis down to a centration of the synthetic cannabinoid in the sample of only 0.5 %.  
We here showed that portable Raman instruments can be used for the identification of NPS, 
which is a great advantage for field analytics at border controls or in the area of policing. This 
was even possible using reference spectra generated by a benchtop instrument as proven by 
chemometry. Thus, only one spectral reference library proved to be necessary for the 
discrimination of unknown substances which can be transferred to the portable Raman system 
evaluated in this study. A PCA model was developed with corresponding loadings plots 
which was used to identify Raman bands characteristic for synthetic cathinone derivatives and 
synthetic cannabinoids but also to discriminate typical structural elements of the NPS 
including core, linker and linked group. Based on the PCA loadings, specific group 
frequencies of NPS were summarised in Tables that enable the assessment of a possible 
chemical structure. We successfully applied the combination of PCA and characteristic 
frequencies and a reference library (established using purified standards obtained from 
seizures) to characterise the active compound in various (herbal) seizures. The results 
demonstrate the high capability of the presented approach for forensic investigations both in 
laboratory but also on-site using portable devices. The benefits of Raman spectroscopy justify 
the application in public institutions, including the high discrimination power, the ability of 
portable usage of Raman devices, the analysis through packaging material and the safe 
handling of hazardous drugs for on-site operators. 
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4 Terahertz spectroscopy for the contactless and 
non-destructive detection of synthetic 
cannabinoids to uncover drug trafficking 
4.1 Abstract 
The demand for analytical techniques to uncover exploitation of the mail service for the 
transport of hazardous substances like explosives or drugs is still rising. Especially new 
psychoactive substances (NPS) are sold via internet in specialised shops and frequently sent 
via the ordinary mail service to the costumer. The supply chains may stay unrevealed during 
the security inspection in postal facilities and pose a potential health risk presented by the 
unknowingly handling of drugs. We tested a method to detect NPS in postal packages using 
terahertz time domain spectroscopy (THz-TDS). Spectroscopic data of 16 synthetic 
cannabinoids were recorded including the centre frequency of the feature, FWHM and the 
cut-off frequency. Synthetic cannabinoids providing the same structural components show 
similar specific features, thus class identification is feasible. Synthetic cannabinoids 
containing an indazole-core showed centres of features at 1.2 THz and indole-cores at 1.3 
THz. The indazole-based synthetic cannabinoids with a pentyl-group as a tail generated an 
additional feature at 2.4 THz. Naphthylindole-synthetic cannabinoids with an ester linkage 
showed significant features around 0.8 THz and 1.3 THz whereas a ketone-linkage showed 
five significant features at 0.8, 1.2, 2.2, 2.4-2.5, 3.7-3.9 THz. Naphthylindazole-synthetic 
cannabinoids (THJ-2201) possess nearly the same features with 0.8, 1.2, 2.1, 2.8 and 3.5 THz 
but two additional features were observed at 1 and 1.8 THz. Transillumination images of 
packed materials simplified and accelerated the selection of a grid of measurement points. 
4.2 Introduction  
At present, the rise in worldwide threats like terrorism, drug smuggling and assassination 
attempts calls for increased security measures. Public institutions are particularly at risk 
including custom controls, prisons, authorities, embassies, banks and political institutions.
252
 
The ordinary mail service is frequently miused for the transport of hazardous substances, 
especially for drugs.  
Since 2004, a new phenomenon has arisen besides the use of classical drugs like 
amphetamine, cocaine, heroin or THC: the production of new psychoactive substances (NPS). 
The substances are sold as “designer drugs”, “legal highs”, “bath salts”, “research chemicals” 
Terahertz spectroscopy 
 
 
75 
 
or “laboratory reagents”.1 The United Nations Office on Drugs and Crime (UNODC) 
established a clear terminology: “New psychoactive substances are substances of abuse, either 
in a pure form or a preparation, that are not controlled by the 1961 Single Convention on 
Narcotic Drugs
4
 or the 1971 Convention on Psychotropic Substances,
5
 but which may pose a 
public health threat. In this context, the term ‘new’ does not necessarily refer to new 
inventions but to substances that have recently become available”.6 NPS have initially been 
designed to mimic established illicit drugs, such as cannabis, cocaine, amphetamine and 
LSD.
2,3
 Their effects are unpredictable for NPS-consumers and sometimes fatal
10-12
 as there is 
no information about the active drug given on the product label. Synthetic cannabinoids 
represent the most common subgroup of NPS.
168
 They are primarily sold via internet in 
specialised shops in colourful and professionally designed packages of herbal products or of 
pure powders.
16,17
 The selling of pure powders (in most cases at a scale of > 3 g according to 
data of State Office of Criminal Investigation Rhineland-Palatinate) is an indication of a 
subsequent processing of the synthetic cannabinoids (to for example herbal mixtures or e-
liquids) and thus a dealer network. Currently, the security inspection in postal facilities stays 
unrevealed. Another fact that has to be taken into account is the potential health risk present 
due to handling of drugs. These challenges are not limited to postal facilities but also refer to 
other public institutions. 
Several inspection techniques have been used such as x-ray scanning, canine detection, trace 
detections, ion mobility spectrometry (IMS), millimetre wave imaging and Raman or infrared 
imaging. In case of the detection of drugs, these techniques show some limitations.
266
 The 
ability of x-ray scanners is limited to the identification of the shape of for example a plastic 
bag but not the type of the drug or material and its elemental composition.
267
 The utilisation 
of trace detection techniques like portable ion mobility spectrometry makes sense only if there 
are detectable amounts of the concealed drugs outside the envelope.
248
 Millimetre wave 
imaging is limited to a spatial resolution of several millimetres and does not provide spectral 
information.
266
 Therefore, the characterisation of a drug type is difficult to realise. 
Spectroscopic techniques like infrared or Raman spectroscopy are invincible in the field of 
identification of unknown substances due to the chemical fingerprint region in the spectra. 
One disadvantage of these techniques is the high degree of absorption and scattering in paper 
which prevents an accurate analysis of the paper samples such as with NPS impregnated 
papers. Papers are used as a matrix in order to bring NPS into prisons by post. Therefore, NPS 
are dissolved in a solvent such as acetone and sprayed onto a piece of paper, tobacco or 
textiles and sent as a postal package or letter to the prison. The potential carrier substances are 
reduced to small pieces and then smoked or swallowed.
248
 
As a result, the demand of an alternative technique is tremendous to detect and characterise 
NPS and related drug trafficking. 
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The THz frequency radiation possesses a combination of desirable properties for the detection 
of drugs in postal packages.
268
 The contactless THz-measurement principle is non-destructive, 
due to the low energy THz-waves, which do not induce a change in the chemical structure of 
the material under investigation. Moreover, THz-radiation is non-ionising and therefore not 
dangerous for human beings.
269
 
THz radiation is located in the far infrared range from 0.1 to 10 THz between the microwave 
and the infrared portion of the electromagnetic spectrum with respective wavelengths from 
3 mm to 30 µm.
269,270
 The properties of the THz radiation are characterised by a combination 
of the characteristics of both adjacent spectral ranges: Nonpolar and nonmetallic materials and 
dielectrics such as paper, clothes, wood and ceramics that are usually opaque at optical 
wavelength, are transparent to THz radiation.
271
 The same phenomenon is observed for 
microwaves. THz radiation cannot penetrate metal and is strongly attenuated in water.  
The IR range provides spectroscopic data with structural information of a substance due to 
spectral fingerprint region. In a medium, THz radiation primarily excites inter- and 
intramolecular oscillations but also rotational transitions.
272
 Intramolecular oscillations 
describe the collective movement of molecules within a crystal lattice around their 
equilibrium state. Amorphous substances and liquids do not show any signatures, since 
intermolecular lattice oscillations are not excited in the crystal due to the near-order.
273
 In the 
last two decades, the extensive research in the field of THz radiation paved the way for the 
application in the field of science and technology.
274
 There is a wide variety of analytical 
purposes including communication,
270
 biology and medical sciences,
275,276
 pharmaceutical 
settings
272,277,278
 and space instrumentation.
279
 Since common packaging materials are 
dielectric, THz imaging is interesting in the field of defence and security for the inspection of 
scaled packages in public institutions without violating postal secrecy.
280
 
The most common application of THz radiation in forensic science is the detection of 
explosives and chemical warfare agents.
268,280
 For drug analysis, the THz technology is hardly 
applied and is currently limited to the detection of classical drugs.  
In principal, the analysis of different drugs can be carried out in packaging material like 
plastic bags and / or papers (envelopes) including methamphetamine,
266,271,281-283
 3,4-
methylenedioxymethamphetamine (MDMA),
266,271,283-285
 3,4-methylenedioxyamphetamine 
(MDA),
283,284
 cocaine,
271,286
 morphine,
284,286
 heroine,
271,284
 acetylcodein,
284
 acetaminophen,
271
 
terefandine
271
 and ketamine.
284,285
 New innovations were demonstrated using cryogenic 
cooling with temperatures below -150°C and exchange of ambient air by the application of 
nitrogen. This reveals multiple spectral features that were not reported previously in room-
temperature terahertz studies.
281,284
 In addition, the use of the solid-state density functional 
theory to correlate spectral features with molecular vibrations for methamphetamine, 
ketamine and 3,4-methylene-dioxymethamphetamine.
281,282,285,287
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This paper presents first tests for uncovering NPS drug trafficking of synthetic cannabinoids 
in postal packages using THz spectroscopy. The time domain and frequency domain spectra 
of 15 synthetic cannabinoids are presented. Furthermore, the experimental data are evaluated 
for each synthetic cannabinoid including the centre frequency of the feature, FWHM and die 
cut-off frequency which could serve as parameters in databases. The utility of the THz 
spectroscopy is successfully demonstrated by the analysis of synthetic cannabinoids in postal 
packages like plastic bags and envelopes. In addition, papers and herbal mixtures impregnated 
with synthetic cannabinoids were evaluated. We found out, that THz radiation is less sensitive 
than other spectroscopic techniques like Raman or IR spectroscopy to detect the synthetic 
cannabinoids due to the interfering matrix.  
4.3 Materials and Methods 
4.3.1 Chemicals 
The reference standards of 16 synthetic cannabinoids (exclusively powders) employed in this 
study were taken from criminal cases provided by the State Office of Criminal Investigation 
Rhineland-Palatinate (Germany) and listed in Table 4-1. These include 5F-AB-PINACA (N-
[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)indazole-3-carbosamide), 5F-
ADB (N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-D-valine, methyl ester), 
5F-ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide), 5F-AMB (N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-
valine, methyl ester), 5F-PB-22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic 
acid), 5F-UR-144 ((1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone), AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-
methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide), ADB-PINACA (N-
(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1-H-indazole-3-carboxamide), AM-2201 
([1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone), EG-018 (naphthalen-1-yl(9-
pentyl-9H-carbazol-3-yl)methanone), FDU-PB-22 (1-[(4-fluorophenyl)methyl]-1H-indole-3-
carboxylic acid, 1-naphthalenyl ester), JWH-018 (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-
methanone, THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl]-1-naphthalenyl-methanone).  
For GC-MS and UPLC-DAD measurements, methanol (LC-MS-grade, Geyer, Rennigen, 
Germany) was used. For NMR analysis, acetone-d6 (purchased from Deutero, Kastellaun, 
Germany) and internal calibrant 3,5-dinitrobenzoic acid (Fluka, TraceCERT, 99.66 %) were 
used.  
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Table 4-1 List of 16 synthetic cannabinoids with the data from GC-MS with fragment masses (m/z-values) and 
retention times (Rt) and the sample purity as determined by NMR  
Substance 
MW 
in g/mol 
GC-MS  NMR 
m/z Rt in min 
Purity in 
% 
5F-ADB 377.46 233, 145, 130, 289, 321 10.9 98.7 
5F-AMB 363.44 233, 145, 304, 249, 131 10.9 98.5 
5F-PB-22 376.43 232, 144, 116, 89, 376 18.2 99.6 
5F-UR-144 329.45 232, 144, 314, 116, 247 10.7 98.5 
5F-AB-PINACA 348.42 233, 304, 145, 234, 131 12.3 98.7 
5F-ADB-PINACA 362.50 233, 318, 145, 131, 289 12.5 97.6 
AB-FUBINACA 368.41 109, 252, 324, 145, 83 13.4 94.9 
AB-PINACA 330.41 215, 286, 145, 216, 131 11.8 96.3 
ADB-PINACA 344.51 215, 300, 144, 130, 271 11.9 97.9 
AM-2201 359.45 359, 127, 284, 232, 144 15.2 99.8 
EG-018 391.50 334, 391, 335, 127, 179 23.8 94.6 
FDU-PB-22 395.44 109, 252, 253, 143, 83 22.8 76.5 
JWH-018 343.47 127, 341, 214, 284, 144 13.7 98.6 
ADB-CHMINACA 370.50 241, 326, 145, 131, 55 13.4 91.6 
MDMB-CHMICA 384.51 240, 144, 296, 328, 268 12.6 97.0 
THJ-2201 434.5 290, 434, 179, 346, 378 23.1 98.3 
4.3.2 Methodology: Characterisation of NPS powders from seizures 
4.3.2.1 Gas chromatography-mass spectrometry 
As not all NPS were commercially available during the experimental work of this study, 
material from seizures was used as standards. Identity and purity of each seized drug powder 
were determined using a gas chromatograph with mass spectrometric detection (GC-MS). 
Information on the technical parameters, a detailed explanation of the sample preparation and 
the method parameters used are described in Chapter 2.3.2.1 and the corresponding 
publication.
248
 5 mg of powdered samples were dissolved in 1 mL methanol. Papers spiked 
with NPS were covered with methanol for extraction (10 min) in a glass vial. Afterwards, the 
solution was transferred into a second glass vial and evaporated to dryness. Then, 100 µL 
methanol were added to the glass vial and the solution was transferred to a GC-MS vial with a 
cone-shaped insert (Wicom, Heppenheim, Germany). The mass spectrum derived for each 
compound was compared to in-house libraries. Standards containing other substances than the 
drug of interest (e.g. cutting agents) were excluded from method optimisation and database 
setup. 
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4.3.2.2 NMR 
The purity determination of NPS samples from seizures was conducted by quantitative NMR 
(qNMR) analysis. Technical information, the sample preparation steps and method parameters 
are described by Schoenberger.
49
 In Chapter 2 and in the publication of Metternich et al., the 
details of NMR analysis are summarised.
248
  
4.3.2.3 Terahertz time domain spectroscopy 
In this study, a multipurpose Terahertz spectrometer T-spectralyzer TRF (Hübner, Kassel, 
Germany) was used. This technique is a time domain spectroscopy system (THz-TDS) based 
on infrared pulse transmission via optical single-mode fibers. A Ti:sapphire laser was applied 
to pump and detect THz waves, with the central wavelength of 810 nm, pulse duration of 100 
fs, repeat frequency of 82 MHz and output power of 980 mW. The measurements were 
performed in the linear stage-based measurement mode and with reflection mode. For each 
measurement of pellets or powders, a grid of measurement points was chosen with defined 
number of points in x- (10 points ) and y-direction (10 points). 2 mg of the powdered material 
were pressed into disks of 13 mm in diameter with a force of 7.5 tons with a hand hydraulic 
press (max. 25 t) from Specac (Orpington, UK) resulting in thicknesses of about 1.5-3 mm 
and a diameter of about 13 mm. The limit of detection was examined for EG-018 using 5 
pellets with decreasing tablet thicknesses of 1.7(~200 mg), 1.5 (~180 mg), 1.0 (~120 mg) and 
0.6 mm (~70 mg). 
To imitate real samples, one gram of each drug standard was packed in a plastic bag. 
Moreover, the plastic bag was additionally packed into a paper envelope to imitate postal 
packages. Herbal mixtures were provided by the State Office of Criminal Investigation 
Rhineland-Palatinate. The papers (standard copy papers 80 g/m²) were impregnated with 
different synthetic cannabinoids dissolved in methanol at two concentration levels (see Table 
2-3) referring to common dosages.
247
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a) 
 
b) 
 
c) 
 
Figure 4-1 THz data of EG-018 depicted as a) the signals in the time domain for the reference (background 
measurement) and the average of sample measurements b) the corresponding curve in the frequency domain 
after FFT and c) the calculated extinction with a feature at 1.4 THz  
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The raster-scan THz imaging was performed by defining a rectangle with a representative 
area of interest. The THz image was superimposed on the optical image. The system 
automatically provides a “pixel” preview and an expected resolution. 
Use the mouse to draw a rectangle, representing the area of interest, which you want to image. 
You will get a “pixel” preview, giving you an estimate of the resolution you can expect. One 
major advantage of THz technology is its ability to measure amplitude and phase of the 
electric field and not only the intensity of a THz wave. The interaction of the THz pulse with 
a sample leads to an attenuation and shift of the original THz pulse. Primarily, this provides 
information on a substance by the complex refractive index including the absorption by the 
sample. A mode-locked laser (e.g. fiber laser or Ti:sapphire) generated ultrashort laser pulses 
with typical pulse durations of about 100 fs and a respective THz range of 0.1 to 4 THz. The 
THz pulse is splitted at the beam splitter and transferred by optical fibers to the emitter and to 
the detector. The key of this technique is the synchronisation of the emitter and the detector, 
resulting in a repetitive measurement of the same section of the THz pulse and not statistically 
varying sections. The detector is only active for a very short period of time (less than one 
picosecond). Therefore, a specific section of the electric field of the THz pulse is recorded. 
By varying the optical path length in the detector arm with e.g. a delay line, the section in 
which the detector is active changes. Therefore, the complete THz pulse is realised. The 
higher the delay line the longer the distance until the THz pulse reaches the detector. As the 
detector is only active for a very short time period, it responds only to a small fraction of the 
THz electric field, which is then seen as a quasi-DC field. These DC values are acquired and 
numerically assigned to the corresponding time delays. The measurement outcome is the 
sampled electric field as a function of time (delay) as shown in Figure 4-1a. This information 
can be transformed into a spectrum by fast Fourier transformation (FFT) (Figure 4-1b) or as 
an extinction function (Figure 4-1c).  
4.3.2.4 UPLC-DAD 
The quantitative analysis of synthetic cannabinoids in 26 herbal mixtures from seizures were 
carried out using an UPLC Aquity-System (Waters, Milford, MA, USA) equipped with diode 
array detection (DAD). Further technical information, method parameters are given in 
Chapter 2.3.2.3 and in the publication of Metternich et. al.
248
The quantification of herbal 
mixtures was carried out using a 7-point-calibration (n = 3) in the range of 0.25-0.005 mg/mL 
(in methanol) with the appropriate reference standard. 100 mg of the herbal mixture were 
suspended in 10 mL methanol for 20 min. The solutions were filtered with syringe filters from 
Macherey-Nagel (Düren, Germany) with a pore size of 0.20 µm and a diameter of 25 mm. 
Subsequently, 100 µL of the filtered sample solution were transferred into UPLC vials and 
diluted with 900 µL methanol for injection (injection volume 5 µL). The results are shown in 
Table 4-2. 
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Table 4-2 Results of 26 casework samples (herbal mixtures) with UPLC-DAD data including λmax, R² deriving 
from the calibration lines and the content of the active ingredient in the herbal mixture (see Section 2.2.2 UPLC-
DAD)  
Casework samples 
UPLC-DAD 
λmax in nm R² Active ingredient content in % 
5F-ADB 
1 
301 0.9999 
2.11 
2 3.63 
3 1.80 
4 3.82 
5 3.65 
6 2.29 
7 5.07 
8 1.53 
9 4.17 
10 3.33 
ADB-CHMINACA 
11 
301 0.9998 
3.82 
12 2.12 
13 1.91 
14 1.02 
15 0.55 
16 1.68 
17 1.28 
18 1.34 
19 0.93 
20 5.58 
AB-FUBINACA 
21 
301 0.9999 
11.41 
22 9.11 
THJ-018 
23 
218, 320 0.9997 
6.92 
24 6.22 
5F-AMB 
25 
301 0.9998 
12.51 
26 12.31 
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4.4 Results  
4.4.1 Characterisation of NPS with GC-MS and NMR 
For standards, samples from seizures were used. The powders were characterised by GC-MS 
and NMR to determine their purity and to exclude the presence of impurities. These 
substances served as reference material in this study. Initially, the powder material was 
analysed by GC-MS and the retention times and the characteristic m/z values of each 
substance are reported in Table 4-1 (arranged according to their importance). For 
identification of the synthetic cannabinoids, the MS spectra of the different samples were 
compared to in-house MS libraries. In addition, each sample was characterised with UPLC-
DAD. The retention times and the λmax values are presented in Table 4-1 for each standard. 
The purity was determined using 
1
H-NMR to be > 94.6 %, except FDU-PB-22 with only 
76.4 %. This sample also contained diethylamine and ethanol, which did not impair THz 
measurements. Other samples with impurities were not taken into consideration. Impurities 
included cutting agents that could also be present as an active ingredient in seized samples 
like paracetamol, caffeine, sugars or other drugs like e.g. amphetamine, cocaine or 
tetrahydrocannabinol. 
4.4.2 THz procedure 
Table 4-3 summarises the corresponding characteristic parameters from the spectral data like 
the centre frequency of the feature, FWHM and the cut-off frequency. 
The centre frequencies of synthetic cannabinoids ranged from 0.6 to 3.7 THz, with FWHM of 
0.1-0.5 THz. No correlation between the cut-off frequencies of the synthetic cannabinoids, 
which ranged from 1.4 to 3.9 THz, and the thickness of a pellet was observed. Based on the 
THZ spectroscopic data, some similarities in frequency domain spectra were emerged for 
structurally related compounds.  
In this study, the indole-based synthetic cannabinoids 5F-PB-22, 5F-UR-144, AM-2201, 
FUB-PB-22, JWH-018 and MDMB-CHMICA show a feature around 1.3 THz (Table 4-3). 
The centre frequency of the main feature for indazole-based synthetic cannabinoids is located 
around 1.2 THz. This includes the substances 5F-ADB, 5F-AMB, 5F-ADB-PINACA, 5F-AB-
PINACA, AB-FUBINACA, AB-PINACA, ADB-PINACA, ADB-CHMINACA and THJ-
2201. The indazole-based synthetic cannabinoids which possess a pentyl-group as a tail show 
an additional feature around 2.4 THz. Figure 4-1 presents the spectra of 5F-ADB PINACA 
and 5F-AB-PINACA, which show only one feature around 1.2 THz, whereas in the spectra of 
ADB-PINACA and AB-PINACA an additional strong and sharp feature around 2.4 THz were 
observed. 
 
Terahertz spectroscopy 
 
 
84 
 
5F-ADB-PINACA 
  
5F-ADB 
  
5F-PB-22 
  
5F-UR-144 
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AB-FUBINACA 
  
AM-2201 
  
FUB-PB-22 
  
JWH-018 
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ADB-CHMINACA 
  
THJ-2201 
  
Figure 4-2 THz data of 10 of the investigated substances with frequency domain curve (left) and extinction curve 
(right) 
Some of the investigated substances are naphthylindole-synthetic cannabinoids, where the 
indole core group is connected via an ester- or a ketone-linkage to a naphthyl-group as a 
linked group. 5F-PB-22 and FUB-PB-22 belong to the class of naphthylindole-synthetic 
cannabinoids with an ester linkage and show two significant features around 0.8 THz and 1.3 
THz. Naphthylindole-synthetic cannabinoids with a ketone-linkage including AM-2201 and 
JWH-018 show five significant features at 0.8, 1.2, 2.2, 2.4-2.5, 3.7-3.9 THz. 
Naphthylindazole-synthetic cannabinoids (THJ-2201) revealed nearly the same features with 
0.8, 1.2, 2.1, 2.8 and 3.5 THz but two additional features were observed at 1 and 1.8 THz. 
EG-018 is the only carbazole-based synthetic cannabinoid and shows a broad feature at 1.4 
THz with a FWHM of 3.5 THz.  
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Table 4-3 Spectroscopic evaluation of THz measurements of synthetic cannabinoids including their chemical 
structure, die thickness of the pellet, the centre frequency of the feature, FWHM and die cut-off frequency 
Sample 
Chemical 
structure 
Pellet 
thick-
ness in 
mm 
Centre 
frequency of 
feature 
in THz 
FWHM 
in THz 
Cut-off 
frequency 
in THz 
5F-AB-PINACA 
 
0.6 
0.4 
0.3 2.2 
1.2 
5F-ADB 
 
1.9 1.2 0.2 1.7 
5F-ADB PINACA 
 
1.9 1.2 0.3 2.2 
5F-AMB 
 
1.7 1.2 0.1 1.6 
5F-PB-22 
 
3.0 
0.8 0.2 
2.1 
1.2 0.1 
1.3 0.1 
5F-UR-144 
 
3.0 0.6 0.2 1.4 
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Sample 
Chemical 
structure 
Pellet 
thick-
ness in 
mm 
Centre 
frequency of 
feature 
in THz 
FWHM 
in THz 
Cut-off 
frequency 
in THz 
AB-FUBINACA 
 
1.7 1.2 0.2 2.7 
AB-PINACA 
 
1.7 
1.2 0.3 
2.7 
2.4 0.1 
ADB-PINACA 
 
1.6 
1.25 0.3 
2.7 
2.4 0.1 
AM-2201 
 
1.5 
0.8 0.1 
2.5 
1.6 0.5 
2.2 
0.1 2.4 
3.9 
EG-018 
 
1.7 1.4 0.2 3.6 
FUB-PB-22 
 
1.8 
0.8 
0.1 
3 1.3 
2 0.3 
JWH-018 
 
1.1 
0.8 0.2 
3.9 
1.3 0.3 
2.2 0.1 
2.5 0.2 
3.7 0.2 
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Sample 
Chemical 
structure 
Pellet 
thick-
ness in 
mm 
Centre 
frequency of 
feature 
in THz 
FWHM 
in THz 
Cut-off 
frequency 
in THz 
ADB-CHMINACA 
 
0.8 1.2 0.2 2.4 
MDMB-CHMICA 
 
1.1 1.3 0.2 2.5 
THJ-2201 
 
2.1 
0.8 0.2 
3.5 
1 0.1 
1.2 0.2 
1.8 0.3 
2.1 0.1 
2.8 0.4 
3.5 0.1 
 
The sensitivity of the method was investigated with 5 different pellets of EG-018 with 
decreasing tablet thicknesses of 1.7, 1.5, 1.0 and 0.6 mm. The extinction spectra recorded 
with samples of different tablet thicknesses are shown in Figure 4-3: At a pellet thickness of 
only 0.6 mm, no signal was observed. 
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a) 
 
b) 
 
c) 
 
Figure 4-3 Different extinction plots for EG-018 with different pellet thicknesses including a) 1.7 mm, b) 1 mm 
and c) 0.6 mm 
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4.4.3 Model applications and matrix tolerance 
In this study, samples with different matrices were analysed to investigate the matrix 
tolerance for THz spectroscopy including powders in packaging material, herbal matrices and 
papers, which were impregnated with synthetic cannabinoids. The grid chosen for these 
measurements is shown in Figure 4-4. 
a)    b) 
 
c)    d) 
 
Figure 4-4 Imaging window of a) a tablet with a grid of measurement points (10x10), b) a transillumination 
images of an envelope containing a plastic bag with powder and a tablet, c) a plastic bag with powder and a 
grid of measurement points (10x10) and d) a paper (24 cm²) impregnated with EG-018 and a grid of 
measurement points (10x10) 
THz spectra of analytes in pellet and powder samples were compared. For this purpose, EG-
018 and UR-144 were chosen as representative substances. The pure powder was analysed in 
a grip bag and as a tablet. The spectra are shown in Figure 4-5. The centre of frequency, 
FWHM and the cut-off frequency for tablets coincides with those for powders, except the 
intensity of the feature, which is lower for powders. The lower intensity is due to scattering 
phenomena: It is standard practice in far-infrared (THz) spectroscopy to press samples into 
pellets due to the fact that powders often have grain sizes comparable to the THz wavelength. 
Then, strong scattering of the THz radiation occurs.  
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a)         b) 
  
c)         d) 
 
Figure 4-5 Extinction plots for a) UR-144 (powder), b) UR-144 (tablet), c) EG-018 (powder) and d) EG-018 
(tablet) 
The THz wavelengths are 10’s to 100’s of microns in scale and thus rough surfaces or 
interfaces between materials or the granular nature of substances can cause frequency-
dependent scattering with the potential to alter or obscure signatures. The scattering effects 
are influenced by a number of factors including the angle of incidence and scattering, the 
operating frequency, the material contrast, the viewing geometry, and the statistics of the 
surface height variation.
288
 In Figure 4-6, this phenomenon is depicted: In case of a flat 
surface/interface (Figure 4-6), the reflected wave will be perfectly phase coherent and will 
appear only in the specular direction or the direction where the scattered angle is equal to the 
incident angle. For a rough surface with random height profile, energy from the incident wave 
will be redistributed in other directions, decreasing the coherent reflection, and producing 
incoherent (diffuse) scattering at non-specular angles.
288
 
 
Figure 4-6 Left-hand side shows coherent specular scattering from a flat surface versus rough surface scattering 
(right-hand side) containing both coherent and incoherent scattering 
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Postal packages in mail services were simulated by packing tablets and powders of the 
synthetic cannabinoids into a plastic grip bag, which was additionally packed into a paper 
envelope. A pre-screening step of the envelope was carried out to obtain a transillumination 
image to avoid measuring the whole packaging material. In Figure 4-4b the transillumination 
image of an envelope containing a grip bag with a powder and a tablet is shown. The analysis 
demonstrated that materials like plastic or paper do not interfere with the measurements and 
the features generated were similar to those without any packaging material (data not shown, 
because spectra are similar to those of Figure 4-2).  
In addition, herbal matrices containing different synthetic cannabinoids were quantified by 
THz spectrometry. In Table 4-2, UPLC-DAD data including the λmax, R² of the corresponding 
calibration line and the active ingredient contents of the synthetic cannabinoids in the herbal 
mixture are shown. The active ingredient contents ranged from 0.5 to 12.5 %, which are 
common percentages found in herbal mixtures.
265
 No signals of the NPS present in the herbal 
matrices were observed by THz spectroscopy. This is due to the fact, that synthetic 
cannabinoids were dissolved in an organic solvent and sprayed onto the plant material, 
resulting only in a thin coating of the active ingredient on the dried plant material. The THz 
spectrometer employed in this study was not sensitive enough to detect synthetic 
cannabinoids and to trigger specific intramolecular vibrations. The same applied to 
impregnated papers: To simulate drug transport via paper, pieces of paper were impregnated 
with synthetic cannabinoids at concentrations correlating to current dosages as described on 
internet platforms (Table 2-3). Here again, no spectral information were gathered. In order to 
estimate limits of detection, the dosage concentration for one EG-018, which shows a strong 
THz feature, was increased to 2 mg/cm², 4 mg/cm² und 8 mg/cm². Even at the highest dose, 
only 1 % of all measurements (n = 100) revealed a feature (Figure 4-7).  
 
Figure 4-7 Extinction plot of EG-018, impregnated onto a paper at a concentration of 8 mg/cm² 
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4.5 Discussion 
THz spectroscopy is an analytical technique only rarely applied in forensics. Currently, the 
relatively high costs of such systems impede their routine application in diverse institutions 
and limits research. For drug analysis THz spectroscopy is not widespread,
280
 because of the 
constant changes in chemical structures of NPS. THz spectroscopy provides information on 
the intramolecular rotational vibrations and the intermolecular constitution of a substance but 
does not provide information on specific structural components.
289
 In addition, THz 
spectroscopy is a lab-based technique, whereas other spectroscopic devices are also available 
as portable techniques, e.g. IR and Raman spectroscopy.  
In this study, the features of synthetic cannabinoids were examined. Synthetic cannabinoids 
with identical core-structures and linked-groups showed similar features in the THz spectra. A 
distinction between substances with very similar structural components was not possible. In 
comparison, with Raman spectroscopy (Chapter 3), the analysis of structurally closely related 
substances was possible according to the spectral fingerprint region in the spectra. For 
example, AB-CHMINACA and ADB-CHMINACA differs only in the addition of one 
methyl-group in the linked group and show clear differences in the Raman spectrum. 
Therefore, THz-spectroscopy is suitable for the detection of substance classes but not for the 
identification of a substance. Regarding selectivity towards other drugs-of-abuse, synthetic 
cannabinoids show different features in the THz spectra compared. Table 4-4 summarises the 
THz features of classical drugs like cocaine, methamphetamine, MDMA, MDA diamorphine, 
morphine and ketamine. Each proscribed drug is characterised by a different absorption 
spectrum with sharp absorption peaks located within the Terahertz frequency range. Morphine 
is the only substance, which shows a feature at 1.25 THz similar to some synthetic 
cannabinoids. Here, the calculation of the exact centre of frequency with supporting 
chemometric methods is essential to distinguish between the feature of synthetic cannabinoids 
with indole-core of 1.3 THz, indazole core of 1.2 THz and morphine. 
Table 4-4 A collection of feature band centre position frequency of some Drugs with the corresponding reference 
Substance Centre frequency of feature in THz Reference 
Cocaine HCl 1.54, 2.1, 2.6 
286
 
Cocaine free base 1.54, 2.25, 2.5 
267
 
methamphetamine 1.2, 1.7, 1.8, 2.4 
280,282,283
 
MDMA 1.2, 1.4, 1.7, 1.9, 2.4 
280,285
 
MDA 1.39, 1.68, 2.21 
283
 
Diamorphin (Heroin) 1.42, 3.94 
267
 
morphine 1.25 
286
 
ketamine 1.16, 1.35, 1.52, 1.93, 2.40 
285
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Besides classical drugs, street samples contain cutting agents and impurities and these 
materials are often crystalline organic materials such as caffeine, lactose, or other 
pharmaceutical products, which will have spectral features in the THz range.
267,286
 Based on 
the statistical data of the State Office of Criminal Investigation Rhineland-Palatinate, 
synthetic cannabinoids appear as pure powders without any accompanying substances.  
The rare application of THz spectroscopy in forensic science can be explained by several 
facts: The THz spectrum of a substance could be affected by different factors like different 
classes of multicomponent molecular crystals of drugs. Davies et al. described the influence 
of different matrices on the feature of cocaine. The THz-TDS spectra of cocaine free base and 
cocaine hydrochloride showed clear differences with only one common peak at 1.54 THz (see 
Table 4-4. Cocaine hydrochloride has a considerably larger absorption coefficient probably 
owing to the large Cl counter ion, which increases the magnitude of the dipole moment and 
thus the change in dipole moment during a normal mode vibration.
267
 Synthetic cannabinoids 
do not occur in salt form or other crystal forms but as it can be seen in Figure 4-2, the features 
are relatively weak and broad and tend to be masked by the combined effects which are 
explained as follows.
290
 But also different packaging materials and therefore the attenuation 
properties of the covering layers,
291,292
 the scattering effects related to the morphology and 
inhomogeneity of the substance surface,
288,293
 changes in the atmospheric humidity due to 
strong attenuation properties of water vapor during the measurements
294
 lead to low 
repeatability of this method.  
In most publications and also predominant in this study, THz-TDS were performed on tablets, 
neglecting the scattering and diffraction phenomena. In addition, water features tend to 
fluctuate in strength and slightly in position. This leads to imprecision in the determination of 
the THz features from the quotient of the reference and the sample.
294
 To avoid absorption 
features within the spectral range caused by atmospheric water vapor, some publications used 
a dry-air box in which the optical setup was encapsulated.
285,294,295
 In this study, humidity was 
not considered, but should be controlled for future measurements.  
Another challenge is the analysis of more than one sample in a package that complicates to 
extract the fingerprint of each of them. Moreover, THz spectroscopy is not very sensitive. The 
analysis of synthetic cannabinoids in different matrices like herbal mixtures, e-liquids or 
papers was not possible due to amounts of active ingredient in the matrix below limits of 
detection. The analysis of (pure) powders or pellets at a thickness of > 0.6 mm was possible.  
Similar measurement procedures for the analysis of drugs were used in most literature studies. 
Usually, the powders under investigation were pressed into a pellet in order to measure the 
THz transmission spectra. Most publications mixed the analyte material with an inert matrix 
or filler material which is typically transparent for THz radiation, such as polyethylene 
(PE)
280,282,284,296
 or PTFE
267,281,296
. This allows to dilute concentrations of a highly absorbing 
agent to be measured. As the presence of matrix material can influence the measured THz 
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spectra, the use of a matrix material with an index of refraction that closely matches that of 
the powder can minimize the scattering by reducing the effect of the dielectric mismatch in 
the THz range. In reality, smugglers are not going to prepare their samples with specific 
matrix materials and so we decided to carry out the measurements of the synthetic 
cannabinoids in realistic form. as powders and pellets without filling material. In this study, 
the limit of detection was determined on the basis of the pellet thickness. To the best of our 
knowledge, the LOD of drugs-of-abuse were not discussed in other publications. In general, 
the sample thickness was described ranging between 0.5 and 3 mm.
277,281,284-286
 LODs were 
given in studies for pharmaceuticals pressed into pellets with nearly same thicknesses of 
approximately 2 to 3 mm.
297
 For each pharmaceutical, different pellets were prepared by 
mixing the pharmaceutical powder with PE at different concentrations from 0 to 100 % 
w/w.
277,294,297
 LODs ranged between 4-10 % w/w,
277,294
 but in most cases, a detection below 
1 % w/w was impossible.
297
 In case of the detection of powders of synthetic cannabinoids, 
information about the minimal detection thickness is decisive since those substances show 
almost no addition of cutting agents.  
The advantages of THz spectroscopy can only be taken, when several grams of powders are 
present in packaging material, many nonmetallic and nonpolar materials do not absorb THz 
radiation.
269
 This enables the spectral analysis of materials concealed within dry packaging, 
such as paper, plastics, cardboard, and enabling the imaging of concealed objects.
271
 In this 
study, the spatial distribution of synthetic cannabinoids concealed in a plastic bag and an 
envelope, is obtained from terahertz multispectral transillumination images and absorption 
spectra. To avoid measuring the whole packaging material, a pre-screening step is proposed, 
by first detecting the presence of powders in the envelopes and then defining the grid of 
measurement points (Figure 4-4). Kawase et al. demonstrated the successful detection and 
discrimination of methamphetamine, MDMA, aspirin, where the substances were hidden in a 
plastic bag or envelope,
266
 whereas Fischer et al. described the analysis of cocaine and 
morphine through a plastic bag.
286
 
Competing detection technologies such as x-rays and millimetre wave imaging were not able 
to provide a spectral fingerprint in their respective electromagnetic frequency ranges to 
distinguish illicit drugs from legal drugs.
266,267
 In Raman spectroscopy, the radiation may also 
transmit materials like glass
88
 and polymer packaging
68
 but not paper materials. Like Raman 
spectroscopy, IR imaging has the capability to distinguish different drugs based on fingerprint 
spectra in the infrared region, but most packaging are opaque for IR radiation.
280
 
Thus, THz-technology shows some advantages as a complementary preliminary test at 
security points or mail service and can provide a first hint on the NPS subclass. It can thus 
uncover drug trafficking of NPS powders by a contactless and non-destructive measurement 
technology. Before reaching a final conclusion on a future relevance of THz spectroscopy in 
forensic science, further tests should be carried out including the in-field testing under 
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different atmospheric conditions and influences of air humidity, measurements in different 
packaging materials, the analysis of a large number of different powders to gain a better 
understanding of possible scattering effects. 
4.6 Conclusion 
The analysis of synthetic cannabinoids using THz-TDS was described. Previous studies 
concentrated on the characterisation of classical drugs like cocaine and amphetamine but not 
on the analysis of NPS. Based on different core-structures and linked groups, spectroscopic 
data of 16 synthetic cannabinoids were recorded including the centre frequency of the feature, 
FWHM and the cut-off frequency. Specific substance identification is not possible due to the 
fact that synthetic cannabinoids providing the same structural components show similar 
specific features. Thus, class identification is feasible. The strength of this technique lies only 
in the analysis of powders and not in the analysis of various matrices containing different 
active ingredients like herbal mixture and impregnated papers. Here, THz technique is not 
sensitive enough for the concentrations observed in field work. THz spectroscopy could be 
used in security institutions or mail centres due to desirable properties like the contactless and 
non-destructive measurement to get a first hint on possible illegal substance like drugs in 
packages and envelopes and the possibility of transillumination images of packed materials. 
Further in-field analysis should be performed with a large number of different samples. This 
could reveal the importance of interfering parameters such as humidity in air, medium, salt 
form. 
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5 Structural similarity of synthetic cannabinoids in 
herbal mixtures allows to cross-calibrate analytes 
without reference material by UPLC-DAD 
5.1 Abstract 
The steady appearance of new psychoactive substances (NPS) on the European drug market 
represents a challenge for analytical forensic investigations. The determination of the active 
ingredient in casework samples is one of the main tasks in forensic institutes due to specific 
punishment corresponding to different types and quantities of drugs. Problems arise from the 
fact that only for older NPS, reference substances are available. The traditional approaches 
and timescales of reference material production and certification are being increasingly 
challenged by the appearance of ever new substances. The effort required may become 
questionable given the short lifetime of many NPS on the market. In this study, the need for 
reference materials was circumvented by evaluating the possibility of cross calibrations of 20 
synthetic cannabinoids using a small set of reference substances as calibrants for other NPS. 
This was possible due to the structural similarity of synthetic cannabinoids grouped into 
classes based on the core structure: eight indole-core, ten indazole-core and two carbazole-
core synthetic cannabinoids could be quantified with one common calibration curve for each 
class. Bias values < 4.9 % were obtained with best results ranging from -1.5-1.0 % for pairs of 
substances containing similar linker- and tail-groups attached to the core-group. 
5.2 Introduction  
The phenomenon of new psychoactive substance (NPS) poses great challenges for the 
legislative, executive and forensic laboratories. By the end of 2018, the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) summarised more than 730 new 
psychoactive substances, 55 of which were detected for the first time in Europe in 2018.
8
 
According to the dynamically changing NPS market, the availability of suitable reference 
material poses a major challenge for forensic institutions with regard to both identification 
and quantification of NPS. The traditional and time consuming production of reference 
material often requires several months, which is not appropriate for the rapidly changing drug 
market. Alternative approaches are required to produce materials of a suitable quality to 
satisfy the requirements of a robust quality system
298
 and also for quantification as described 
by Archer et al.
32
 The production of in-house reference materials requires significant effort 
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and synthetic as well as analytical capability and is not not feasible for routine laboratories. 
However, the identification and the quantification of the active ingredient content of casework 
samples is one of the main tasks in forensic institutes due to specific punishments 
corresponding to different types and quantities of drugs. 
The methods most commonly employed for the quantitative routine analysis of NPS in 
forensic laboratories are chromatographic techniques coupled to mass spectrometry, mostly 
gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. Some 
publications describe the utilisation of LC in combination with UV-detection.
2,140
 The 
published LC-applications focus on the analysis of synthetic cannabinoids in biofluids 
including urine,
103,117,124-126,128
 hair,
120
 oral fluids
118,119
 and serum/blood.
115,121,123,127,130
 Simple 
liquid-liquid extraction followed by LC-MS is usually used for sample preparation because of 
the high hydrophobicity of the drugs. The LODs reported ranged from 6-2000 ng/L. GC-MS 
applications mostly concentrate on the analysis of herbal mixtures with simple sample 
preparation steps, e.g. mixing the herbal material with an organic solvent and filtering the 
supernatant.
100,102
 LODs of 0.5-1.0 mg/L are usually higher than in LC-MS analysis. Another 
disadvantage of GC-MS analysis is its inability to identify cyclopropyl or ester analogs, such 
as UR144 or PB-22 (see Table 5-1) because cyclopropyl analogs have a low thermal stability 
and are easily degraded already in the injection port of the GC instrument.
299,300
 GC-MS with 
chemical or electron ionisation provides information on structural elements, whereas LC-ESI-
MS would need specialised instrumentation for MS/MS analysis. For all chromatographic 
techniques, quantification is only possible via calibration with reference standards.  
In the last few years, NMR has been established for the characterisation of NPS in herbal 
mixtures or powders.
46-53
 It is a fast technique which allows unambiguous structural 
elucidation of unknown compounds. In contrast to most other analytical methods, the use of 
standard references for the determination of the purity of a sample is not necessary. 
Quantification of a substance is based on integration of the analyte signal correlated to the 
signal of an internal calibrant. A detailed explanation on the determination of standard sample 
purity using high precision 
1
H-NMR was given by Schoenberger.
49
 A prerequisite is the 
selection of an appropriate internal standard so that the integral regions in the spectrum must 
be completely free of impurity or analyte signals. A structural similarity between the internal 
calibrant and the analyte is not necessary in NMR. Disadvantages of this technique are the 
high costs and the required technical expertise which limits the applicability in routine 
analysis.
2
 At present, there are no alternative methods to NMR published for the fast and 
effective quantification of NPS, which allow the quantification independent of reference 
standards.  
In this study, we investigated, if it is possible to use an NPS, for which reference material is 
commercially available, as a cross calibrant for other NPS. The procedure was tested for 20 
synthetic cannabinoids using UPLC-DAD. For this, we discuss the required structural 
UPLC-DAD 
 
 
100 
 
crosslinks between indole-, indazole- and carbazole-core synthetic cannabinoids via two 
Quality Control (QC) samples for each synthetic cannabinoid to establish calibration curves 
for different NPS. The feasibility of cross calibration was judged using bias values. The 
methodology was validated in terms of accuracy, precision and sensitivity and its applicability 
proven by the analysis of 24 herbal mixtures with known active ingredient content. 
5.3 Materials and Methods 
5.3.1 Chemicals 
All reagents were of analytical grade. Ultrapure water was used throughout this work. For 
UPLC-DAD and GC-MS measurements, methanol from Th. Geyer (Renningen, Germany) 
was used. NMR analysis was carried out using acetone-d6 (purchased from Deutero, 
Kastellaun, Gemany) and the internal calibrant 3,5-dinitrobenzoic acid (Fluka, TraceCERT, 
99.66 %). 
The reference standards of 20 synthetic cannabinoids (powders) employed in this study were 
taken from criminal cases provided by the State Office of Criminal Investigation Rhineland-
Palatinate (Germany) and are listed in Table 5-1. The purity of the reference samples was 
investigated using 
1
H-NMR and GC-MS. The herbal mixtures analysed in this study were 
provided by the State Office of Criminal Investigation Rhineland‐Palatinate (Germany). The 
samples were taken from caseworks and corresponding IUPAC names and structural formulas 
are summarised in Table 5-1. 
Table 5-1 Chemical structures, IUPAC names, purity determined by NMR and GC-MS parameters retention time 
Rt and m/z values of the reference standards (powders) evaluated in this study including synthetic cannabinoids 
containing indazole-, indole- and carbazole-core structures. 
Substance Chemical structure IUPAC name 
NMR GC-MS 
Purity in 
% 
Rt 
in min 
m/z 
Indazoles 
5F-AKB-48 
 
N-(adamantan-1-yl)-1-(5-
fluoropentyl)-1H-indazole-3-
carboxamide 
99.7 8.3 
233 
145 
294 
365 
383 
5F-AMB 
 
Methyl-(2S)-2-([1-(5-
fluoropentyl)-1H-indazol-3-
yl]formamid)-3-methylbutanoate 
98.5 10.9 
233, 
145, 
304, 
249, 
131 
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Substance Chemical structure IUPAC name 
NMR GC-MS 
Purity in 
% 
Rt 
in min 
m/z 
5F-ADB 
 
Methyl-(S)-2-[1-(5-
Fluoropentyl)-1H-indazole-3-
carboxamido]-3,3-
dimethylbutanoate 
98.7 10.9 
233, 
145, 
130, 
289, 
321 
5F-SDB-005 
 
Naphthalene-1-yl 
1-(5‐fluoropentyl)‐1H‐indazole‐
3‐carboxylate 
97.3 15.2 
233, 
145, 
115, 
213, 
115 
AB-
FUBINACA 
 
N-[(1S)-1-(aminocarbonyl)‐2‐
methylpropyl]‐1‐[(4‐
fluorophenyl)methyl]‐1H‐
indazole‐3‐carboxamide 
94.9 13.4 
109, 
252, 
324, 
145, 
83 
FUB-AMB 
 
N-[[1-[(4-fluorophenyl)methyl]‐
1H‐indazol‐3‐yl]carbonyl]‐L‐
valine, methyl ester 
99.9 10.9 
109, 
253, 
324, 
254, 
383 
MAB-
CHMINACA 
 
N-[(2S)-1-amino-3,3-dimethyl-1-
oxobutan-2-yl]-1-
(cyclohexylmethyl) indazole-3-
carboxamide 
91.6 13.4 
241, 
326, 
145, 
131, 
55 
THJ-2201 
 
 
 
[1-(5-fluoropentyl)-1H-indazol-
3-yl](1-naphthyl)methanone 
97.2 14.1 
127, 
271, 
360, 
259, 
155 
Indoles 
5F-PB-22 
 
1‐(5‐fluoropentyl)‐8‐quinolinyl 
ester-1H‐indole-3-carboxylic 
acid 
99.6 18.2 
232, 
144, 
116, 
89, 
376 
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Substance Chemical structure IUPAC name 
NMR GC-MS 
Purity in 
% 
Rt 
in min 
m/z 
APICA 
 
N-(1-adamantyl)‐1‐pentyl‐1H‐
indole‐3‐carboxamide 
98.5 16.9 
214, 
144, 
307, 
364, 
347 
AM-2201 
 
[1-(5-Fluoropentyl)-1H-indol-3‐
yl]‐1‐naphthalenyl‐methanone 
99.8 15.2 
359, 
127, 
284, 
232, 
144 
BB-22 
 
1-(Cyclohexylmethyl)-8-
quinolinyl ester-1H-indole-3-
carboxylic acid 
97.2 24.8 
240, 
144, 
116, 
241, 
55 
MMB-2201 
 
(S)-Methyl-2-(1-(5-
fluoropentyl)-1H-indole-3-
carboxamido)-3-
methylbutanoate 
96.6 11.7 
232, 
248, 
144, 
362, 
233 
MDMB-
CHMICA 
 
Methyl-(2S)-2-([1-
(cyclohexylmethyl)-1H-indol-3-
yl]formamido)-3,3-
dimethylbutanoate 
97.0 12.6 
240, 
144, 
296, 
328, 
268 
PB-22 
 
1-Pentyl-1H-indole-3-carboxylic 
acid 8-quinolinyl ester 
98.2 17.7 
214, 
144, 
116, 
89, 
358 
STS-135 
 
N-(adamantan-1-yl)-1-(5-
fluoropentyl)-1H-indole-3-
carboxamide 
98.9 11.1 
232 
144 
307 
382 
264 
116 
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Substance Chemical structure IUPAC name 
NMR GC-MS 
Purity in 
% 
Rt 
in min 
m/z 
UR-144 
 
(1-Pentylindol-3-yl)-(2,2,3,3-
tetramethylcyclopropyl) 
methanone 
98.8 10.3 
214, 
144, 
296, 
311, 
252 
XLR-11 
 
(1-(5-Fluoropentyl)-1H-indol-3-
yl)(2,2,3,3-
tetramethylcyclopropyl) 
methanone 
97.1 11.1 
232 
144 
314 
329 
270 
Carbazoles 
EG-018 
 
 
Naphthalen-1‐yl-(9‐pentyl‐9H‐
carbazol‐3‐yl)-methanone 
94.6 23.8 
334, 
391, 
335, 
127, 
179 
MDMB-
CHMCZCA 
 
Methyl-(S)-2-(9-
(cyclohexylmethyl)-9H-
carbazole-3-carboxamido)-3,3-
dimethylbutanoate 
98.3 23.1 
290, 
434, 
179, 
346, 
378 
5.3.2 Methodology 
5.3.2.1 Gas chromatography-mass spectrometry 
As not all NPS standards were commercially available during the experimental phase of this 
study, material from seizures was used. Identity and purity of each seized drug powder or 
herbal mixture were determined by GC-MS. Information on the technical parameters, a 
detailed explanation of the sample preparation and the method parameters used are described 
in Chapter 2.3.2.1 and the corresponding publication.
248
 
The samples were prepared as follows: Five mg of powdered samples were dissolved in 1 mL 
methanol. 200 mg of herbal or tobacco mixtures were suspended in 3 mL methanol. In cases, 
where less material was available, the amount of methanol was reduced until the whole 
material was covered with organic solvent. The solutions were filtered with syringe filters 
from Macherey-Nagel (Düren, Germany) with a pore size of 0.20 µm and a diameter of 
25 mm directly into GC-MS vials for injection.  
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5.3.2.2 NMR 
The purity determination of NPS samples from seizures was conducted by quantitative NMR 
(qNMR) analysis. Technical information, the sample preparation steps and method parameters 
are described by Schoenberger.
49
 In Chapter 2 and in the publication of Metternich et al., the 
details of NMR analysis are summarised.
248
  
 
5.3.2.3 UPLC-DAD 
A UPLC Aquity-System (Waters, Milford, MA, USA) equipped with DAD was used for the 
quantitative analysis of 20 synthetic cannabinoids. Information on the technical parameters, a 
detailed explanation of the sample preparation and the method parameters used are described 
in Chapter 2.3.2.1 and the corresponding publication.
248
 
Two samples of herbal mixtures, 100 mg each, were suspended in 10 mL methanol. The 
suspensions were filtered with syringe filters from Macherey-Nagel (Düren, Germany) with a 
pore size of 0.20 μm and a diameter of 25 mm. Then, 100 μL of the filtered sample solution 
were mixed with 900 μL methanol directly in UPLC vials for injection. 
5.3.2.4 Cross calibration 
The cross calibration of synthetic cannabinoids was carried out using a 7-point-calibration 
(n = 3) in the range of 5-100 mg/L (in methanol) with different reference standards. Two 
quality control (QC) samples, one with a low (10 mg/L) and one with a high concentration 
(75 mg/L), were prepared daily, called QC1 and QC2. The evaluation was carried out using 
the program Valistat 2.0 by Avercon (Walldorf, Germany). 
5.4 Results and discussion 
5.4.1 Characterisation of reference samples including NMR and GC-MS 
The reference standards used in this study were samples from seizures and the purity was 
determined using 
1
H-NMR and GC-MS. Initially, the powder material was analysed via GC-
MS to investigate the overall composition of the samples and identify active ingredient via the 
in-house GC-MS library. The retention times and the characteristic m/z values of each 
substance are reported in Table 5-1 (arranged according to their signal intensity). Afterwards, 
the purity was determined using 
1
H NMR to be > 91.6 %. Samples with significant impurities 
such as cutting agents (paracetamol, caffeine, sugars) or other drugs (e.g. amphetamine, 
cocaine or THC) were not taken into consideration. 
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5.4.2 Evaluation of the UPLC-DAD method 
5.4.2.1 UV-Spectra  
The UV absorption spectra of compounds are highly characteristic and sensitive to changes 
upon substitution at the chromophore-region. The UV spectra of the synthetic cannabinoids 
investigated during this study are shown in Figure 5-1 and the corresponding chemical 
structures are summarised in Table 5-1. Generally, UV spectra of indoles have intense bands 
at 216, 262 and 280 nm.
301
 The band near 262 nm can be shifted or even absent for many 
substituted indoles. E.g., alkylation of the indole nitrogen leads to bathochromic shifts of up 
to 10 nm.
301
 In case of 1-acetylindole the band around 280 nm is shifted to 290 nm. All 
investigated indole-core synthetic cannabinoids that contain an amide or ester linkage show 
bands around 216 nm and 290 nm in their UV spectra as already described.
302
 An exception 
was observed for indole-core synthetic cannabinoids having an adamantly-group attached to 
the linker with only one band around 301 nm as can be seen for STS-135 and APICA. Indole-
core synthetic cannabinoids which possess a keto-linker show intense bands at 216 nm, 
245 nm and 305 nm like in UR-144 and XLR-11 (see Figure 5-1). The latter was shifted from 
290 to 305 nm due to the aromatic system being extended by the double bond. 
The UV spectrum of 1H-indazole shows two characteristic bands around 250 and 290 nm (see 
Figure 5-1). N-methylation shifts the latter band to ~300 nm as visible for many indazole-core 
synthetic cannabinoids with an amide- and ester-linker. The linked group naphthalene in THJ-
2201, AM-2201 leads to an additional band at ~220 nm. The spectrum of carbazole shows 
bands at 236 nm, 277 nm, 340 nm and the presence of a naphthalene group (e.g. in EG-018, 
see Figure 5-1) even show a band around 220 nm. 
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Figure 5-1 UV spectra of the synthetic cannabinoids investigated during this study, recorded during UPLC-
DAD. Separation parameters given in Materials and Methods 
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5.4.2.2 Figures of merit 
Table 5-2 summarises the figures of merit from the validation of the method in terms of 
linearity, sensitivity and precision. In addition, the wavelengths of the maxima in the 
spectrum, UVmax, and the retention times of the analytes are summarised in Table 5-2. Figure 
5-2 shows a chromatogram of all synthetic cannabinoids investigated during this study. 
Examination of linearity was performed by the analysis of three calibrations each consisting 
of seven calibrators spread over the substance-specific calibration range. In Table 5-2, the 
calibration equation and the corresponding correlation coefficients with R
2
 > 0.997 for all 
analytes are listed. Sensitivity calculations including limit of detection (LOD) and limit of 
quantification (LOQ) were conducted according to DIN 32645. LODs and LOQs were in the 
range of 0.49-4.17 mg/L and 1.57-10.1 mg/L, respectively. The precision was determined 
with two quality control samples (QC) of high and low concentration, which were analysed 
daily (n = 2) on eight consecutive days. The intraday and interday imprecision was ≤ 2.21 % 
and ≤ 5.11 % (for QC1 and QC2). 
 
Figure 5-2 UPLC-DAD chromatograms (overlay) of the synthetic cannabinoids investigated during this study 
(1 = AB-FUBINACA. 2 = 5F-AMB, 3 = FUB-AMB, 4 = MAB-CHMINACA, 5 = XLR-11, 6 = 5F-ADB, 7 = 5F-
PB-22, 8 = MDMB-CHMICA, 9 = UR-144, 10 = STS-135, 11 = PB-22, 12 = MMB-2201, 13 = THJ-2201, 
14 = 5F-SDB-005, 15 = APICA, 16 = AM-2201, 17 = 5F-AKB-48, 18 = BB-22, 19 = MDMB-CHMCZCA, 
20 = EG-018; Separation parameters given in Materials and Methods 
5.4.2.3 Possibility of quantification of analyte classes with a common calibrator 
The possibility to cross calibrate synthetic cannabinoids with other substances of the same 
substance class with regard to the core of the synthetic cannabinoid was evaluated using 7-
point calibrations of each reference standard. Peak area was used to reduce impairments from 
peak broadening. Two QC samples of each substance were measured and the bias (%) of the 
calculated concentration was evaluated with the calibration data of all other synthetic 
cannabinoids (Table 5-2).  
UPLC-DAD 
 
 
108 
 
The synthetic cannabinoids are subdivided into 3 classes to study the effect of structural 
analogies on the feasibility of cross calibration: indazoles, indoles and carbazoles (Table 5-1). 
In the State Office of Criminal Investigation Rhineland-Palatinate (Germany), a general 
measurement uncertainty of 10 % is accepted for quantification. This value stems from 
empirical values of quantifications of classical drugs which allow a maximum deviation of 
5 % during measurements. Consequently, the scope of uncertainty was established to be a 
twofold deviation of 5 %. The calculated bias must therefore be less than 5 %, all deviations 
above this value indicate that the possible cross-calibrator substance is unsuitable for the 
quantification of the analyte of interest.  
In this study, eight different indazole-core synthetic cannabinoids were evaluated. Table 5-3 
summarises the bias of the QC-samples for each pair of analyte and cross-calibrator. The 
fields marked in blue show the results when the analyte concentration is determined by its 
own calibration curve. Green fields mark bias values < 5 %, were cross calibration is feasible 
with the respective cross-calibrator. The following trend was observed: synthetic 
cannabinoids with same linker connected to the indazole-core group show a bias < 4.9 % and 
quantification within this substance class is possible. E.g. THJ-2201 and 5F-SDB-005 have a 
keto- and an ester-linkage, respectively. The different linkers lead to elevated bias values of 
5.2 to 37.5 %, which is unacceptable for precise quantification. Best results with bias values 
that ranged from -1.5-1.0 % were recognised for pairs of substances additionally containing 
similar tail-groups such as the pair AB-FUBINACA and FUB-AMB or the pair 5F-ADB with 
5F-AMB. The linked group was observed not to influence quantitative results. E.g. AB-
FUBINACA possesses an amido- and FUB-AMB an ester-group, but similar bias values were 
observed. 
In contrast, the tail plays a subordinate role in comparison to the linker which is illustrated by 
the substance pair of 5F-AKB-48 and MAB-CHMINACA. For 5F-AKB-48 containing a 
fluoro-pentyl-group the best cross-calibrator was FUB-AMB with a fluorobenzyl-group. For 
MAB-CHMINACA with a cyclopentyl-group best results were obtained with 5F-AMB 
containing a fluoro-pentyl group (see Table 5-1 and Table 5-3). For indazole-core synthetic 
cannabinoids, the UV spectra were very similar with UVmax around 300 nm except for THJ-
2201, a substance with a keto linkage with UVmax of 218 and 320 nm. 5F-SDB-005 shows a 
band at ~300 but an ester-linker and thus, could not be quantified using the calibration data of 
any other substance. 
Clearly, similar UV spectra themselves are not decisive but the slope of the calibration curve. 
Table 5-2 summarises the equations of the calibration curves and similar slopes represent an 
indication for possible cross links between substances. E.g., the indazole-core synthetic 
cannabinoids show values of m = 17134.7-18610.4 µV*sec*L*kg
-1
. THJ-2201 and 5F-SDB-
005 have different slope values with m = 1633.2 and m = 22256.1 µV*sec*L*kg
-1
, 
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respectively (see Table 5-2). Thus, the slope is a reliable indicator for cross calibration 
possibilities between substances. 
A similar evaluation of the data for ten indole-core synthetic cannabinoids (see Table 5-4) 
revealed similar trends as for the indole-core cannabinoids: Three different linker types 
including amide-, keto- and ester-linkage allowed cross calibration within these substance 
classes. Across the classes, inacceptable bias values of -62.4 to 152.1 % were obtained (see 
Table 5-4). For the class with an amide-linker including MDMB-CHMICA, STS-135, APICA 
and MMB-2201 cross calibration was possible with bias values < 4.9 % despite differences in 
the UV-spectra: the spectra of MDMB-CHMICA and MMB-CHMICA have bands at 216 and 
290 nm, whereas STS-135 and APICA spectra show only one band at around 300 nm. The 
values of the slope are similar, ranging from m = 11939.1-12734.1 µV*sec*L*kg
-1
. AM-
2201, UR-144 and XLR-11 belong to the class with a keto linkage and are feasible for cross 
calibration (bias values < 4.4 %). AM-2201 show the highest bias values of these three 
substances and the slope value of m = 19420.1 µV*sec*L*kg
-1 
differs from that of UR-144 
(m = 18224.3 µV*sec*L*kg
-1
) and XLR-11 (m = 18976.1 µV*sec*L*kg
-1
). The last class 
with an ester-linkage includes PB-22, 5F-PB-22 and BB-22. Bias < 5 % were observed here 
(Table 5-4) with values of the slope that ranged from m = 29391.6-28526.7 µV*sec*L*kg
-1
. 
As expected, structurally similar substances showed best cross calibration results with lowest 
bias values: e.g., STS-135 and APICA are structurally very similar except the fluoro atom 
attached to the pentyl tail in STS-135. The same applies to PB-22 with 5F-PB-22 and UR-144 
with XLR-11. These substances show best cross calibration results with lowest bias values 
ranging from 0.3 to -1.6 %. Cross calibration of PB-22 with 5F-PB-22 achieved bias values 
< 1.6 % whereas bias values for BB-22 ranged from -5.0 to -3.6 % (see Table 5-4). 
Only few carbazole-core synthetic cannabinoids have appeared on the NPS drug market so 
far. In this study only two representative substances were investigated including EG-018 and 
MDMB-CHMZCZA differing in linker, tail and linked group. Accordingly, cross calibration 
was not feasible with bias values > 300 % (data not shown), showing the limitations of the 
cross calibration approach for this class of cannabinoids.  
We further tested, if a cross calibration between indole- and indazole-core synthetic 
cannabinoids is possible. Bias values ranged from -0.1 % to 95.9 % (see Table 5-5 and Table 
5-6) and slopes of the calibration curve often differed. Cross calibration was shown to be 
possible only for indole-core synthetic cannabinoids with a keto-linker (UR-144 and XLR-11 
and AM-2201) with indazole-core synthetic cannabinoids containing an amide-linkage with 
bias values that range from -4.9-4.5 %.  
For quantification of casework samples in forensic applications, some general rules were 
deducted: The most important prerequisite for possible cross calibration are same core- and 
linker-groups present in the synthetic cannabinoids leading to a similar sensitivity given by 
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the slope of the calibration curve. Similarities in the tail-group can be advantageous but are 
not a precondition. 
Indazole-core synthetic cannabinoids with an amide linkage represent the most common 
chemical structure of NPS and FUB-AMB and 5F-ADB show the lowest bias values in cross 
calibration with other synthetic cannabinoids of this group and can be regarded as suitable 
cross calibrants for the whole class. In the case of indole-core synthetic cannabinoids, for 
every linker type one substance is observed to reveal low bias values including 5F-PB-22 
(ester-linker), STS-135 (amide-linker), UR-144 (keto-linker). For these substances, reference 
material is commercially available. Overall, only five synthetic cannabinoids standards are 
thus requires for precise quantification via only a few cross calibrations, which also 
considerably reduces the effort and working time. 
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Table 5-2 Validation of synthetic cannabinoids evaluated in this study including linearity, sensitivity and 
precision, UVmax and retention time Rt,) with quality control samples QC1 (10 mg/L) and QC2 (75 mg/L) 
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Table 5-3 Bias values in % of the cross calibration of indole-core synthetic cannabinoids (blue = origin 
calibration, green = possible cross calibration partner with bias < 5) 
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CA 
 
THJ-2201 
 
5
F
-A
K
B
-4
8
 
-0
.5
 
-2
.0
 
2
.5
 
2
.3
 
0
.7
 
0
.6
 
-2
2
.1
 
-2
2
.4
 
1
.7
 
3
.7
 
-0
.7
 
0
.2
 
2
.7
 
2
.6
 
7
.9
 
7
.8
 
5
F
-A
M
B
 
-2
.3
 
-3
.2
 
-0
.1
 
-0
.5
 
1
.0
 
-0
.7
 
-2
2
.7
 
-2
3
.3
 
3
.5
 
3
.8
 
2
.3
 
-0
.8
 
2
.1
 
1
.5
 
7
.2
 
6
.7
 
5
F
-A
D
B
 
4
.3
 
4
.6
 
-1
.0
 
-0
.7
 
-0
.7
 
0
.1
 
-2
2
.5
 
-2
2
.6
 
3
.8
 
-3
.9
 
2
.2
 
2
.6
 
2
.3
 
2
.2
 
7
.4
 
7
.4
 
5
F
-S
D
B
-0
0
5
 
3
0
.6
 
2
6
.1
 
2
8
.7
 
2
3
.2
 
2
7
.5
 
2
1
.6
 
-0
.6
 
-2
.3
 
2
3
.2
 
1
7
.4
 
2
4
.9
 
1
9
.5
 
3
0
.6
 
2
4
.5
 
3
7
.2
 
3
0
.8
 
A
B
-
F
U
B
IN
A
C
A
 
2
.1
 
1
.5
 
2
.9
 
2
.7
 
2
.7
 
3
.8
 
-1
9
.7
 
-1
9
.6
 
-0
.2
 
-0
.2
 
0
.3
 
2
.0
 
1
0
.7
5
 
5
.4
 
-1
9
.5
 
1
1
.5
 
F
U
B
-A
M
B
 
3
.9
 
2
.8
 
4
.7
 
4
.9
 
2
.5
 
1
.7
 
-2
0
.6
 
-2
1
.0
 
-1
.5
 
2
.2
 
1
.4
 
1
.7
 
4
.7
 
4
.2
 
1
0
.3
 
9
.4
 
M
A
B
-
C
H
M
IN
A
C
A
 
3
.2
 
4
.8
 
0
.8
 
1
.4
 
-1
.9
 
-1
.8
 
2
4
.2
 
-2
4
.3
 
-5
.5
 
-6
.0
 
-2
.5
 
-2
.0
 
0
.1
 
0
.2
 
5
.2
 
5
.3
 
T
H
J-
2
2
0
1
 
-7
.2
 
-8
.0
 
-8
.2
 
-7
.9
 
-7
.2
 
-7
.3
 
-2
8
.1
 
-2
8
.3
 
-1
0
.7
 
-1
1
.0
 
8
.2
 
-8
.0
 
6
.1
 
-5
.3
 
-0
.4
 
-0
.5
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Table 5-4 Bias values in % of the cross calibration of indazole-core synthetic cannabinoids (blue = origin 
calibration, green = possible cross calibration partner with bias < 5) 
A
ct
iv
e 
in
g
re
d
ie
n
t 
o
f 
Q
C
-
sa
m
p
le
s 
Substances for cross calibration 
MDMB-
CHMIC
A 
 
PB-22 
 
5F-PB-
22 
 
STS-
135
 
BB-22 
 
APICA 
 
AM-
2201 
 
UR-144 
 
XLR-11 
 
MMB-
2201 
 
M
D
M
B
-
C
H
M
IC
A
 
1
.2
 
2
.1
 
-6
2
.4
 
-6
0
.0
 
-6
0
.3
 
-6
1
.6
 
-1
.8
 
-1
.7
 
-5
4
.9
 
-5
2
.9
 
-3
.5
 
-2
.4
 
-3
8
.6
 
-3
7
.8
 
-3
7
.8
 
-3
7
.5
 
-3
4
.2
 
-3
5
.3
 
-3
.1
 
-2
.1
 
P
B
-2
2
 
1
4
8
.6
 
1
4
7
.6
 
-1
.6
 
-0
.6
 
-0
.8
 
-0
.7
 
1
3
6
.7
 
1
3
5
.4
 
6
.3
 
5
.3
 
1
3
7
.4
 
4
1
.4
 
5
1
.4
 
5
4
.6
 
5
4
.6
 
5
4
.2
 
6
1
.4
 
6
3
.8
 
1
3
3
.0
 
1
3
3
.0
 
5
F
-P
B
-2
2
 
1
5
2
.1
 
1
5
0
.3
 
-0
.3
 
0
.1
 
0
.6
 
0
.3
 
1
4
0
.0
 
1
3
7
.9
 
7
.9
 
6
.5
 
1
3
8
.6
 
1
3
9
.6
 
5
3
.0
 
5
3
.0
 
5
6
.2
 
5
6
.7
 
6
3
.1
 
6
2
.5
 
1
3
5
.5
 
1
3
2
.8
 
S
T
S
-1
3
5
 
4
.5
 
4
.5
 
-5
9
.1
 
-5
7
.2
 
-5
8
.3
 
-5
7
.6
 
0
.7
 
0
.6
 
-5
4
.5
 
-5
4
.7
 
-1
.5
 
-1
.1
 
-3
4
.6
 
-3
5
.8
 
3
4
.6
 
-3
8
.8
 
-3
1
.6
 
-3
7
.7
 
-0
.5
 
-0
.1
 
B
B
-2
2
 
1
3
5
.6
 
1
3
5
.5
 
-4
.3
 
-3
.8
 
-5
.0
 
-4
.0
 
1
2
3
.9
 
1
2
4
.0
 
0
.2
 
0
.7
 
1
2
5
.7
 
1
2
3
.9
 
4
4
.1
 
4
3
.7
 
4
6
.7
 
4
6
.7
 
5
3
.2
 
5
5
.1
 
1
2
1
.8
 
1
2
2
.2
 
A
P
IC
A
 
4
.1
 
4
.6
 
-5
9
.5
 
-5
8
.9
 
-5
7
.5
 
-5
7
.6
 
0
.7
 
0
.3
 
-5
2
-0
 
-5
3
.2
 
-0
.6
 
-0
.1
 
-3
4
.1
 
-3
4
.7
 
-3
3
.0
 
-3
3
.5
 
-2
9
.6
 
-3
0
.3
 
3
.4
 
1
.7
 
A
M
-2
2
0
1
 
6
5
.7
 
6
4
.8
 
-3
5
.9
 
-3
5
.2
 
-3
4
.5
 
-3
4
.4
 
5
8
.3
 
5
7
.0
 
-2
8
.4
 
-2
9
.3
 
5
4
.8
 
5
6
.1
 
0
.8
 
0
.5
 
2
.7
 
2
.5
 
7
.5
 
7
.2
 
5
6
.4
 
5
5
.3
 
U
R
-1
4
4
 
6
1
.7
 
6
0
.7
 
-3
6
.7
 
-3
5
.7
 
-3
5
.8
 
-3
5
.9
 
5
4
.2
 
5
3
.7
 
-3
0
.5
 
-3
0
.8
 
5
2
.1
 
5
2
.7
 
-1
.5
 
-1
.2
 
1
.5
 
0
.5
 
5
.1
 
5
.1
 
5
2
.5
 
5
2
.5
 
X
L
R
-1
1
 
5
6
.0
 
5
5
.2
 
-3
9
.9
 
-3
9
.1
 
-3
8
.4
 
-3
8
.3
 
4
9
.1
 
4
7
.9
 
-3
2
.4
 
-3
3
.4
 
4
5
.8
 
4
6
.7
 
-4
.2
 
-4
.4
 
-3
.4
 
-3
.5
 
1
.2
 
0
.9
 
4
6
.3
 
4
7
.4
 
M
M
B
-
2
2
0
1
 
4
.3
 
4
.9
 
-5
9
.7
 
-5
8
.8
 
-5
8
.0
 
-5
7
.7
 
2
.9
 
2
.2
 
-5
3
.0
 
-5
3
.7
 
-1
.7
 
-0
.1
 
-3
5
.0
 
-3
5
.0
 
3
3
.8
 
-3
3
.6
 
-3
0
.7
 
-2
9
.8
 
1
.0
 
1
.2
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Table 5-5 Bias values in % for the cross calibration of indazole-core synthetic cannabinoids with indole-core 
synthetic cannabinoids, green columns indicate possible cross calibration partners 
A
ct
iv
e 
in
g
re
d
ie
n
t 
o
f 
Q
C
-s
am
p
le
s 
Substances for cross calibration 
MDMB-
CHMICA 
PB-22 
5F-PB-
22 
STS-
135 
BB-22 APICA 
AM-
2201 
UR-
144 
XLR-
11 
MMB-
2201 
5
F
-A
K
B
-4
8
 
5
4
.2
 
5
2
.3
 
-4
1
.2
 
-4
0
.2
 
-3
9
.3
 
-4
0
.1
 
4
7
.4
 
4
7
.2
 
-3
2
.2
 
-3
8
.2
 
4
3
.7
 
4
3
.7
 
-6
.4
 
-6
.8
 
-4
.7
 
-4
.8
 
-0
.2
 
-0
.3
 
4
5
.8
 
4
6
.2
 
5
F
-A
M
B
 
5
4
.6
 
5
4
.8
 
-4
1
.3
 
-4
1
.8
 
-3
9
.2
 
-3
9
.8
 
4
8
.7
 
4
8
 
-3
2
.5
 
-3
2
.2
 
4
2
.6
 
4
2
.8
 
-6
.4
 
-6
.2
 
-4
.6
 
-4
.4
 
-0
.7
 
-0
.4
 
4
6
.2
 
4
6
.3
 
5
F
-A
D
B
 
5
5
.7
 
5
5
.8
 
-4
0
.9
 
-4
0
.8
 
-3
9
.9
 
-3
9
.3
 
4
8
.7
 
4
8
.8
 
-3
2
.3
 
-3
2
.2
 
4
3
.6
 
4
3
.2
 
-5
.9
 
-5
.3
 
-4
.2
 
-4
.8
 
0
.4
 
0
.8
 
4
6
.6
 
4
5
.3
 
5
F
-S
D
B
-0
0
5
 
9
5
.7
 
9
5
.9
 
-2
3
.9
 
-2
3
.9
 
-2
2
.4
 
-2
2
.9
 
8
6
.8
 
8
1
.9
 
-1
5
.6
 
-1
5
.9
 
8
3
.8
 
8
1
.9
 
1
9
.1
 
1
9
.9
 
2
1
.4
 
2
1
.9
 
2
7
 
2
7
.9
 
8
4
.8
 
8
5
 
A
B
-
F
U
B
IN
A
C
A
 
6
1
.5
 
6
0
 
-3
8
.8
 
-3
8
.1
 
-3
6
.4
 
-3
5
.8
 
5
4
.6
 
5
5
.2
 
-2
9
.7
 
-2
9
.2
 
5
0
.6
 
5
0
.8
 
-2
 
-2
.2
 
-0
.2
 
-0
.1
 
4
.6
 
4
.1
 
5
2
.7
 
5
3
.6
 
F
U
B
-A
M
B
 
5
8
.4
 
5
8
 
-3
9
.7
 
-3
9
.8
 
-3
7
.6
 
-3
7
.8
 
5
1
.4
 
5
1
.9
 
-3
1
.2
 
-3
1
.3
 
4
6
.3
 
4
6
.8
 
-4
.3
 
-4
.9
 
-2
.2
 
-2
.3
 
2
.5
 
2
.2
 
4
9
.6
 
5
0
.1
 
M
A
B
-
C
H
M
IN
A
C
A
 
5
3
.2
 
-4
2
.2
 
-4
2
.2
 
-4
2
.5
 
-3
9
.9
 
-3
9
.9
 
4
6
.8
 
4
6
.2
 
-3
3
.1
 
-3
3
.2
 
4
0
.9
 
4
0
.2
 
-7
.2
 
-7
.2
 
-5
.5
 
-5
.5
 
-1
 
-1
.5
 
4
5
 
4
2
.3
 
T
H
J-
2
2
0
1
 
4
3
.9
 
4
3
.3
 
-4
5
.1
 
-4
5
.3
 
-4
3
.2
 
-4
3
.3
 
3
7
.7
 
3
6
.3
 
-3
7
.4
 
-3
6
.3
 
3
3
.5
 
3
3
.3
 
-1
2
.7
 
-1
3
.3
 
-1
1
.1
 
-1
1
.6
 
-6
.9
 
-7
 
3
6
 
3
7
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Table 5-6 Bias values in % for the cross calibration of indole-core synthetic cannabinoids with indazole-core 
synthetic cannabinoids, green columns indicate possible cross calibration partners 
A
ct
iv
e 
in
g
re
d
ie
n
t 
o
f 
Q
C
-s
am
p
le
s 
Substances for cross calibration 
AKB-48 5F-AMB 5F-ADB 
5F-SDB-
005 
AB-
FUBINACA 
FUB-
AMB 
Mab-
CHMINACA 
THJ-2201 
M
D
M
B
-
C
H
M
IC
A
 
-3
5
.6
 
-3
6
.3
 
-3
4
.5
 
-3
3
.8
 
-3
4
.5
 
-3
5
.0
 
-4
9
.9
 
-4
3
.3
 
-3
6
.7
 
-3
6
.8
 
-3
5
.7
 
-3
5
.9
 
-3
3
.4
 
-3
3
.0
 
-2
9
.2
 
-2
9
.2
 
P
B
-2
2
 
6
4
.6
 
6
3
.2
 
6
4
.5
 
6
3
.1
 
6
4
.5
 
6
5
.2
 
2
9
.6
 
3
0
.1
 
6
0
.4
 
6
1
.2
 
5
8
.5
 
5
7
.3
 
6
9
.2
 
7
0
.2
 
7
7
.6
 
7
7
.5
 
5
F
-P
B
-2
2
 
6
5
.6
 
6
4
.2
 
6
5
.5
 
6
4
.1
 
6
5
.5
 
6
4
.8
 
3
0
.4
 
3
1
.2
 
6
1
.5
 
6
2
.3
 
5
9
.6
 
6
0
.0
 
7
0
.3
 
6
9
.4
 
7
8
.7
 
8
0
.0
 
S
T
S
-1
3
5
 
-3
1
.5
 
-3
2
.2
 
-3
0
.9
 
-3
2
.1
 
-3
0
.9
 
-3
1
.2
 
-4
6
.0
 
-4
5
.2
 
-3
3
.0
 
-3
3
.2
 
-3
2
.6
 
-3
3
.1
 
-2
9
.1
 
-3
0
.2
 
-2
5
.5
 
-2
4
.1
 
B
B
-2
2
 
5
7
.0
 
5
6
.3
 
5
5
.0
 
5
4
.2
 
5
6
.8
 
5
4
.5
 
2
3
.6
 
2
4
.2
 
5
3
.0
 
5
3
.4
 
5
1
.1
 
5
2
.2
 
6
1
.3
 
6
2
.4
 
6
9
.3
 
7
0
.2
 
A
P
IC
A
 
-3
1
.4
 
-3
2
.3
 
-2
9
.5
 
-3
0
.0
 
-3
0
.4
 
-2
9
.8
 
-4
5
.8
 
-4
2
.3
 
-3
2
.8
 
-3
3
.4
 
-3
1
.6
 
-3
3
.1
 
-2
8
.7
 
-3
2
.1
 
-2
5
.1
 
-2
4
.8
 
A
M
-2
2
0
1
 
7
.9
 
8
.0
 
8
.1
 
8
.3
 
8
.4
 
9
.0
 
-1
4
.9
 
-1
3
.2
 
4
.3
 
4
.4
 
4
.2
 
4
.5
 
1
1
.3
 
1
2
.0
 
1
6
.9
 
1
7
.1
 
U
R
-1
4
4
 
4
.5
 
4
.2
 
4
.1
 
4
.3
 
4
.1
 
4
.0
 
-1
6
.8
 
-1
5
.7
 
3
.1
 
2
.9
 
3
.2
 
3
.4
 
9
.0
 
8
.6
 
1
4
.4
 
1
2
.3
 
X
L
R
-1
1
 
1
.3
 
1
.4
 
1
.8
 
2
.0
 
1
.9
 
2
.2
 
-2
0
.1
 
-2
2
.0
 
-1
.0
 
-1
.3
 
-1
.0
 
-1
.3
 
4
.6
 
4
.7
 
9
.8
 
1
0
.2
 
M
M
B
-2
2
0
1
 
-3
0
.9
 
-3
2
.1
 
-2
9
-6
 
-3
0
.1
 
-3
0
.1
 
-3
1
.4
 
-4
5
.4
 
-4
6
.7
 
-3
2
.4
 
-3
2
.8
 
-3
1
.6
 
-3
2
.1
 
-2
8
.4
 
-2
9
.4
 
-2
4
.8
 
-2
5
.9
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5.4.3 Application to casework samples 
The applicability of the studied crosslinks for quantification was examined analysing 24 
herbal mixtures with synthetic cannabinoids as active ingredient. First, GC-MS analyses were 
performed to determine the of the active ingredient of the samples. Afterwards, quantification 
was carried out via UPLC-DAD. Incense materials were purchased by the State Office of 
Criminal Investigation Rhineland-Palatinate (Germany) and the results which were obtained 
by UPLC-DAD were summarised in Table 5-7. Generally, identification was via retention 
time and UV spectra. First, the content of the active ingredient in the sample was calculated 
with the corresponding calibration curve of the target synthetic cannabinoid using the 
reference standard characterised previously by NMR. In addition, the active ingredient 
contents were calculated with other possible calibration curves of synthetic cannabinoids that 
were proven to be suitable for cross calibration (see Table 5-3 -, Table 5-6) by structural 
similarity and the slopes of the calibration curves. In Table 5-7, the name of the product, the 
active ingredient, the active ingredient content and the possible cross calibration with a 
synthetic cannabinoid are summarised together with the associated bias for each cross 
calibration. The calculated bias values were < 4.3 % and correspond well to the bias values 
given in Table 5-3 and Table 5-4. The five synthetic cannabinoids, that were identified to be 
suitable for general cross calibrations (5F-ADB, FUB-AMB, STS-135, PB-22, UR-144) 
during the method validation, showed acceptable bias values that ranged from -2.0-2.4 %, so 
that this small set of NPS can be regarded suitable for a broader application. In case of a 
newly emerged synthetic cannabinoids, the developed general procedure for cross calibration 
is: First, the active ingredient has to be identified with regard to its chemical structure with 
core, the linker and the tail by suitable methods (here, NMR and GC-MS. Second, based on 
this information, one of the five cross calibrators is chosen based on the highest structural 
similarity. Third, the analyte is quantified by UPLC-DAD. In general, the higher the 
similarity in the chemical structures (core, linker, linked group and tail), the higher the 
quantitative precision. Indazole-core synthetic cannabinoids with an amide-linker could be 
cross calibrated with FUB-AMB or 5F-ADB. Indole-core synthetic cannabinoids show a 
higher availability of possible linkers on the drug market and therefore, three different 
substances could be considered for cross calibration: PB-22 (ester-linker), STS-135 (amide-
linker), UR-144 (keto-linker). Due to the low number of substances with a carbazole-core 
synthetic cannabinoid investigated during this study, possible cross links could not be 
obtained. In case of unknown samples, which were not further characterised, the UVmax values 
give a first insight of the presence of an indazole, indole or carbazole-core synthetic 
cannabinoid. 
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Table 5-7 Cross calibration for casework samples (herbal mixtures) with active ingredient content of the 
substance investigated with the corresponding calibration line, the package label and the concentrations 
determined from the calibration curves of other cross calibrators with bias values (mean value); performance of 
the analysis of herbal mixtures using UPLC-DAD as explained in Section Materials and Methods 
ingredient 
content 
in% 
Package label 
Concentration (in %) determined from calibration curves of the cross-
calibrators 
5F-ADB 5F-AKB-48 5F-AMB 
AB-
FUBINACA 
FUB-AMB 
MAB-
CHMINACA 
6.57 Trank 6.41 6.52 6.32 6.73 6.71 
4.73 Amnesia 4.62 4.70 4.55 4.83 4.83 
1.28 Abduccion 1.25 1.27 1.23 1.31 1.31 
1.12 Armageddon 1.09 1.11 1.08 1.14 1.14 
0.89 
Hexen 
Sabbat 
0.87 0.88 0.87 0.91 0.91 
4.82 Trank 4.70 4.78 4.64 4.94 4.93 
3.16 Diablo 4 g 3.09 3.13 3.05 3.22 3.22 
4.52 
Hexen 
Sabbat 
4.41 4.50 4.35 4.63 4.62 
0.87 Hexenmeister 0.85 0.86 0.84 0.89 0.88 
8.31 Diablo 4g 8.14 8.24 7.99 8.51 8.49 
Bias (%) (mean value) -2.5 -0.8 3.8 2.4 2.2 
MDMB-CHMICA STS-135 APICA MMB-2201  
0.61 
Grazy 
Monkey 
0.60 0.59 0.59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.70 ICE Dragon 0.69 0.68 0.68 
0.73 No name 0.72 0.71 0.71 
4.34 
Deadman 
Walking 
4.27 4.20 4.22 
3.88 
Deadly 
Cobra 
3.81 3.78 3.76 
1.39 
Hexen 
Sabbat 
1.38 1.36 1.35 
2.38 
Deadly 
Cobra 
2.34 2.30 2.31 
3.45 Joker 3.43 3.35 3.34 
4.89 No name 4.81 4.72 4.76 
1.23 No name 1.21 1.19 1.19 
Bias (%) (mean value) < -1.7 < -3.5 < 3.1 
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ingredient 
content 
in% 
Package label 
Concentration (in %) determined from calibration curves of the cross-
calibrators 
5F-AMB 
AB-
FUBINCA 
5F-AKB-48 5F-ADB FUB-AMB 
MAB-
CHMINACA 
0.90 No Name 0.88 0.89 0.93 0.92 0.93 
Bias (%) -3.2 -2.2 2.5 1.0 1.8 
FUB-AMB 
AB-
FUBINCA 
5F-AKB-48 5F-AMB 5F-ADB 
MAB-
CHMINACA 
1.44 
Alabama 
Wildfire 
1.42 1.48 1.50 1.47 1.50 
Bias (%) -1.5 3.0 4.5 2.0 4.3 
MAB-CHMINACA 5F-AKB-48 5F-AMB 5F-ADB FUB-AMB  
0.83 
Keep calm 
and show 
middle finger 
0.86 0.84 0.82 0.81 
 
Bias (%) 3.3 0.9 -1.8 -2.0 
MMB-CHMICA 
MDMB-
CHMICA 
STS-135 APICA  
3.88 Bob Marley 4.05 3.96 3.86 
 
Bias (%) 4.3 2.1 -0.5 
5.5 Conclusion 
A UPLC-DAD method has been developed for the quantification of synthetic cannabinoids 
via cross calibration using only five calibrators to circumvent the quantification problem, 
when reference material of new occurring NPS products is not available. This approach 
represents a powerful tool for forensic toxicological applications. The sudden appearance and 
sometimes brief lifetime in the market of many of these novel legal highs or research 
chemicals does not justify organic synthesis or large-scale purification of reference material. 
Our study clearly indicates that similarities in the core, the linker and the tail structure of a 
synthetic cannabinoid were decisive for possible cross calibration with acceptable bias values 
≤ 5 %. We showed that only 5 cross-calibrator substances for indoles (5F-PB-22, STS-135, 
UR-144) and for indazoles (5F-ADB, FUB-AMB) were required. However, for carbazole-
based synthetic cannabinoids, the current number of seizures is too low to be able to define 
suitable cross-calibrators. The applicability of the study was proven by the successful 
quantification of 24 herbal mixtures containing synthetic cannabinoids as active ingredient 
using the cross calibrators defined during method development. The transferability of the 
method to new NPS will be carried out with the help of round robin testing (Germany) in the 
future. 
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6 Chiral discrimination of NPS using CE-DAD: 
Enantioselective separation of synthetic cathinone 
derivatives by capillary electrophoresis with UV 
6.1 Abstract 
Chiral discrimination of new psychoactive substances (NPS) and the related development of 
stereoselective analytical methods gain in importance in medicinal chemistry and forensic 
toxicology. Since R and S enantiomers contain the same substituent atoms or groups, they 
may have different affinity and intrinsic activity at receptor sites. Many synthetic cathinone 
derivatives are on the market as racemic mixtures due to the use of racemic precursors during 
the manufacturing process. 
In this study, the effective and fast enantioselective separation and detection of racemic 
mixtures of 36 synthetic cathinone derivatives using capillary electrophoresis with diode array 
detection is demonstrated. Two analytical methods were developed for different applications: 
First, a screening method for the simultaneous chiral analysis of synthetic cathinones was 
developed using reversed polarity and long-end injection mode with a maximum migration 
time of 26 min. The second method allows the fast determination of the enantiomeric excess 
of single synthetic cathinone derivative samples using normal polarity and short-end injection 
mode with an overall migration time of only 6 min. Both methods were validated using a 
suitable internal standard. The utility of this approach is demonstrated by the successful 
analysis of seized samples containing synthetic cathinone derivatives as active ingredients 
present in different bulking agents. 
6.2 Introduction  
Over the last decade, new psychoactive substances (NPS) have rapidly emerged in the 
European drug market as a “legal” alternative to conventional controlled substances.250 A 
challenging task for drug policies is how to effectively respond to the dynamic and constantly 
changing market of narcotics.
6
 Only a small number of NPS is controlled under drug law or 
equivalent legislation in European countries and even small modifications in the chemical 
structure of such listed substances already allow circumventing existing law.
1,7
 This 
circumstance induced a race between the legal prosecution and the producers as those strive to 
be one step ahead by generating new NPS products. 
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NPS have initially been designed to mimic established illicit drugs by imitating both 
appearance and consumption as well as the psychotropic effects. They are primarily sold via 
the internet as, inter alia, “research chemicals”, ‘‘designer drugs’, “legal highs” or “bath salts” 
and are usually manufactured as powder, pills or capsules.
27,251
 The focus of this study is on 
synthetic cathinone derivatives, the second most frequently seized group of new psychoactive 
substances, accounting for almost one-third of the total number of seizures in 2018.
250
 The 
five most frequently seized cathinone derivatives in 2016 were α-PVP, 4-CMC, 3-CMC, 4-
methyl-N,N-dimethylcathinone and 3-MMC (for abbreviations see Section 2.1.2 Reference 
materials).
250
 Synthetic cathinone derivatives are ß-ketoamphetamines and chemically related 
to cathinone, a naturally occurring stimulant in the khat plant (Catha edulis).
6
 In contrast to a 
classical drug class, the group of synthetic cathinone derivatives covers a broad spectrum of 
psychotropic effects caused by a multitude of possible chemical modifications in their 
chemical structures.
11
 Synthetic cathinone derivatives predominantly act as central nervous 
system stimulants to inhibit the actions of monoamine transporters such as dopamine 
transporter (DAT), noradrenaline transporter (NAT), and serotonin transporter (SERT) like 
amphetamine, methamphetamine, MDMA and cocaine.
11,27,303,304
 
Synthetic cathinone derivatives without a substitution on the benzene ring (e.g. 
methcathinone) show similar simulant effects to amphetamine acting as an inhibitor of DAT 
and NAT.
24
 Synthetic cathinone derivatives containing a methylenedioxy substitution in the 
benzene ring like methylone, ethylone, and butylone show actions similar to cocaine and 
MDMA.
305
 The non-selective inhibition of the monoamine reuptake is similar to the one of 
cocaine, which shows greater affinity to DAT than SERT. The inhibition of SERT by 
synthetic cathinone derivatives is similar to MDMA.
22,24,303,306-308
 Alongside of a stimulating 
effect, synthetic cathinone derivatives also show entactogenetic effects. Methamphetamine 
inhibits the preferential reuptake of catecholamines and liberation of dopamine, the same 
applies to synthetic cathinone derivatives with an alkyl or halogen substituent at any possible 
position of the aromatic ring (for example 4-MMC, flephedrone, and 4-CMC).
24,306
 Cutting 
agents can mimic, enhance, or potentiate the effects of controlled drugs of abuse. The most 
common reported cutting agents in synthetic cathinone derivative products are benzocaine, 
lidocaine and caffeine.
21,112,113,309
 
The synthesis of synthetic cathinone derivatives is analogous to the manufacture of 
amphetamine and MDMA-related substances including 1) reductive amination and 2) the 
Leuckart reaction, both with an aromatic ketone as precursor, 3) the use of aromatic aldehydes 
under Knoevenagel conditions
28
 and 4) the oxidation of the readily available pharmaceuticals 
pseudoephedrine and ephedrine.
27,29
 The routes 1) and 2) are the most common production 
processes found in clandestine laboratories. Here, the precursors like ketones contain a 
stereogenic center at the ß-carbon of the ketone structure.
5,30
 In 1929, Saem de Burnaga 
Sanchez published a synthetic strategy for mephedrone as the first cathinone starting with 
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1­tolylpropan­1­one as a precursor, which was α­brominated and then reacted with 
methylamine to produce racemic 4-methylmethcathinone.
31
 Today, almost all synthetic 
cathinone derivatives exist as racemic mixtures.
26
 
The R and S enantiomers show significant differences in their pharmacodynamic activity and 
their pharmacokinetic properties due to differences in their affinity or intrinsic activity at 
receptor sites.
144,145
 
As a consequence, chiral discrimination and the availability and development of 
stereoselective analytical methods gain in importance in medicinal chemistry, and forensic 
toxicology. The most common technique is HPLC-UV with chiral stationary phases
146-152
 or 
an achiral stationary phase with cyclodextrins (CDs) added to the mobile phase.
153
 Few 
studies used GC-MS for the chiral analysis of synthetic cathinone derivatives separating 
diastereomers after derivatization with chiral trifluoroacetyl-L-prolyl chloride
154-156
 or α-
methoxy-α-trifluoromethylphenylacetic acid.150 Several publications deal with the 
enantioselective separation of synthetic cathinone derivatives using capillary electrophoresis 
(CE-DAD or CE-MS) in combination with different CDs as chiral selector including ß-
CD,
157,158
 highly sulphated-ß-CD (HS-ß-CD),
154,159
 highly sulphated-y-CD (HS-y-CD).
160
 
Capillary electrochromatography with chiral stationary phases was also applied for the 
analysis of synthetic cathinone derivatives.
149,310
 
The chiral separation of synthetic cathinone derivatives was demonstrated to be feasible with 
further publications and different analytical techniques.
154,157-159
 In order to cope with the 
constant changes in NPS, screening methods have to be developed which are applicable to a 
large number of structurally different synthetic cathinone derivatives. To the best of our 
knowledge, no further publication demonstrated the simultaneous separation of a large 
number of analytes including the discrimination of enantiomers of structurally closely related 
substances like regioisomers which differ only in the C4 or C5 position of a halogen-atom in a 
pentyl-chain. The reported analysis times of HPLC-methods range from 12-85 min,
147,150-153
 
of GC-MS of 21-40 min
154-156
 and CE of 16-22 min.
154,157-159
 Analysis times may be shortened 
significantly when only one enantiomer pair is analysed (4-6 min) as shown e.g. by Weiß et 
al. and Aboul et al.
146,150
  
Besides the need for screening methods, the demand of fast methods ( < 10 min) increases to 
enable high-throughput of a large number of samples to obtain a fast estimate of the 
enantiomeric excess of one substance. Furthermore, almost no publication thematises the 
analyses of seized samples with possible bulking agents. Silva et al. described the analysis of 
real samples with presence of bulking agents but without demonstrating that the selectivity is 
high enough to discriminate between bulk and active agent.
152
 
The aim of this study is the effective and fast enantioselective separation and detection of 36 
newly emerged synthetic cathinone derivatives using CE-DAD. First, a chiral screening 
method for a large number of synthetic cathinone derivatives was developed using reversed 
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polarity after long-end injection. The utility of this approach was demonstrated by the 
successful analysis of seized samples containing bulking agents. Second, a high-throughput 
method enabling the fast determination of the enantiomer ratio for specific cathinone 
derivatives using short-end injection and normal polarity mode was established.  
6.3 Materials and Methods 
6.3.1 Chemicals 
All reagents were of analytical grade. Ultrapure water, purified by a Milli-Q gradient system 
(18.2 MΩ) from Millipore (Bedford, MA, USA), was used throughout this work. HS-ß-CD 
(ß-cyclodextrin, highly sulphated sodium salt with 12-15 mol per mol β-CD) was purchased 
from Sigma Aldrich (Steinheim, Germany) and ß-CD, HP-ß-CD (2-hydroxypropyl)-ß-
cyclodextrin) and HP-y-CD ((2-hydroxypropyl)-y-cyclodextrin) from Fluka (Buchs, 
Switzerland). During this study, two different lots of HS-ß-CD were used without a 
significant influence on the separation behaviour and strength. Sodium dihydrogenphosphate 
dihydrate (NaH2PO4*2H2O) and aqueous ortho-phosphoric acid 85 % (H3PO4) were obtained 
from Fluka (Buchs, Switzerland) and Riedel-de Häen, (Seelze, Germany). Aqueous sodium 
hydroxide solution (c = 1.0 M) was delivered by Agilent Technologies, Waldbronn and 
methanol from Merck (Darmstadt, Germany). 
6.3.1.1 Buffer preparation 
Phosphate buffers used for CE experiments were prepared daily and a pH of 2.3 was adjusted 
with 0.1 M orthophosphoric acid.  
For long-end injection, 2.5 % HS-ß-CD were dissolved in 25 mM phosphate buffer whereas 
3.5 % HS-ß-CD were dissolved in 35 mM phosphate buffer for short-end injection. All 
electrolyte solutions for the CE separation were stored in glass bottles at +4°C. 
6.3.1.2 Reference samples 
Reference material in this study partly derived from the EU-project “ADEBAR”. It is a 
Cooperation Project of the Federal Criminal Police Office, seven State Bureaus of Criminal 
Investigation and German Customs. Within this project, new drugs appearing on the illicit 
drug market in Germany from 07/2017 to 07/2019 were structurally characterised with 
different analytical techniques (1H-NMR, LC-MS, GC-MS, infrared spectroscopy, Raman 
spectroscopy) in order to generate analytical standards. This includes the synthetic cathinone 
derivatives dibutylone, 3-CMC, α-PiHP, DMC, MDPHP, methylone, 3-MMC, buphedrone, 4-
Cl-pentedrone, NEH. The other synthetic cathinone derivatives were obtained either by the 
Australian Government National Measurement Institute (Canberra, ACT, Australia) including 
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methedrone and NEC, or Lipomed (Cambridge, MA, USA) including MDBD, ethylone, 
which are shown in Table 6-1.  
Stock standard solutions of 1000 mg/L of each compound were prepared in ultrapure water 
and stored at +4 °C. From these standard solutions, working standard solutions with lower 
concentrations of all compounds were prepared daily by dilution with water and stored at 
4 ºC.  
6.3.1.3 Casework samples  
The seizures analysed in this study derived from the EU-project “ADEBAR” including 3,4-
DMMC, 4-BMC, 4-CBC, 4-CEC, 4-CMC, 4-MEC, 4MMC, 4-M-α-PPP, 4Cl-PVP, α-PHP, 
butylone, ephylone, methcathinone, NEHP and NEMNP. The samples α-PBP, α-PVP, 
pentedrone, MDPV, mexedrone and flephedron and mixtures of synthetic cathinone 
derivatives were taken from criminal cases provided by the State Office of Criminal 
Investigation Rhineland-Palatinate (Germany). All substances are summarised in Table 6-1. 
Several cutting agents were analysed including lidocaine (2-(diethylamino)-N-(2,6-
dimethylphenyl) acetamide), caffeine (1,3,7-trimethylpurine-2,6-dione) from Sigma-Aldrich, 
(Steinheim, Germany) and benzocaine (ethyl-4-aminobenzoate) from Fluka (Buchs, 
Switzerland). Each compound was dissolved in water (1000 mg/L) and working solutions 
were prepared by diluting in water:phosphate buffer (2:8), with the addition of the internal 
standard 1-(2-chlorophenylpiperazin (oCPP). Table 6-1 shows all synthetic cathinone 
derivatives investigated in this study.  
The enantiomeric excess (ee) determination was carried out using working solutions of 
50 mg/L in water:phosphate buffer (2:8) of each synthetic cathinone derivatives.  
6.3.1.4 Internal standards 
Different internal standards (1 mg/mL) were tested including 1-(3-chlorophenylpiperazin) 
monohydrochloride (mCPP), 1-(2-chlorophenylpiperazin) monohydrochloride (oCPP); (1-(4-
chlorophenylpiperazin) monohydrochloride (p-CPP) each with a purity of 98 %, which were 
purchased by Alfa Aesar (Karlsruhe, Germany)), phentermine, phenethylamine and chinin 
((R)-(6-methoxyquinolin-4-yl)[(1S,2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol) (Sigma 
Aldrich, Steinheim, Germany). Finally, oCPP was chosen (see Section 3.3 Selection of 
internal standard). 
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Table 6-1 Chemical structures of synthetic cathinone derivatives evaluated in this study 
 
Substance IUPAC names R1 R2 R3 R4 R5 
3,4-DMMC 
(RS)-1-(3,4-dimethylphenyl)-2-
(methylamino)propan-1-one), 
CH3 H CH3 H CH3 
3-CMC 
(RS)-1-(3-chlorophenyl)-2-
(methylamino)-1-propanone 
CH3 H H H Cl 
3-MMC 
(RS)-2-(methylamino)-1-(3-
methylphenyl)propan-1-one 
CH3 H H H CH3 
4-BMC 
(RS)-1-(4-bromophenyl)-2-
(methylamino)propan-1-one 
CH3 H Br H H 
4-CBC 
(RS)-1-(4-chlorophenyl)-2-( 
butylamino)propan-1-one 
C4H9 H Cl H H 
4-CEC 
(RS)-1-(4-chlorophenyl)-2-
(ethylamino)-1-propanone 
C2H5 H Cl H H 
4-Cl-
pentedrone 
(RS)-1-(4-chlorophenyl)-2-
(methylamino)pentan-1-one 
CH3 H Cl C2H5 H 
4-Cl-PVP 
(RS)-1-(4-chlorophenyl)-2-(1-
pyrrolidinyl)-1-pentanone 
pyrrolidinyl Cl C2H5 H 
4-CMC 
(RS)-1-(4-chlorophenyl)-2-
(methylamino)-1-propanone 
CH3 H Cl H H 
4M-α-PPP 
(RS)-2-(pyrrolidin-1-yl)-1-(p-
tolyl)propan-1-one 
pyrrolidinyl CH3 H H 
4-MEC 
(RS)-2-ethylamino-1-(4-
methylphenyl)propan-1-one 
C2H5 H CH3 H H 
4-MMC 
(RS)-2-methylamino-1-(4-
methylphenyl)propan-1-one 
CH3 H CH3 H H 
α-PBP 
(RS)-1-phenyl-2-(1-pyrrolidinyl)-
1-butanone) 
pyrrolidinyl H CH3 H 
α-PHP 
(RS)-1-phenyl-2-(pyrrolidin-1-
yl)hexan-1-one 
pyrrolidinyl H C3H7 H 
α-PiHP 
(RS)-4-methyl-1-phenyl-2-
(pyrrolidin-1-yl)pentan-1-one 
pyrrolidinyl H C3H7 H 
α-PPP (RS)-1-phenyl-2-(1-pyrrolidinyl)- pyrrolidinyl H H H 
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Substance IUPAC names R1 R2 R3 R4 R5 
1-propanone 
α-PVP 
(RS)-1-phenyl-2-(1-pyrrolidinyl)-
1-pentanone 
pyrrolidinyl H C2H5 H 
buphedrone 
(RS)-2-(methylamino)-1-
phenylbutan-1-one 
CH3 H H CH3 H 
DMC 
(RS)-2-(dimethylamino)-1-
phenyl-1-propanone 
CH3 CH3 Cl H H 
flephedrone 
(RS)-1-(4-fluorophenyl)-2-
(methylamino)propan-1-one 
CH3 H F H H 
MDPHP 
(RS)-1-(2H-1,3-benzodioxol-5-
yl)-2-(pyrrolidin-1-yl)hexan-1-
one) 
pyrrolidinyl H C3H7 H 
methcathinone 
(RS)-2-(methylamino)-1-phenyl-
propan-1-one 
CH3 H H H H 
mexedrone 
(RS)-3-methoxy-2-
(methylamino)-1-(4-
methylphenyl)propan-1-one 
CH3 H CH3 OCH3 H 
methedrone 
(RS)-1-(4-methoxyphenyl)-2-
(methylamino)propan-1-one 
CH3 H OCH3 H H 
NEC 
(RS)-N-ethylcathinone, (2-
(ethylamino)-1-phenylpropan-1-
one 
C2H5 H H H H 
NEH 
(RS)-N-ethylhexedron, (RS)-2-
(ethylamino)-1-phenylhexan-1-
one 
C2H5 H H C3H7 H 
NEHP 
(RS)-N-ethyl-heptedrone or, 2-
(ethylamino)-1-phenylheptan-1-
one 
C2H5 H H C4H9 H 
NEMNP 
(RS)-2-(ethylamino)-1-(4-
methylphenyl)-1-pentanone 
C2H5 H CH3 C2H5 H 
pentedrone 
(RS)-1-phenyl-2-
(methylamino)pentan-1-one 
CH3 H H C2H5 H 
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Substance IUPAC names R1 R2 R3 
butylone 
(RS)-1-(1,3-benzodioxol-5-yl)-2-
(methylamino)butan-1-one 
CH3 H CH3 
dibutylone 
(RS)-1-(benzo[d][1,3]dioxol-5-yl)-2-
(dimethylamino)butan-1-one 
CH3 CH3 CH3 
ethylone 
(RS)-1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)propan-1-one 
C2H5 H H 
ephylone 
(RS)-1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)pentan-1-one 
C2H5 H C2H5 
MDPV 
(RS)-1-(1,3-benzodioxol-5-yl)-2-
(pyrrolidin-1-yl)pentan-1-one 
pyrrolidinyl C2H5 
methylone 
(RS)-1-(1,3-benzodioxol-5-yl)-2-
(methylamino)propan-1-one 
CH3 H H 
MDBD* 
(RS)-(1-(1,3-benzodioxol-5-yl)-N-
methylbutan-2-amine 
CH3 H CH3 
*(this substance does not contain a keto group on α-carbon) 
6.3.2 Methodology 
The separation of synthetic cathinone derivative standards and seized drug samples was 
performed using the capillary electrophoresis system G1600 from Agilent Technologies 
(Waldbronn, Germany) equipped with a diode array detector (CE-DAD). Measurements were 
performed in 50 µm id uncoated fused silica capillaries with a total length of 68.5 cm and an 
effective length of 60.0 cm from Polymicro Technologies (Phoenix, AZ, USA). New 
capillaries were preconditioned by rinsing at 1 bar with 1.0 M NaOH for 15 min, water for 20 
min and electrolyte for 20 min. At the beginning of a measurement series, the capillary was 
conditioned by flushing at 1 bar for 10 min with 1 M NaOH, 15 min with water and 15 min 
with BGE. CE-UV detection was performed on-column using a wavelength of 230 nm. The 
column temperature was maintained at 20°C.  
The screening method was performed with hydrodynamic long-end injection mode 
(conventional injection) (50 mbar × 5 s). A constant voltage of -20 kV was applied so that the 
anode was located at the capillary outlet at the detector (reversed polarity) with a resulting 
current of 49 µA. Between runs, the capillary was equilibrated with BGE for 2 min.  
The high-throughput method was performed using a short-end injection mode by applying 
vacuum at the inlet (-50 mbar × 5 s) for sample injection. So the sample was injected from the 
end of the capillary nearest to the detector. The CE instrument was operated with positive 
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polarity (detection-end electrode was the cathode) with a voltage of +16 kV and a resulting 
current of 49 µA.  
6.4 Results and discussion 
6.4.1 Chiral separation optimisation 
6.4.1.1 Screening method 
The dynamically changing drug market and the generation of more and more structurally 
similar NPS necessitates highly efficient and selective analytical methods for the 
discrimination of structurally closely related compounds as envisaged in this study of 
cathinones. Cathinones differ in the substitution at their benzyl-ring (alkyl-, bromo-, chloro- 
or fluoro-substitutions), at the α and ß-carbon atoms or with regard to N-alkylations. In some 
cathinones, the nitrogen atom is part of a pyrrolidino ring. As cathinones can easily be ionised 
at the nitrogen atom, capillary electrophoresis is well suited to enable the separation of 
structurally closely related compounds. Upon addition of chiral selectors to the BGE, also 
chiral analysis is possible. The initial conditions for the separation were adapted from a 
previous study developed in this laboratory for the separation of (RS)-methamphetamine, 
(RS)-pseudo-ephedrine and (RS)-ephedrine.
311
 These compounds were separated within 30 
min using a 100 mM phosphate buffer at pH 2.5 with 2.5 % (w/v) HS-ß-CD as chiral 
selctor.
311
 For the analysis of synthetic cathinone derivatives, buffer concentration and pH, 
type and concentration of CD, and temperature were optimised. 
In prestudies, different CDs were tested to achieve baseline resolution of enantiomers using a 
mixture of four representative synthetic cathinone derivatives (DMC, dibutlyone, MDPHP, α-
PiHP). Separations were carried out using a 100 mM phosphate buffer (pH 2.3) containing 
0.5 %, 1.0 % and 1.5 % native CDs (ß-CD and γ-CD), 1.0 %, 1.5 % and 2.0 % 
hydroxypropyl-ß-CDs (HP-ß-CD and HP-γ-CD) and one highly sulphated CD (HS-ß-CD) 
with concentrations of 1.5 %, 2.0 % 2.5 % and 3.0 %. In case of y-CD and HP-y-CD, no 
separation of enantiomers was observed. ß-CD and HP-ß-CD were incapable to separate the 
enantiomers of DMC and dibutylone. Only the racemic mixture of synthetic cathinone 
derivatives where the nitrogen atom is part of the pyrrolidino ring (MDPHP and α-PiHP) 
showed different host-guest stability constants of R and S enantiomers resulting in different 
migrations times and/or differences in the effective electrophoretic mobility of the 
diastereomeric complexes.
312
 HS-ß-CD proved to be the CD of choice because all enantiomer 
pairs were separated. This combination of oppositely charged CDs and analytes proved to be 
successful in several other studies.
159,313-316
 At the acidic pH (2.3) chosen, the EOF is 
negligible and with the reversed separation polarity the anionic chiral selector migrates 
towards the anode, while the free analytes migrate towards the cathode. At a CD 
CE-DAD 
 
 
129 
 
concentration of 2.0 %, the equilibrium is shifted to the negatively charged CD-analyte 
complex so that the observed electrophoretic mobility is towards the anode.
317
 Thus, a 
complexation of the analytes with the negatively charged HS-ß-CD leads to a net migration 
towards the detector. Hence, short migration times indicate strong interaction with HS-ß-
CD.
318
 
Afterwards, the adjustment of the buffer composition, pH and the HS-ß-CD concentration 
were varied simultaneously. In order to avoid excessive Joule heating with noisy baselines 
due to refractive index changes of the electrolyte,
319
 75 mM, 50 mM and 25 mM phosphate 
buffers with 3.0 %, 2.5 %, 2.0 % and 1.5 % (w/v) HS-ß-CD were examined using a mixture of 
14 different racemic synthetic cathinone derivatives, listed in Table 6-2. The 
electropherograms for BGEs with different buffer concentrations are shown in Figure 6-1a-c. 
With increasing buffer concentration, the migration times increase accompanied by 
decreasing number of theoretical plates (N) with 150°000 for 75mM, 190°000 for 50 mM and 
210°000 for 25 mM each with 2.5 % HS-ß-CD. Not all racemates could be resolved at buffer 
concentrations of 75 mM and 50 mM. The concentration of the HS-ß-CD has a marked effect 
on both the resolution and the migration times as visible in Figure 6-1d-g. Higher 
concentrations of HS-ß-CD resulted in increased migrations times and at 2.5 % HS-ß-CD in a 
BGE of 25 mM phosphate all enantiomer pairs were at least partially separated (see Figure 
6-1f).  
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Table 6-2 Comparison of enantiomeric excess ee, the separation efficiency of long-end injection and short-end 
injection in terms of resolution R and plate number N determined for each enantiomer of synthetic cathinone 
derivatives 
Substance 
ee 
in 
% 
Long-end injection mode Short-end injection mode 
Time in min R N Time in min R N 
3-CMC 0.43 
11.9 
19.18 
180000 3 
7.34 
13000 
13.5 150000 3.5 13300 
3-MMC 0.40 
14.3 
4.13 
95000 3.9 
1.64 
10200 
14.8 140000 4 13100 
4-Cl-pentedrone 2.56 
16.9 
39.21 
210000 5 
12.76 
12700 
21.1 214000 6.6 14600 
α-PiHP 2.89 
12.9 
35.7 
140000 3.2 
9.75 
4600 
16.4 167000 4.6 6600 
buphedron 0.37 
15.3 
13.15 
148000 4.2 
5.86 
10900 
16.7 163000 4.9 12000 
dibutylone 2.83 
10.3 
11.21 
131000 2.4 
4.46 
10000 
11.2 153000 2.7 12500 
DMC 3.16 
13.6 
11.28 
237000 3.5 
3.21 
10400 
14.4 331000 3.8 11300 
ethylone 2.25 
11.5 
4.29 
228000 3.9 
1.44 
2000 
11.8 191000 4.2 1900 
MDBD 0.01 
9.1 
4.12 
93000 2.1 
1.55 
6700 
9.4 83000 2.2 7800 
MDPHP 0.35 
13.8 
11.78 
161000 3.6 
4.75 
10400 
14.9 157000 4.1 12600 
methylone 0.39 
11.3 
1.52 
177000 2.7 
1.43 
11200 
11.4 190000 2.8 17000 
methedrone 0.64 
10.5 
3.53 
100000 2.6 
1.36 
10300 
10.8 130000 2.7 12500 
NEC 1.39 
15.1 
10.23 
142000 4.2 
3.49 
9100 
16.1 172000 4.6 9700 
NEH 0.96 
23.5 
27.29 
204000 5.7 
10.57 
9700 
27.7 185000 6.4 7700 
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Figure 6-1 Electropherograms of 14 racemic mixtures of synthetic cathinone derivatives using the screening 
method (1+2 = (R/S)-MDBD, 3+6 = (R/S)-dibutlyone, 4+5 = (R/S)-mephedrone, 7+10 = (R/S)-methylone, 
8+9 = (R/S)-ethylone, 11+13 = (R/S)-3-CMC, 12+23 = (R/S)-α-PiHP, 14+17 = (R/S)-DMC, 15+19 = (R/S)-
MDPHP, 16+18 = (R/S)-3-MMC, 20+22 = (R/S)-NEC, 21+24 = (R/S)-buphedrone, 25+26 = (R/S)-4-Cl-
pentedrone, 27+28 = (R/S)-NEH) with a) 25 mM, b) 50 mM and c) 75 mM phosphate buffer concentration (pH 
2.3) with 2.5 % HS-ß-CD and d) 1.5 %, e) 2.0 %, f) 2.5 % and g) 3.0 % HS-ß-CD in 25 mM phosphate buffer 
(pH 2.3), long end-injection (50 mbar × 5 s) , -20 kV, detection wavelength 230 nm, sample concentration of 50 
mg/L in water/phosphate buffer (2:8) 
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Different temperatures were investigated including 20, 25, 30, 35 and 40 °C. With increasing 
temperature, the enantiomers of synthetic cathinone derivatives migrated faster through the 
capillary due to viscosity changes in the BGE, but a loss of separation efficiency and 
resolution was observed as well as elevated migration times (data not shown). For further 
experiments, the temperature was kept at 20 °C. The high separation selectivity reached in the 
final method came at the expense of a separation time of 26 min. 
6.4.1.2 High-throughput method 
Fast analysis of enantiomers or racemates in samples that contain only one active ingredient 
was accomplished using short end injection at normal polarity (vacuum injection). The 
effective and total length of the capillary were 8.5 and 68.5 cm. Using the optimised BGE 
from long end injection, the analysis time decreased from 27.7 to 6.4 min (factor 4.3), 
however at the cost of separation efficiency and resolution.
320
 Plater numbers decreased by a 
factor of 16.  
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Figure 6-2 Electropherograms of 4 mixtures of the 14 racemic mixtures of synthetic cathinones derivatives using 
the high-throughput method without comigration events (1+2 = (R/S)-MDBD, 3+4 = (R/S)-mephedrone, 
5+6 = (R/S)-ethylone, 7+8 = (R/S)-NEC, 9+10 = (R/S)-methylone, 11+12 = (R/S)-DMC, 13+14 = (R/S)-
buphedron, 15+16 = (R/S)-dibutlyone, 17+20 = (R/S)-α-PiHP, 18+19 = (R/S)-MDPHP, 21+22 = (R/S)-4Cl-
pentedrone, 23+24 = (R/S)-3-CMC, 25+26 = (R/S)-3-MMC, 27+28 = (R/S)-NEH) with 3.5 % HS-ß-CD in 50 
mM phosphate buffer (pH2.3), short-end injection (-50 mbar × 5 s), +16 kV, detection wavelength 230 nm, 
sample concentration of 50 mg/L in water/phosphate buffer (2:8), * indicates internal standard 
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The enantiomers of MDBD, methylone and ethylone were no longer separated. Different 
BGE concentrations (25-100 mM) and HS-ß-CD concentrations were tested (1.5-3.5 %, 
(w/v)) to improve resolution. Optimal resolution and peak shape were obtained at 3.5 % HS-
ß-CD in 50 mM phosphate buffer (pH 2.3) with all enantiomer pairs separated within 6.2 min, 
see Figure 6-2. Several synthetic cathinone derivatives comigrate including the enantiomer 
pairs of regioisomers (3-CMC, 4-CMC, 3-MMC and 4-MMC) or other synthetic cathinone 
derivatives like methedrone and methylone, α-PiHP and DMC, ethylone and 3-MMC and 
NEC and bupehdrone (Table 6-2). All enantiomers of the substances were baseline separated 
expect mephedrone and ethylone, which were only partially separated. 
6.4.2 Selection of internal standard 
The use of internal standards is sufficient to ensure the necessary precision and accuracy. 
Only a few forensic publications on CE thematise the use of suitable standards explicitly. 
Moini et al. applied amphetamine as internal standard with a BGE of formic acid and HS-γ-
CD in conjunction with (+)-18-crown-6-tetracarboxylic acid as chiral selectors.
160
 Li et al. 
described the separation 24 regioisomers of synthetic cathinone derivatives in a 80 mM 
phosphate buffer with HP-ß-CD within 18 min with nicotineamide as internal standard.
321
 In 
this study, several internal standards were tested with structural similarities to the investigated 
synthetic cathinone derivatives. These included phentermine, phenethylamine, chinin, pCPP 
and oCPP). Phentermine and phenethylamine had insufficient absorption at the detection 
wavelength of 230 nm due to their λmax of 260 and 250 nm. In addition, both substances 
migrated at 11-13 min in the screening method and thus interfered with several analytes (see 
Table 6-2). Chinin was detectable at 230 nm but impaired the analysis of MDBD. In case of 
CPP derivatives, only pCPP and oCPP were considered for analysis. mCPP is classified as a 
controlled substance in some European countries (Germany, Switzerland, Belgium, Denmark, 
Finland, Hungary and Netherlands). oCPP showed best performance with a migration time of 
10 min where no comigration with analytes occurred. 
6.4.3 Figures of merit  
Both methods were validated in terms of linearity, intraday and interday precision, sensitivity 
(LOD and LOQ) and accuracy using Valistat 2.0 (Avercon, Walldorf, Germany). All data are 
summarised in Table 6-3 and Table 6-4. The validation software was constructed for blood or 
urine analysis in GC-MS according to the guidelines of the Society of Toxicological and 
Forensic Chemistry (GTFCh) in consideration of DIN EN ISO 17025.  
Linearity of the method was confirmed via a 6-point calibration curve in the range of 5 to 
50 mg/L (n = 6) with correlation coefficients ranging between 0.9901 and 0.9981 for the 
screening method and 0.9900 to 0.9995 for the high-throughput method. All substances 
passed the outlier test (Grubbs-test), the variance homogeneity (Cochran-test) and linearity 
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test (Mandel-F-test). The sensitivity of the developed methods was investigated by the slope 
of the calibration curves according to DIN 32646. LODs and LOQs ranged from 1.04-
2.38 mg/L and 5.23-10.54 mg/L for the screening method and for the high-throughput method 
from 0.54-2.60 mg/L and 2.85-10.57 mg/L.  
The analytical intra-day (n = 6) and inter-day (8d/n = 3) precision were estimated with two 
quality control samples (QC1 and QC2) of each synthetic cathinone derivative covering the 
specified linear range of the procedure with 2 different concentration levels (0.01 and 
0.05 mg/L). The use of the internal standard oCPP improved precision for both methods from 
≤ 5.0 % for intra-day and ≤ 17.6 % for inter-day precision to 1.72 % for intra- and interday 
precision. The same applied to RSD values for the peak area of each compound signal which 
were improved from 1.9-16.4 % for intra-day and 3.7-27.5 % for inter-day precision to RSD ≤ 
6.0 % (screening method) and ≤ 7.0 % (high-throughput method) for intra- and inter-day 
experiments (see Table 6-3 and Table 6-4). The trueness was determined with a bias that 
ranged from -4.6 to 4.6 % for both methods (Table 6-4). In the State Office of Criminal 
Investigation Rhineland-Palatinate (Germany), a general measurement uncertainty of 10 % 
was stated to be acceptable for quantification results. This value stems from empirical values 
of quantifications of classical drugs which allow a maximum deviation of 5 % during 
measurements. Consequently, the scope of uncertainty was established to be a twofold 
deviation of 5 %. 
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Table 6-3 Validation of screening method with the usage of the internal standard in terms of linearity, 
sensitivity, precision and trueness (QC1 = 0.01 mg/L and QC2 = 0.05 mg/L) evaluated for each enantiomer of 
synthetic cathinone derivatives 
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Table 6-4 Validation data of the high-throughput method with the use of internal standard in terms of linearity, 
sensitivity, precision and trueness (QC1 = 0.01 mg/L and QC2 = 0.05 mg/L) determined for each enantiomer of 
synthetic cathinone derivatives 
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6.4.4 Applications 
6.4.4.1 Extension to other synthetic cathinone derivatives 
The range of substances was extended by analysing 22 further synthetic cathinone derivatives 
from seizures by separate injections of 3,4-DMC, 4-BMC, 4-CL-PVP, 4-CMC, 4M-α-PPP, 4-
MEC, 4-MMC, α-PHP, butylone, ephylone, methcathinone, NEHP, NEMNP, 4-CBC, 4-CEC, 
α-PBP, α-PVP, flephedrone, MDPV, mexedrone, pentedrone (for structures see Table 6-1). 
These samples were exclusively white powders without cutting agents present. The samples 
were analysed by both methods, migration time and resolution data are given in Table 6-5.  
Table 6-5 Enantiomeric excess ee, migration times and their corresponding chiral resolution R of synthetic 
cathinone derivatives in 22 seized samples for screening and high-throughput method 
Substance 
ee 
in % 
Screening method high throughput 
Time in min R enantiomers Time in min R enantiomers 
3,4-DMC 0.86 11.43 14.15 8.48 2.46 2.76 2.86 
4-BMC 2.74 11.31 11.48 2.39 2.94 3.00 0.71 
4-Cl-PVP 0.27 14.14 14.62 2.00 4.32 4.48 1.02 
4-CMC 0.34 13.17 13.96 9.32 3.58 3.88 3.01 
4-M-α-PPP 1.63 12.51 13.95 14.13 2.83 3.24 2.94 
4-MEC 0.00 14.09 15.53 5.38 3.53 4.02 2.91 
4-MMC 2.89 13.56 14.20 4.79 3.35 3.58 2.14 
α-PHP 0.29 15.63 18.16 22.02 4.96 6.29 7.40 
α-PPP 0.40 14.66 16.18 12.79 5.02 6.32 10.94 
butylone 0.42 11.21 11.83 3.59 2.54 2.74 1.58 
ephylone 0.69 13.81 15.83 21.51 3.18 3.62 2.88 
methcathinone 0.30 15.31 16.61 7.67 3.80 4.18 2.72 
NEHP 2.20 18.43 20.53 19.53 5.93 7.01 4.50 
NEMNP 0.03 14.96 19.97 46.73 4.16 6.21 15.10 
4-CBC 0.98 14.99 15.15 1.75 4.02 4.22 1.04 
4-CEC 0.58 16.12 16.37 1.76 3.71 3.96 1.45 
α-PBP 1.86 12.31 12.81 4.83 2.76 2.88 1.17 
α-PVP 0.43 15.20 16.05 7.09 3.42 3.63 2.20 
flephedrone 1.08 17.95 22.72 39.02 4.57 6.07 10.04 
MDPV 1.93 11.44 11.89 5.56 2.62 2.73 1.79 
mexedrone 1.19 21.79 29.40 39.55 5.13 7.26 13.02 
pentedrone 0.40 17.97 23.67 43.90 4.32 6.03 14.86 
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Every racemate was separated into its enantiomers with a migration time window of 11.1-29.4 
min for the screening method and 2.4-7.2 min for the high-throughput method. The reduction 
of migration times in case of short-end injection is accompanied with a loss in resolution by a 
factor of 3 (0.7-15.1 compared to 1.7-46.7 for the screening method). The high-throughput 
method shows limitations with regard to the simultaneous analysis of more than one synthetic 
cathinone derivative. Here, the screening method is the analytical technique of choice: In 
Figure 6-3, successful separation of the chiral separation of regioisomers is demonstrated 
including 3-CMC, 4-CMC and 3-MMC and 4-MMC.  
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Figure 6-3 Electropherograms of a) (R/S)-3- and (R/S)-4 CMC and b) (R/S)-3- and (R/S)-4-MMC with screening 
method; long end-injection(50 mbar × 5 s), -20 kV, detection wavelength 230 nm, sample concentration of 
50 mg/L in water/phosphate buffer (2:8)  
6.4.4.2 Exclusion of matrix effects by cutting agents 
Most cathinones are seized as powders and some of them contain cutting agents, mostly 
lidocaine, benzocaine and caffeine.
21,112,113,309
 Both, the screening method and the high-
throughput method were not impaired by these compounds as demonstrated by spiking 
experiments (see Figure 6-4). Migration times of lidocaine and benzocaine were 36 and 21 
min so that they could be identified with the same method. In contrast, caffeine, being neutral 
in the BGE chosen, was detected at 54 min. Presumably, the complexation with CD is very 
weak for this very polar compound. The possibility of analysing synthetic cathinone 
derivatives simultaneously with their cutting agents was proven by the analysis of three 
mixtures which were taken from criminal cases: Figure 6-4 shows the electropherograms of 
Mixture 1 (methylone and α-PBP), Mixture 2 (methylone, MDPV) both with benzocaine as 
cutting agents and Mixture 3 (methylone, α-PIHP, MDPHP). Clearly the identification of all 
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synthetic cathinone derivatives was possible via their migration times without interference 
from cutting agents. 
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Figure 6-4 Electropherogram of a) 14 racemic mixtures of synthetic cathinone derivatives using screening 
method (1+2 = (R/S)-MDBD, 3+6 = (R/S)-dibutlyone, 4+5 = (R/S)-mephedrone, 7+10 = (R/S)-methylone, 
8+9 = (R/S)-ethylone, 11+13 = (R/S)-3-CMC, 12+23 = (R/S)-α-PiHP, 14+17 = (R/S)-DMC, 15+19 = (R/S)-
MDPHP, 16+18 = (R/S)-3-MMC, 20+22 = (R/S)-NEC, 21+24 = (R/S)-buphedrone, 25+26 = (R/S)-4-Cl-
pentedrone, 27+28 = (R/S)-NEH) with possible cutting agents benzocaine, lidocaine and caffeine with following 
running conditions: 25 mM phosphate buffer (pH 2.3) with 2.5 % HS-ß-CD with * internal standard oCPP and 
b) detailed view of migration time window 9-18 min. long end-injection(50 mbar × 5 s) , -20 kV, detection 
wavelength 230 nm, sample concentration of 50 mg/L in water/phosphate buffer (2:8) 
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6.4.4.3 Applicability to other substance classes 
The developed screening method represents a versatile analytical tool for chiral separation of 
racemic mixtures of substances. In forensic investigation, the suitability of a screening 
method for more than one substance class is preferable. For this reason the enantioselective 
separation of further substance classes including piperazines and other phenethylamines was 
successfully tested also for methamphetamine, ephedrine and pseudoephedrine in less than 14 
min, as well as for regioisomers of mCPP including pCPP and oCPP in 11 min. The 
corresponding electropherograms are shown in Figure 6-5. Thus, due to the use of highly 
charged CDs, the developed method has a very broad application range for forensic drug 
analytics. 
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Figure 6-5 Electropherograms of seized samples measured with the screening method including a) Mixture 1 
((R/S)-methylone, (R/S)-MDPV and benzocaine), b) Mixture 2 ((R/S)-methylone and (R/S)-α-PBP) and c) 
Mixture 3 ((R/S)-methylone, (R/S)-α-PIHP, (R/S)-MDPHP) with * internal standard, long end-injection (50 
mbar × 5 s) , -20 kV, detection wavelength 230 nm, sample concentration of 50 mg/L in water/phosphate 
buffer(2:8) 
6.5 Discussion 
6.5.1 Interaction of synthetic cathinone derivatives with HS-ß-CD 
With an understanding of the interaction of specific structural elements of the cathinones, 
hints on the identification can be gained from migration times. ß-CDs are cyclic 
oligosaccharides consisting of seven glucopyranose units with a truncated cone providing a 
hydrophobic cavity.
322
 The glucose units are arranged in chair conformations leading to 
special arrangement of functional groups in the CD molecule. The secondary hydroxyl groups 
are located on the interior, the primary hydroxyl groups on the exterior of the cavity.
323
 Thus, 
the outer cavity is hydrophilic, making the CDs soluble in aqueous solution, while the inside 
cavity is apolar and hydrophobic (compared to water). Modifications of the CDs induce 
CE-DAD 
 
 
143 
 
different selectivity in enantiomeric separation. Highly sulphated ß-cyclodextrins are 
negatively charged in aqueous buffers. The interaction of synthetic cathinone derivatives with 
HS-ß-CD is often based on the insertion of their benzene ring into the CD cavity.
324
 Among 
all 36 chiral cathinones studied here, MDBD, an MDMA derivate with a 3,4-methylenedioxy 
substitution on the benzene ring, shows the strongest interaction with the chiral selector and 
thus the shortest migration time (see Figure 6-2). Next, the structurally related synthetic 
cathinone derivatives butylone, dibutylone, methylone, ethylone and ephylone are detected, 
also with a 3,4-methylenedioxy substitution on the benzene ring. The substance 3,4-DMMC 
shows similar migrations times with a 3,4-dimethyl substitution on the benzene ring (Table 
6-2 and Table 6-5). Obviously, both the degree and the position of substitution is decisive for 
the interaction with the CD. Substances with 1,4-chloro- and 1,4-methyl-substituted benzene 
rings migrate after 3,4-di-substituted substances (Figure 6-2). Another interesting point is the 
consideration of different halogenated substitutions on the benzene ring. In case of bromo, 
chloro and fluoro substituents, the molecular size seems to play a role as visible in the 
migration order 4-BMC (bromo) < 4-CMC (chloro) < flephedrone (fluoro) with otherwise 
similar structures (see Table 6-2 and Table 6-5). Longest migration times and thus 
comparatively weak interaction with CDs were observed for synthetic cathinone derivatives 
without a substitution on the benzene (see Figure 6-2).  
Regarding the substitution on the α-carbon atom (see position R4 in Table 6-1) it can be 
observed that the longer the alkyl-chain on the α-carbon the lower is the interaction strength 
between the CD and the analyte with migrations times of NEH (23.5 and 27.1 min), 4-Cl-
pentedrone (16.9 and 21.1 min) and NEHP (18.4 and 20.5 min). 4-Cl-pentedrone represents 
the only substance with a propyl group on the α-carbon (see Table 6-1). Mexedrone and 
methedrone have a similar chemical structure with an ether group on the position R4 
(mexedrone) and R3 (methedrone) and mexedrone migrates twice as long as methedrone. 
Substances with 1,3-substituted benzene rings such as 3-CMC or 3-MMC migrate faster than 
their 1,4-substituted counterparts such as 4-CMC and 4-MMC (see Figure 6-3). Whether the 
nitrogen atom is present in a pyrrolidino ring or not does not seem to influence CD interaction 
as related cathinones can be observed over the whole migration time window (see Table 6-2 
and Table 6-5).  
Regarding the interaction between enantiomer pairs and HS-ß-CD on the basis of their 
resolution values, several factors were involved such as hydrophobicity, configuration on the 
ß-carbon, configuration of the benzene ring, hydrogen bonding, dipole interactions and Van 
der Waals forces. Maximum apparent mobility differences and hence maximum resolution 
between the enantiomer pairs were investigated for benzene-cathinones, methylphenyl-
cathinones and chloro-phenyl-cathinones which possess an alkyl substitution (≥ C2H5) on the 
ß-carbon atom (see Table 6-1). NEMNP (R = 46.7), mexedrone (R = 39.5), 4Cl-pentedrone 
(R = 39.2) pentedrone (R = 43.9) and α-PIHP (R = 35.7) show the highest resolution values 
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due to alky-chain and thus increased lipophilicity (see Table 6-2 and Table 6-5). These 
substances show also the highest migration times thus, the migration time is directly 
connected to enantiomeric pairs resolution (see Table 6-2and Table 6-5). Iwata et al. 
discussed the influence of ring-substitution and configuration that occurs on the ß-carbon on 
the basis of amphetamine type stimulants. α-PIHP (R = 35.7) and α-PHP (R = 22.0) represent 
stereoisomers with different alkyl substituents on the ß-carbon.. The higher the observed 
degree of branching the higher the resolution of an enantiomeric pair. Resolution values 
decrease to R = 5.5-22.02 with synthetic cathinone derivatives differing in the substitution on 
the ß-carbon ≥ C2H5 in combination with a pyrrolidino ring including MDPV, α-PVP, 
MDPHP and α-PHP. The lowest resolution values were achieved for synthetic cathinone 
derivatives which possess an hydrogen atom on the ß-carbon. Especially chloro-ring-
substituted substances show resolutions < 2 followed by methyl-, methylenedioxy- and 
substances without ring-substitution (R = 3.5-8.5 when only one methyl-group is attached to 
the nitrogen-atom). In case of methyl-substitution on R1 and R2 like in dibutylone and DMC, 
resolution values rise to ~10. Thus, configuration on R1 and R2 change the lipophilicity of the 
substance and the inclusion of the molecules in the HS-ß-CD. 
 
To summarise, the substitution on the benzene ring of synthetic cathinone derivatives seems 
to be most important for the interaction strength with the CD visible in high migration times, 
whereas the substitution on the ß-carbon atom has more strongly influences chiral separation 
selectivity. 
6.5.2 Comparison of the screening method and high-throughput method with 
literature methods 
In this study, chiral separation of synthetic cathinone derivatives (Table 6-1) was performed 
with two different methods in CE-DAD, first, using conventional long-end injection in a 
screening method (Figure 6-1 and Figure 6-4) and second, a short-end injection method in a 
high-throughput method (Figure 6-2) for the fast determination of the enantiomeric excess. 
The results for both methods are summarised in Table 6-2. Optimal resolution and peak shape 
for all investigated synthetic cathinone derivatives was obtained with an additive 
concentration of 2.5 % HS-ß-CD in 25 mM phosphate buffer (pH 2.3) with an analysis time 
of 27 min using the screening method. A slightly higher concentration of HS-ß-CD of 3.5 % 
and in 50 mM phosphate electrolyte (pH 2.3) in combination with the short-end injection 
mode revealed a strongly reduced analysis time of only 6 min and thus gave rise to a high-
throughput for chiral analysis of single enantiomer pairs.  
The screening method has benefits in its improved chiral resolution and the possibility to 
simultaneously analyse more than one synthetic cathinone derivative. In addition, the chiral 
separation of enantiomers of structurally closely related substances like regioisomers which 
differ only in the C4 or C5 position of a halogen-atom in a pentyl-chain was achieved. The 
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number of theoretical plates was about a factor 21 smaller with the screening method to the 
high-throughput method.  
The advantages of the high-throughput method lie in the possibility to use a BGE of higher 
ionic strength and reduction of the EOF resulting in a faster analysis time, improved peak 
symmetry by enhanced stacking effects and by minimisation of sorption to the capillary wall 
and in decreased buffer depletion effects leading to higher precision. Both CE-DAD methods 
were able to determine the enantiomeric excess but the high throughput method allowed faster 
analysis (5.3 fold) and superior peaks symmetries. In Table 6-2 and Table 6-5 the migrations 
times and the resolution are given for various enantiomer pairs. The current stayed nearly 
constant during analysis, whereas in long-end injection, the current continuously increased by 
up to 10 µA over prolonged injection sequences (> 5 measurements).  
The use of an internal standard was shown to greatly improve migration time and peak area 
precision by a factor of 10 and 5, respectively. Regarding method validation, the calculated 
peak area and migration time precisions were nearly equal for both methods (see Table 6-4 
and Table 6-5). Reliable results were also achieved for peak areas with RSD ≤ 7.0 % for intra- 
and inter-day experiments in both CE-DAD methods. Likewise, LODs and LOQs were nearly 
equal for both methods (see Table 6-3 and Table 6-4).  
The broad applicability of the developed methods was proven by the successful analysis of 22 
casework samples (results given in Table 6-5). In case of samples with only one active 
ingredient, the high-throughput method is preferred for qualitative analysis with migration 
times below 7.3 min and enantiomeric resolutions of 0.7-15.1. The high-throughput method, 
however, requires a prior identification of the cathinone as comigration of different cathinones 
are possible (see Table 6-2 and Table 6-5). Especially, overlapping signals were observed for 
the regioisomers 3-CMC, 4-CMC, 3-MMC and 4-MMC and also other synthetic cathinone 
derivatives like methedrone and methylone, α-PiHP and DMC, ethylone and 3-MMC and 
NEC and buphedrone (Table 6-2 and Table 6-5). Thus, the analysis of unknown casework 
samples with more than one active ingredient or the presence of a cutting agent is only 
possible with long-end injection (Figure 6-4 and Figure 6-5). With this method, the 
regiosomers of 3-CMC, 4-CMC, 3-MMC and 4-MMC were well separated. To the best of our 
knowledge, no further publication demonstrated a method capable of the simultaneous chiral 
separation of 14 or more different racemic mixtures of synthetic cathinone derivative. Only 
Merola et al. 
158
 showed the chiral separation of 12 synthetic cathinones within 18 min using 
CE-DAD. In our study, we also demonstrated that the method’s selectivity is high enough to 
enable the analysis of casework samples with bulking agents.  
The broad applicability of the newly developed screening method was demonstrated not only 
for synthetic cathinone derivatives but also for other substance classes including the chiral 
separation of methamphetamine, ephedrine, pseudoephedrine and oCPP, mCPP and pCPP is 
possible (see Figure 6-6).  
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Figure 6-6 Stacked electropherograms of the enantioselective separation of a) (R/S)-pseudoephedrine, b) (R/S)-
ephedrine, c) (R/S)-methamphetamine and d) mCPP, oCPP, pCPP with * internal standard using the screening 
method, long end-injection (50 mbar × 5 s), -20 kV, detection wavelength 230 nm, sample concentration of 
50 mg/L in water/phosphate buffer (2:8)  
Usually, methods are published for single substance classes, only. The simultaneous chiral 
separation of methamphetamine, ephedrine and pseudoephedrine was reported using CD as 
chiral selector for CE-DAD analysis with migration times from 15 to 32 min.
325-328
 or within 
13-17 min using a cationic coating.
321
 Chiral GC-MS analysis after derivatisation to 
diastereomer or with chiral stationary phases was shown with retentions times of up to 
15 min, however with higher needs for sample preparation than in our CE-UV method.
329,330
 
Puetz et al. described baseline-separation of the three positional isomers of 1-
chlorophenylpiperazine by CE-ESI-MS utilising the chiral selector 2-hydroxylpropyl-beta-
cyclodextrin with migration times of 10-13 min. The application of non-volatile chiral 
selectors as additives in CE-ESI-MS contributes to loss of sensitivity due to ion suppression 
during the electrospray process and cause contamination of the mass spectrometer.
331
 With 
the broad applicability and selectivity, it was possible to characterise 20 synthetic cathinone 
derivative enantiomers pairs not covered by any other publication. In this study the ease of 
sample treatment and preparation of chiral buffer solutions without disturbing effects during 
detection makes the procedure highly effective for large sample cohorts.  
The advantage of the high throughput method compared to other chiral methods published is 
the possibility to estimate the enantiomeric excess of enantiomer pairs in less than 6 minutes 
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when the identity of the cathinone is known. Other publications reported migration times for 
synthetic cathinone derivatives between 10-20 min with CE applications
154,157,158,160
 and 12-85 
min for LC methods (studies including more than one substance) and 12-40 min for GC 
applications. In addition, with the CD just added to the BGE, the CE-DAD method is 
comparatively cheap without the need for chiral stationary phases. Direct analysis without the 
need for derivatisation as necessary for GC is possible.  
The need to use an internal standard was demonstrated by the determination of precision: 
RSD-values for inter-day precision rose by a factor of 5 for area values and by a factor of 10 
for migration time values without the usage of oCPP. Overall, accetable figures of merit were 
obtained. The enantiomeric excess was determined for all seized or purchased synthetic 
cathinone derivatives, which demonstrated that they all exist as (near-)racemic mixtures (see 
Table 6-2 and Table 6-5) with an enantiomeric excess (ee) in the range of 0.01-3.16 %. 
Considering the production conditions of synthetic cathinone derivatives, the formation of 
racemic or enantiopure products is possible. Enantiomeric excess values < 4 % represent a 
negligible deviation mainly caused by random errors. 
6.6 Conclusion 
In this study, the successful development of a screening and a high-throughput method for the 
chiral separation of 36 synthetic cathinone derivatives was demonstrated. Optimal separation 
conditions were achieved with 2.5 % HS-ß-CD in 25 mM phosphate buffer (pH 2.3) for the 
screening method and 3.5 % HS-ß-CD in 50 mM phosphate buffer (pH 2.3) for the high-
throughput method. The latter allowed ee determination in less than 6 min, due to the use of 
short-end injection. The reliability of both methods was proven by figures of merit on 
linearity, intraday and interday precision, sensitivity, LOD and LOQ, and accuracy. Not only 
the inclusion of newly emerged synthetic cathinone derivatives but also the structural 
diversity within this substance class was in the focus of this study. The utility of the approach 
was demonstrated by the successful analysis of 3 seized samples with mixtures of synthetic 
cathinone derivatives as active ingredients in the presence of bulking agents. The high-
throughput method was constructed for the fast analysis of samples with only one identified 
active ingredient in the sample. The time reduction was obtained at the cost of separation 
efficiency and resolution. The screening method had a longer analysis time but is better suited 
for the analysis of seized samples containing more than one active ingredient or cutting 
agents. The interaction of HS-ß-CD with possible substituents concerning the benzene ring, 
the ß-carbon or the nitrogen atom was discussed. The substitution on the benzene ring was 
shown to be a decisive parameter for the strength of the interaction of the analyte with the 
chiral selector. In forensic applications, this represents a helpful tool to characterise an 
unknown substance in order to predict the approximate structure of the substance by its 
migration behaviour. 
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7 Comparison of all analytical techniques applied 
7.1 On site analysis - best choice for a presumptive test 
The rapid emergence of novel NPS products requires the development of rapid and simple 
drug detection methods.
34
 There is a growing number of police agencies, prisons or other 
institutions being interested in on-site drug testing techniques.
34,250
 The choice of a suitable 
analytical technique depends on the application field. For the forensic sector, the advantages 
and limitations of different presumptive tests were described on the basis of defined criteria 
including analysis time, handling and work safety, sensitivity, specificity and identification 
power, selectivity, matrix tolerance, costs and the successful application.  
The main challenge for presumptive drug tests is the dynamically changing NPS-market and 
the resulting high diversity of new substances with similar chemical structures. To ensure the 
actuality of those tests, a constant production of new rapid drug tests and the maintenance of 
analytical databases are inevitable. 
Table 7-1 shows the analytical techniques and summarises their performance with regard to 
different criteria. In general, colour coding tests, immunoassays or Raman and IR 
spectroscopy were applied for roadside drug controls or drug controls in public institutions 
like airports.
87,137
 TLC is frequently used in laboratories of criminal investigation institutions. 
In Chapters 2 and 4, ion mobility and THz spectroscopy was introduced as an alternative 
presumptive test for NPS, which is rarely applied in drug testing and is limited to the 
detection of classical drugs. For NPS analytics, there are no publications and experimental 
data on the application of THz radiation. In this work, a novel approach for uncovering drug 
trafficking was tested: the detection of synthetic cannabinoids in postal packages using THz 
spectroscopy. The time domain and frequency domain spectra of 15 synthetic cannabinoids 
were tested (Table 4-3). The spatial distribution of the illicit drugs concealed in an envelope 
was obtained from terahertz multispectral transillumination images. To avoid imaging the 
whole packaging material, a pre-screening step was proposed, by first detecting the presence 
of powders in the envelopes and then defining the grid of measurement points.  
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Table 7-1 Properties of field devices for presumptive drug testing 
Immuno-
assays 
Colour 
coding 
TLC IMS Raman IR THz 
Analysis time (including sample preparation) 
    Pure powders  
Matrices:  
Pure 
powders 
 
Handling and work safety 
     
Laser application 
 
Not 
portable 
Sensitivity 
 
~ng/mL 
 
~ng/mL 
 
ng range 
 
ng-pg 
range 
 
Several mg 
 
Several mg 
 
Several mg 
Specificity (Need of reference standards) 
       
Selectivity 
       
Matrix tolerance 
 
Body 
fluids 
 
Pure 
powders 
 
 
Herbal 
mixtures, 
body fluids 
 
Herbal 
mixtures, 
papers, 
foods, 
cosmetic, 
several 
fluids 
 
Analysis 
through 
packaging 
material 
like glass 
or plastics; 
Pure 
powders, 
liquids 
 
Pure 
powders, 
liquids 
 
 
Pure 
powders 
Identification – applicability to closely related substances 
Comparison of all analytical techniques applied 
 
 
150 
 
Immuno-
assays 
Colour 
coding 
TLC IMS Raman IR THz 
       
Cost of the device 
3-10 € 5-10 € - 40.000 € 70.000 € 50.000 € 250.000 € 
Successful application 
Preliminar
y testing; 
Body 
fluids 
 
Preliminar
y testing; 
Only 
powders 
Suitable 
for 
laboratorie
s 
Purificatio
n step for 
subsequent 
analysis 
e.g. NMR 
Analysis 
in/on 
several 
matrices 
especially 
papers, 
herbal 
mixtures 
Powders; 
Analysis of 
unknowns, 
Hazardous 
materials 
Powders; 
Analysis of 
unknowns 
Powders; 
Benchtop 
device, not 
for on-site 
analysis 
 
The portable IMS was shown to be a powerful analytical method for the application in prisons 
to uncover NPS drug trafficking. The new IMS approach presented is an effective and non-
destructive presumptive test with a direct indication of the presence of synthetic cannabinoids. 
IMS was shown to allow a fast operation with a simple sample application by wiping the 
surface of a sample with a swab without any further sample preparation, even when rather 
complex matrices are present. In this study, all synthetic cannabinoids in demand were 
successfully detected by IMS when present as single substances, independent of the matrix. In 
contrast to other presumptive tests, the developed database is easily expendable to newly 
occurring narcotics. 
What opportunities or limitations do THz spectroscopy and IMS offer for the analysis of NPS 
in comparison to other presumptive tests like, immunoassays, colour coding tests, TLC, IR or 
Raman? As summarised in Table 7-1, the techniques previously mentioned are all easy to 
handle and thus, they do not require special analytical expertise and skills and can be applied 
by e.g. prison or police officers. An exception is given by the performance of TLC due to the 
need of basic analytical skills and specific laboratory equipment and chemicals. All  
techniques are portable and suitable for on-site analysis except for TLC and the THz 
spectrometer which is not portable and thus bound to firmly installed workplaces like the 
laboratory or mail distribution centre. Regarding health and safety, laser-based devices like 
Raman could include class 3b or 4 lasers which are notifiable and require a laser protection 
officer. Here, further technical instruction is inevitable to avoid health risks. Some portable 
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IMS use radioactive sources for the ionisation process which requires a radiation protection 
commissioner. In contrast, in this study, the portable IMS used a corona ionisation with 
battery systems to maintain the attractiveness of the IMS as a handheld device.  
The analysis time is another important aspect for selecting the most suitable presumptive test. 
Colour coding tests and IMS have the shortest analysis times with a direct indication of the 
presence of analyte. IMS enables a fast operation (10 sec) with a simple sample application by 
wiping the surface of a sample with a swab without any further sample preparation.
248
 For 
immunoassays, the reaction of a single antibody binding site with the antigen takes 8-10 min 
to reach equilibrium.
175
 In TLC, the sample preparation steps and the separation process take 
15-30 min depending on the solvent and the plate material.
2,27
 For Raman, IR or THz 
spectroscopy, the direct measurement of a powder is possible and takes only a few minutes 
including a subsequent library search. Some matrices may necessitate a further extraction 
process.
2,62,63
 
The presumptive tests discussed cover a wide range in terms of sensitivity (see Table 7-1): 
Immunoassays, colour coding tests and TLC are very sensitive and detect analytes in extracts 
at concentrations of 10-50 ng/mL. IMS is also a sensitive technique and the LODs estimated 
for the synthetic cannabinoids in this study are in the range of 0.7-3.6 ng. The high sensitivity 
also provides some limitations including 1) a limited dynamic response range, 2) the ease of 
contaminations with long residence times in the spectrometer, and 3) concentration-dependent 
response characteristics (Chapter 2.4.2). 
In comparison, spectroscopic methods require several milligrams of the sample to produce 
spectroscopic data with an acceptable S/N-ratio. IR is more sensitive than Raman 
spectroscopy followed by THz spectroscopy. However, IR and Raman devices are very 
specific due to spectral fingerprinting which allow the approximate elucidation of a chemical 
substance.
45
 According to the recommendations of the scientific working group for the 
analysis of seized drugs (SWGDRUG), Raman and IR spectroscopy are category A analytical 
techniques with maximum discriminating power.
45
 THz-spectroscopy is limited in the 
applicableness regarding the detection of known substances and the identification of a new 
substance. In Chapter 4 in Table 4-3, limitations of THz spectroscopy become visible in 
conjunction with the distinction of structurally closely related substances. Small changes in 
the structure of NPS do not significantly change the spectra (Figure 4-2).  
With regard to specificity, IMS performance is between the one of spectroscopic techniques 
and colour coding tests and immunoassays. In Chapter 2, it was shown that all synthetic 
cannabinoids of this study were successfully detected by IMS when present as single 
substances, independent of the matrix, although some publications reported that analytes with 
nearly the same chemical structure like the synthetic cannabinoids cannot be 
distinguished.
2,181
 An unambiguous assignment is not possible with IMS, because it is a 
preliminary test which gives a hint to a possible active ingredient based on the size and shape 
of the ion with the reduced mobility as the only parameter available for identification. Colour 
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coding tests or immunoassays are rapid, sensitive, inexpensive and easy but they lack 
specificity. There is a risk of false positive results due to cross-reactivity with other non-
targeted drugs of similar chemical structure including plant materials, flavours or bulking 
agents.
41,43,332
 Immunoassays are more specific than colour coding tests due to the antigen-
antibody recognition. Moreover, the differences in the chemical structure within one 
substance class caused by the increasingly diverse NPS-market would require the constant 
production of new rapid drug tests.
33
 There are also practical limitations to these tests, 
including the risk to produce false positive results due to wrong reagents and a 
misinterpretation of the resulting colour.  
The techniques discussed have one thing in common: the need for reference material. The 
presumptive tests require information on a substance like its chemical structure, Rf- value, 
colour changes, K0-values to guarantee a substance-specific detection. Raman and IR 
spectroscopy are the only technologies which are able to characterise the chemical structure 
according to specific bands in a spectrum as shown by the frequency tables in Chapter 3.4.3. 
With regard to selectivity, the IMS approach is the most suitable method to analyse mixtures 
of more than 3 substances (Figure 2-2). Here, the necessary resolution R > 0.75 of mobile 
IMS for identification was estimated to require differences in drift times and reduced mobility 
values of > 0.15 ms ( > 0.013 cm²V
-1
s
-1
) (Chapter 2.4.2.2). Smaller differences led to a 
positive identification only for the substance present at higher concentration. The analysis of 
mixtures with more than two constituents is challenging for spectroscopic techniques due to 
overlaying bands in the spectra. TLC is also quiet specific and selective and but many of the 
standards show the same or similar responses (Rf-value and colour) by applying same running 
conditions.
44
 Some immunoassays or colour coding tests were designed to detect a selection 
of substances simultaneously. In case of mixtures, immunoassays show different bands of the 
defined substance. For colour coding tests, the analysis of mixtures is difficult because the 
resulting colour is not well defined. 
Another important point is the matrix tolerance and the resulting applicability of the 
techniques: Immunoassays are designed to analyse NPS in body fluids like blood,
127
 serum
41
 
or urine
40
 whereas colour coding tests are dedicated to analyse pure powders. Both techniques 
are suitable for e.g. police roadside presumptive testing to determine on the one hand if an 
individual is operating a vehicle while under the influence of a controlled substance or the 
direct analysis of suspicious substances.
34
 TLC is applicable to different matrices like herbal 
mixtures or body fluids after extraction, thus it is often used as a purification step for 
subsequent identification with e.g. NMR. 
57,58
 
Spectroscopic techniques are less matrix tolerant and are primarily applied to powders or 
liquids. Powders or liquids can be analysed directly provided that there is a relative high 
concentration of the active ingredient in the sample matrix. The analysis of specific matrices 
like herbal mixtures requires a further extraction steps. IR-spectroscopy is more sensitive than 
Raman spectroscopy and with a further extraction step with methanol or acetone, it is possible 
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to obtain a good IR spectrum after evaporating the extract directly on the ATR diamond 
cell.
2,62,63
 In Chapter 3.3.2.1, a simple sample preparation technique was developed to extract 
synthetic cannabinoids from only 100 mg of the plant material using a solid/liquid extraction 
with dichloromethane followed by precipitation of the active ingredient by the addition of 
water. Recoveries proved sufficient for subsequent Raman analysis down to a content of 
0.5 % synthetic cannabinoid in the herbal matrix. To the best of our knowledge, sample 
preparation strategies to purify synthetic cannabinoids from the herbal matrix to avoid 
disturbance of fluorescence in Raman spectroscopy have not been published. The 
applicability of the presented approach was proven by the analysis of 60 casework samples. A 
large number of herbal mixtures were investigated to demonstrate the high matrix tolerance of 
the overall procedure. The extraction process developed is intended to be applied in the 
laboratory and not for on field drug testing.  
In contrast, the low sensitivity of THz analysis was shown to impede the analysis of NPS in 
different matrices like herbal mixtures, e-liquids or papers as discussed in Chapter 4.4.3. Due 
to the low amount of active ingredient in the matrix, the generation of spectral features was 
impossible. THZ spectroscopy is better suitable for the detection of pure powders when 
available in sufficient quantity, e.g. for the security inspection in public institutions like postal 
facilities to avoid potential health risk by contaminations. But THz spectroscopy show some 
more limitations including influences of different packaging materials and therefore the 
attenuation properties of the covering layers,
291,292
 the scattering effects related to the 
morphology and inhomogeneity of the substance surface,
288,293
 changes in the atmospheric 
humidity due to strong attenuation properties of water vapor during the measurements
294
 lead 
to low reliability of identification of this method.  
In comparison to spectroscopic techniques, portable IMS showed high matrix tolerance. In 
Chapter 2.4.2.3, the successful analysis of synthetic cannabinoids in herbal mixtures, papers, 
foods and cosmetics was successful, independent of the matrix. The analysis of active 
ingredients in highly viscous matrices (toothpaste or liquid soap) and medicinal products was 
challenging due to the poor solubility and inhomogeneous distribution of the NPS in the 
cosmetic products with their high viscosity. In general, it seems that only liquids with a low 
viscosity are amenable to the detection of synthetic cannabinoids. To the best of our 
knowledge, no other presumptive test is able to detect NPS which were impregnated onto a 
paper in less than 10 seconds. It can easily be used by non-scientists like prison or police 
officers as no special analytical expertise and skills are required. In contrast to other 
presumptive tests, the databases of spectroscopic techniques and IMS are easily expendable to 
newly occurring narcotics and therefore suitable for the detection of NPS. 
When selecting a presumptive technique for a specific application area, the costs have to be 
considered. Immunoassays and colour coding tests are quite cheap with 2-10 € but they are 
produced for a single use. The costs of the other devices used in this study were (in increasing 
order): IMS (~30.000 €) < IR spectrometer (~50.000 €) < Raman spectrometer 
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(~70.000 €) < THz spectrometer (~250 000 €) (data derived from the acquisitions of those 
techniques by State Office of Criminal Investigation Rhineland‐Palatinate).  
There are no presumptive tests which can cover all application areas, so that the choice of a 
suitable technique depends on the criteria discussed above and in Table 7-1. For the rapid 
identification of unknown chemicals in a field setting e.g. a crime scene or drug and explosive 
detection in e.g. airports the combination of IMS and Raman spectroscopy fulfils most of the 
criteria which are essential for on-site analysis. IMS is a suitable presumptive test for different 
matrices especially herbal mixtures, tobaccos, papers or diverse liquids and gives a hint on 
possible drug trafficking in prison. Suspicious objects can be analysed by wiping the surface 
of a sample with a swab without any further sample preparation. A more detailed 
characterisation of a substance is achieved using Raman spectroscopy. Here, the analysis of 
powders or liquids is preferred and the direct analysis through packaging materials like glass 
or plastics is possible. This is an important aspect when analysing hazardous materials. 
7.2 Identification strength: the characterisation of unknowns 
The dynamic NPS market and the resulting availability of a large number of structurally 
related substances, requires effective tools that provide the necessary structural information 
for their differentiation. According to the recommendations of the SWGDRUG, spectroscopic 
methods like NMR, Raman and IR spectroscopy as well as mass spectrometry are category A 
analytical techniques with maximum discriminating power.
45
  
NMR is the most important technique for structure elucidation and enables unambiguous 
identification of unknown and novel substances like synthetic cannabinoids or synthetic 
cathinone derivatives.
2
 Even the absolute configuration of closely related substances, e.g. 
stereoisomers is determined by 
1
H NMR and 
13
C NMR. The occurrence of specific isomers is 
another way to circumvent the level of legal penalties that conforms to a specific isomer 
which is listed in drug laws.
33
 Except for some rare cases it is not possible to interpret 
complex molecular structures with MS, IR and Raman spectroscopy alone. Major 
disadvantages of this technique are the cost of NMR spectroscopy and the required technical 
expertise, which leads to a limited applicability in routine analysis.
2
  
As a consequence, the benefits of the other techniques have to be fully exhausted. Mass 
spectrometry is not able to distinguish between isomers of a compound having the same 
charge-to-mass (m/z) ratio but it gives information about the molecular weight of a compound 
which is useful in determining a molecular formula for the substance of interest. Additionally, 
MS can tell you if the compound contains certain elements such as bromine and chlorine, 
based on the abundance of their isotopes.  
In comparison to NMR, IR and Raman spectroscopy have a lower identification power but 
due to the fingerprint region in the spectra, the active substances in seizures can be classified 
Comparison of all analytical techniques applied 
 
 
155 
 
according to their specific structural components. Closely related substances were 
differentiated in this study (Figure 3-5). 
In general, a prerequisite for the field application of spectroscopic techniques is the actuality 
and quality of the reference library. In Chapter 3.4.1, the analysis of synthetic cannabinoids 
and synthetic cathinone derivatives was carried out using three different Raman spectrometers 
including one benchtop device and two portable devices. We showed that the Raman spectra 
generated by different spectrometers were very similar using instrument in-built correlation 
algorithms to estimate the hit qualities. Thus, the maintenance of the database can be executed 
centrally and under uniform conditions, so that field analysis is possible with updated 
libraries. Furthermore, the identification power of Raman spectroscopy was demonstrated in 
various applications with a new approach especially for the challenging analysis of unknown 
samples, which were not part of the reference library (Chapter 3.4.4). A PCA model was 
developed to predict the NPS subgroup (synthetic cathinone derivatives and cannabinoids) of 
pure powders or seized samples (herbal mixtures). In Figure 3-2 and Figure 3-3, the formation 
of clusters according to characteristic main vibrational group frequencies visible from the 
loadings plots was observed. The prediction of NPS subclasses was quite accurate. In 
addition, not only the class of a substance but also the possibility to discriminate typical 
structural elements of the NPS including core, linker and linked group was examined. 
Comparing this approach to literature, nearly all other PCA models presented, focus on the 
discrimination of substance classes but not on the distinction of substances within one 
substance class.
71,84,91
 Based on the PCA loadings, specific group frequencies of NPS with 
high identification power were summarised in tables (see Table 3-3-Table 3-7) that enable the 
assessment of a possible chemical structure. Currently, spectral information on specific 
structural vibrations of NPS are limited and, to the best of our knowledge, have not yet been 
published in detail for synthetic cannabinoids (except for the synthetic cannabinoid 5F-
AMB
95
).  
It has been shown that Raman spectroscopy is broadly applicable: Raman spectroscopy is not 
only suitable as a preliminary tests (discussed in Chapter 3) but also the combination of 
Raman spectroscopy with the resulting vibrational frequency tables and a PCA model are 
useful for the characterisation of the chemical structure of unknown samples. 
7.3 Quantification of NPS 
After identification, one of the main analytical tasks in forensic toxicology is the 
quantification of the active ingredient due to the correlated penalties that are regulated in 
specific drug laws. Nearly every analytical technique affords time consuming calibration and 
requires that reference standards with a known purity are available.
32
 Due to dynamic NPS 
market, reference material is not always available. In Chapter 5, a new and unique alternative 
was demonstrated for the determination of active ingredients in casework samples, analysed 
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for the first time: The need for reference standards is circumvented by evaluation of possible 
cross calibrations between different but structurally related synthetic cannabinoids, some of 
which are readily available as reference material. Therefore, a quantitative screening analysis 
of 20 synthetic cannabinoids was developed using UPLC-DAD with maximal retention times 
of 10 min. First, the figures of merit of the method were investigated including linearity, 
sensitivity and precision for all substances (see Chapter 5.4.2.2). For cross calibration 
between synthetic cannabinoids, the accuracy and the corresponding bias values were 
determined by evaluating QC-samples of one substance with calibration curves from other 
synthetic cannabinoids. For quantification of casework samples in forensic applications, some 
general rules were deducted: The most important prerequisite for possible cross calibration 
are same core- and linker-groups present in the synthetic cannabinoids leading to a similar 
sensitivity given by the slope of the calibration curve. Similarities in the tail-group can be 
advantageous but are not a precondition. Overall, only five synthetic cannabinoids standards 
were shown to be necessary for the precise quantification via cross calibration, which also 
considerably reduces the effort and working time. For these substances, reference material is 
commercially available. In case of unknown samples, which were not further characterised, 
the UVmax values gave a first hint to the presence of an indazole, indole or carbazole-core 
synthetic cannabinoid (see Chapter 5.4.2.1).  
Compared to literature, hyphenated techniques dominate quantitative analysis of NPS in 
different matrices mainly including LC-MS
101,111,114-136
 and GC-MS,
36,44,47,54-58,62,100-114
 
followed by LC-UV.
2,140
 Several techniques were described in literature using reference 
standards that are suitable for the quantification of NPS. However, these methods fail, when 
an appropriate reference material is not available as in the case of the dynamic NPS market. 
Then, only NMR can be regarded as a suitable method due to absolute concentration 
determinations that can be assessed with calibrating on a reference substance that gives 
resonance signals in the exited frequency range. As the number of 
1
H atoms present is directly 
proportional to the signal intensity, other substances can be used for referencing.
49
 This 
provides a very high flexibility in the choice of reference substances. As mentioned in 
previous chapters, the availability of NMR spectrometers is limited for routine analysis due to 
the high cost and requirement of technical expertise.
2
  
The lowest cost-variant for quantification of substances is LC-UV but none the less, LC-MS 
is the technique of choice which is proven by the large number of publications. The usage of 
LC-MS offers higher identification strength towards LC-UV due to the resulting mass 
fragmentation patterns. What are the advantages of UV detection? There are two criteria, 
which have to be fulfilled using LC-UV, but not LC-MS: First the molecule must possess a 
chromophore or be tagged with a UV absorbing group and the target compound and co-
elutant must absorb at different wavelengths. Regardless of the type of NPS, every subclass, 
especially synthetic cathinone derivatives and synthetic cannabinoids are UV active. 
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Reported LODs and LOQs of the UPLC-DAD method were significantly higher than for 
chromatographic techniques coupled to mass spectrometry. In the presented study in Chapter 
5, LODs and LOQs ranged from 0.49-4.17 mg/L and 1.57-10.1 mg/L, respectively. This is 
sufficient for the analysis of powdered samples or herbal mixtures.  
LC-DAD shows some benefits for quantification: It is difficult to determine component purity 
from a chromatogram but a DAD detector can easily analyse peak purity by comparing 
spectra within a peak. DAD detectors are equipped with the software to perform peak purity 
assessment, thus providing an extra level of quality control to the LC-DAD analysis. In 
addition, LC-DAD measurements are well reproducible and precise which was proven by the 
low RSD values in the UPLC-DAD method developed in this thesis (Table 5-2).  
Method development for LC-MS is more sophisticated due to the more complex technical 
principle concerning the ionisation mechanism. Ion suppression by matrix components (e.g. 
salts, ion pairing agents) may impair quantification and reduce precision, if isotopically 
labelled standards are not available.  
7.4 Chiral discrimination of NPS  
The availability and development of stereoselective analytical methods gain in importance in 
clinical chemistry and forensic toxicology. Many synthetic cathinone derivatives are on the 
market as racemic mixtures due to the use of racemic precursors during the manufacturing 
process. Often, the R and S enantiomers show significant differences in their pharmacological 
activity.
144,145
 
We developed an effective and fast method for the enantioselective separation and detection 
of racemic mixtures of 36 synthetic cathinone derivatives using capillary electrophoresis with 
diode array detection and HS-ß-CD as chiral selector. The choice of HS-ß-CD in this study 
and the frequent application of CD is based on the beneficial properties such as UV 
transparency, availability, wide application range (polar, nonpolar, charged, uncharged 
analytes), and reasonable solubility in water.
333
 In addition, with the CD just added to the 
BGE, the CE-DAD method is comparatively cheap, as no chiral stationary phases is required. 
Moreover, improved chiral selectivity was observed many times with charged CDs compared 
with neutral ones as a result of an enhanced stability of host–guest complexes due to 
additional electrostatic (Coulomb) interactions of oppositely charged functional groups of 
complexing partners.
165,334
 At the acidic pH (2.3) chosen, the EOF is negligible and with the 
reversed separation polarity the anionic chiral selector migrates towards the anode, while the 
free synthetic cathinone derivatives migrate towards the cathode. 
In this study, two analytical methods were developed for different applications: First, a 
screening method for the simultaneous chiral analysis of synthetic cathinone derivatives was 
developed using reversed polarity and long-end injection mode with a maximum migration 
time of 26 min. To the best of our knowledge, no further publication demonstrated the 
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simultaneous separation of a large number of 36 analytes including the discrimination of 
enantiomers of structurally closely related substances like regioisomers which differ only in 
the C4 or C5 position of a halogen-atom in a pentyl-chain. Furthermore, almost no publication 
thematises the analyses of seized samples with possible bulking agents, demonstrated in this 
study. Silva et al. described the analysis of real samples containing bulking agents but without 
demonstrating that the selectivity is high enough to discriminate between bulk and active 
agent.
152
 
The second method allowed the fast determination of the enantiomeric excess of synthetic 
cathinone derivatives (present as single active agent) using normal polarity and short-end 
injection mode with an overall migration time of only 6 min. The advantage of the high 
throughput method compared to other chiral methods published is the possibility to estimate 
the enantiomeric excess of enantiomer pairs in less than 6 minutes when the identity of the 
cathinone is known. Other publications reported migration times for synthetic cathinone 
derivatives between 10-20 min in CE applications
154,157,158,160
 and 12-85 min for LC 
methods
146-153
 (studies including more than one substance) and 12-40 min for GC 
methods
150,154-156
.  
In general, CE is better suitable for chiral analysis than GC: The direct analysis is possible 
without the need for derivatisation as necessary for GC, which requires (i) the need of a 
functional group that can be derivatised, (ii) a high purity of the derivatization reagent and 
(iii) additional time-consuming sample preparation steps with the risk of racemisation under 
the reaction conditions.  
Comparing chiral LC and CE, CE offers a high separation efficiency, versatility, simplicity, 
short analysis time and good compatibility with aqueous samples.
335,336
 Benefits and 
limitations of LC and CE are discussed comparing the screening UPLC-DAD method in 
Chapter 5 with the chiral screening method using CE-DAD presented in Chapter 6. The 
efficiency of CE is higher than in LC with detected theoretical plates of 210°000 for the 
analysis of synthetic cathinone derivatives. Thus, chiral resolution is better in CE due to 
differences in molecular interactions and the electrically driven separation mechanism giving 
rise to the separation of the diastereomeric complexes, which is not possible in LC with chiral 
stationary phases. The overall sensitivity was nearly equal with LODs and LOQs ranged from 
0.49-4.17 mg/L and 1.57-10.1 mg/L for UPLC-DAD and 1.04-2.38 mg/L and 5.23-
10.54 mg/L for CE-DAD. In some research works, sensitivity of LC-DAD is higher as a 
consequence of the small volumes injected and the short detector path-length in CE compared 
with HPLC.
337
 The precision of both methods is nearly the same. The precision was 
determined with two quality control samples (QC) of high and low concentration, which were 
analysed daily (n = 2) on eight consecutive days. The intraday and interday imprecision was ≤ 
5.1 % for UPLC-DAD and ≤ 6.0 % for CE-DAD.  
Some advantages of CE-DAD emerged during the method development in this work: A series 
of different BGEs was tested since there is no need for a long equilibration time when 
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switching to a different chiral BGE. Furthermore, multiple chiral selectors were screened at a 
lower cost compared to the cost for the purchase of one or more chiral LC columns. Not only 
the overall expenses for the method development were reduced but also the low solvent and 
solute consumption makes CE more environmentally friendly. 
Conclusion 
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8 Conclusion 
In this thesis, the portfolio of new analytical methods was expanded to face the challenges 
given by the dynamically and constantly changing drug market of synthetic cannabinoids and 
synthetic cathinone derivatives, the most frequently seized NPS. These substances pose 
serious risks to public health and raised prominent challenges in law enforcement, executive 
apparatus, public health authorities and forensic and toxicology laboratories. 
One of the main difficulties is the limited availability for actual reference material of new 
emerging drugs in order to verify their identification and especially to enable their 
quantification by routine laboratory methods. Therefore, analytical data for various recently 
launched NPS are lacking which impedes the analysis of casework samples. Using seized 
material, analytical data and reference spectral libraries were updated to facilitate 
identification and to keep up with characterisation of newly emerged synthetic cannabinoids 
and cathinone derivatives using IMS, THz and Raman spectroscopy and UV/VIS-detection. 
A new approach was introduced for the characterisation and also identification of unknowns 
using Raman spectroscopy in Chapter 3: Tables with specific group frequencies were 
developed and used to discriminate typical structural elements of NPS in combination with a 
PCA model. Some of these NPS were characterised for the first time. We successfully 
identified synthetic cannabinoids in herbal seizures using a simple solid/liquid extraction of 
only 100 mg herbal material. 
For quantitative analysis, a possibility to reduce the need for reference material for 
quantification by UPLC-DAD: A similar slope of the calibration curve was present for 
synthetic cannabinoids with high structural similarity was observed, which allow 
quantification via cross calibration using a small set of only five substances, for which 
commercial reference standards are available (Chapter 5).  
The combination of the Raman spectroscopic method presented here with the cross calibration 
approach using UPLC-DAD is a powerful tool for both identification and subsequent 
quantification of NPS in different matrices. Thus, the low identification strength of DAD 
compared to MS or NMR could be balanced.  
The relevance of regioisomers and enantiomers has been increasingly recognised in NPS 
analysis, which requires special analytical methods. In Chapter 6, the successful development 
and validation of a screening and a high-throughput method for the chiral separation of 36 
synthetic cathinone derivatives was demonstrated using HS-ß-CD as chiral selector in CE-
DAD.  
Another important issue is the detection of NPS in public institutions to minimise serious 
risks to staff when handling NPS from drug trafficking. This requires analytical technique to 
be fast, simple to operate also by non-scientists and non-destructive for covert investigations. 
We here show that Raman and IMS are suitable for different aspects of NPS analysis: 
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Raman spectroscopy was shown to be suitable for both the application in the laboratory but 
for on-site analysis in public institutions (Chapter 3). According to chemometric evaluations, 
only one spectral reference library proved to be necessary for the discrimination of unknown 
substances, which can be transferred to other portable Raman systems independent of the 
vendor. This is a great advantage for field analytics at border controls or in for policing when 
centralised databases are available and maintained. 
In addition, two different presumptive tests were applied to detect NPS in different matrices 
or packaging material: A portable IMS was used to successfully characterise 25 different 
synthetic cannabinoids with regard to substance-specific K0 values and drift times which were 
reported for the first time. The IMS method was shown to be highly matrix tolerant. It was 
successfully applied to the analysis of herbal mixtures and paper impregnated with synthetic 
cannabinoids, as well as different cosmetics and liquid food samples (Chapter 2). 
For the first time, the analysis of synthetic cannabinoids was investigated using a THz-TDS 
spectrometer (Chapter 4). We here show that with the instrumentation used, the sensitivity 
only allows to analyse pure powders, however also packed in plastic bags and in envelopes. 
Monitoring was simplified and accelerated using transillumination images of packed 
materials, and then a suitable grid of measurement points for detailed analysis was chosen. 
Here, the importance of interfering parameters such as humidity in air, medium, salt form, etc 
should be tested by performing further in-field analysis with a large number of different 
samples. In addition, technical investigations have to be developed to avoid influences of 
atmospheric conditions. 
What is the impact of the presented laboratory and portable methods for the future NPS 
analytics for the criminal investigation institutions? 
Since October 2018, the IMS method developed in this thesis has been applied in a prison by 
trained prison officers in Rhineland-Palatinate and has guaranteed a fast and non-destructive 
analysis of suspicious samples with a direct indication of the presence of NPS. This became 
feasible because the IMS software was programmed to generate alarms and the actuality of 
the database is constantly updated centrally by the criminal investigation of Rhineland 
Palatinate. Due to the reliable measuring results, the project has expanded to all other prisons 
in Rhineland-Palatinate to analyse suspicious samples. In 2019, more than 200 samples were 
analysed. 
The Raman spectroscopic method as well as the chiral CE-DAD methods were developed 
inter alia for the EU-project ADEBAR. Within this project, the identification, the collection of 
analytical data and the distribution of reference material of newly occurring NPS is organised 
among criminal institutes in the EU. The spectral libraries of the Raman spectrometers used in 
this study were internally published on platforms for Criminal Investigations Offices in 
Germany. In addition, all spectra recorded with different devices were collected in an external 
database (KnowItAll software), which enables the analysis of casework samples in different 
institutions independent of the Raman spectrometer used.  
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Both chiral methods using CE-DAD were applied in the Federal Criminal Police Office 
(Wiesbaden, Germany) for the analysis of casework samples and for the characterisation of 
the samples from the ADEBAR project. 
The quantitative analysis of synthetic cannabinoids via cross calibrations using UPLC-DAD 
was incorporated into the routine analysis in the State Office of Criminal Investigation 
(Rhineland-Palatinate). Based on these results, the possibility to cross-calibrate NPS by a 
small set of commercially available reference standards will further be extended in upcoming 
EU-Project “ADEBAR plus”, which started in October 2019 as a follow up-project of 
ADEBAR. 
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